Year,LocationAbbr,LocationDesc,DataSource,PriorityArea1,PriorityArea2,PriorityArea3,PriorityArea4,Category,Topic,Indicator,Data_Value_Type,Data_Value_Unit,Data_Value,Data_Value_Alt,Data_Value_Footnote_Symbol,Data_Value_Footnote,Confidence_limit_Low,Confidence_limit_High,Break_Out_Category,Break_Out,CategoryId,TopicId,IndicatorID,Data_Value_TypeID,BreakOutCategoryId,BreakOutId,LocationID,GeoLocation
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.0,7.0,,,6.0,8.1,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.4,6.4,,,5.6,7.4,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.0,8.0,,,6.6,9.7,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),9.1,9.1,,,7.5,11.0,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),5.0,5.0,,,4.1,6.1,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.2,5.2,,,4.2,6.3,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.1,1.1,,,0.6,1.9,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.6,8.6,,,7.1,10.3,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),21.4,21.4,,,18.5,24.7,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.1,9.1,,,7.7,10.8,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),25.2,25.2,,,21.0,30.0,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.3,7.3,,,6.2,8.5,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),5.4,5.4,,,4.3,6.8,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.3,7.3,,,5.6,9.4,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.8,8.8,,,5.1,14.7,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.7,6.7,,,5.8,7.7,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.4,7.4,,,6.5,8.2,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.5,7.5,,,6.3,9.0,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.7,8.7,,,7.6,10.0,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),5.9,5.9,,,4.9,7.2,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.2,6.2,,,5.2,7.4,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.9,1.9,,,1.4,2.6,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.7,6.7,,,4.9,9.0,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),24.9,24.9,,,21.8,28.4,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.4,9.4,,,8.2,10.7,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),32.3,32.3,,,27.3,37.7,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.5,7.5,,,6.4,8.7,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.4,7.4,,,6.0,9.1,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),9.0,9.0,,,7.6,10.7,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.8,7.8,,,6.5,9.3,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.9,7.9,,,6.8,9.3,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),9.2,9.2,,,7.7,11.1,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.5,8.5,,,6.8,10.7,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.1,7.1,,,5.9,8.5,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.9,6.9,,,5.8,8.3,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,0.9,2.7,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.1,8.1,,,5.8,11.0,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),27.1,27.1,,,23.5,30.9,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),10.8,10.8,,,9.1,12.8,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),30.8,30.8,,,27.0,34.9,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.6,8.6,,,7.1,10.3,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.0,7.0,,,5.5,8.8,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.3,8.3,,,6.6,10.2,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),29.0,29.0,,,24.5,34.1,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.3,7.3,,,6.6,8.2,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.3,7.3,,,6.2,8.6,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.2,8.2,,,6.8,9.8,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.7,8.7,,,7.9,9.7,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.5,6.5,,,5.1,8.2,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.3,6.3,,,5.0,7.7,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.3,7.3,,,5.8,9.1,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),25.6,25.6,,,23.2,28.2,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.9,9.9,,,8.5,11.5,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),33.1,33.1,,,28.6,37.9,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.3,8.3,,,6.9,9.9,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.9,7.9,,,6.7,9.3,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.6,6.6,,,5.3,8.1,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.8,5.8,,,3.6,9.2,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.3,7.3,,,6.4,8.3,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.2,7.2,,,6.3,8.2,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.3,8.3,,,7.3,9.4,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.6,8.6,,,7.7,9.6,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.4,6.4,,,5.2,7.8,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.0,6.0,,,5.0,7.3,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.4,1.4,,,0.9,2.2,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.1,7.1,,,5.9,8.5,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),25.4,25.4,,,21.6,29.7,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.8,9.8,,,8.5,11.3,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),30.9,30.9,,,25.7,36.6,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.1,8.1,,,6.8,9.5,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.4,7.4,,,6.0,9.0,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.1,8.1,,,6.6,10.0,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.7,7.7,,,5.3,11.1,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.6,6.6,,,4.2,10.2,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.7,6.7,,,5.7,7.8,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.4,6.4,,,5.7,7.2,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),8.5,8.5,,,7.4,9.6,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,7.0,10.0,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),5.0,5.0,,,4.1,6.2,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.7,4.7,,,3.9,5.6,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.3,1.3,,,0.8,2.0,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.2,7.2,,,6.2,8.3,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),20.8,20.8,,,17.7,24.2,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.0,9.0,,,7.8,10.4,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),27.2,27.2,,,24.6,30.1,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.4,7.4,,,6.1,9.0,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.6,7.6,,,6.7,8.5,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.0,7.0,,,5.9,8.2,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,2.9,7.2,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.9,5.9,,,3.9,8.7,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.2,6.2,,,5.5,7.0,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.7,6.7,,,5.7,7.7,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.4,7.4,,,6.3,8.7,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.6,7.6,,,6.2,9.4,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),5.8,5.8,,,5.0,6.6,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.2,5.2,,,4.5,6.1,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.4,1.4,,,0.9,2.3,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),5.9,5.9,,,4.9,7.1,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),22.5,22.5,,,20.1,25.0,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),9.0,9.0,,,7.9,10.2,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),27.2,27.2,,,23.1,31.8,Age,75+,C1,T1,NH001,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.1,7.1,,,6.0,8.3,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.4,7.4,,,6.2,8.9,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.9,6.9,,,5.9,8.1,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,2.6,5.4,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.4,4.4,,,3.4,5.7,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.0,6.0,,,4.8,7.6,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),4.4,4.4,,,3.2,6.1,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.5,7.5,,,5.5,10.0,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.9,6.9,,,4.5,10.6,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),7.4,7.4,,,6.5,8.4,Overall,Overall,C1,T1,NH001,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.7,6.7,,,5.9,7.6,Overall,Overall,C1,T1,NH001,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),7.9,7.9,,,6.7,9.3,Gender,Male,C1,T1,NH001,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,7.2,9.8,Gender,Male,C1,T1,NH001,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.5,6.5,,,5.2,8.1,Gender,Female,C1,T1,NH001,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.8,5.8,,,4.6,7.2,Gender,Female,C1,T1,NH001,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.4,1.2,Age,20-24,C1,T1,NH001,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),1.3,1.3,,,0.8,2.1,Age,25-44,C1,T1,NH001,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.2,6.2,,,5.2,7.5,Age,45-64,C1,T1,NH001,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),25.2,25.2,,,22.5,28.2,Age,65+,C1,T1,NH001,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),10.0,10.0,,,8.8,11.3,Age,35+,C1,T1,NH001,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),8.7,8.7,,,7.4,10.1,Race,Non-Hispanic White,C1,T1,NH001,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),6.5,6.5,,,5.5,7.7,Race,Non-Hispanic Black,C1,T1,NH001,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.8,6.8,,,5.6,8.2,Race,Non-Hispanic Black,C1,T1,NH001,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.2,4.2,,,3.1,5.8,Race,Non-Hispanic Asian,C1,T1,NH001,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),4.0,4.0,,,2.6,6.1,Race,Non-Hispanic Asian,C1,T1,NH001,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,3.0,5.0,Race,Hispanic,C1,T1,NH001,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.9,4.9,,,3.9,6.1,Race,Hispanic,C1,T1,NH001,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Age-Standardized,Percent (%),6.1,6.1,,,4.4,8.3,Race,Other,C1,T1,NH001,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Major Cardiovascular Disease,Prevalence of major cardiovascular disease among US adults (20+); NHANES,Crude,Percent (%),5.1,5.1,,,3.5,7.5,Race,Other,C1,T1,NH001,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.9,3.9,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.6,3.6,,,3.0,4.2,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),5.5,5.5,,,4.4,6.8,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.9,4.9,,,4.0,6.1,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.9,1.9,,,1.4,2.7,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.4,2.7,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),5.0,5.0,,,3.9,6.2,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),9.9,9.9,,,8.1,12.1,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.7,4.7,,,3.9,5.7,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),12.1,12.1,,,9.7,15.1,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,3.3,4.5,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.4,3.7,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,1.9,4.9,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.6,3.9,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.5,3.5,,,2.9,4.1,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.5,4.5,,,3.6,5.5,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.0,5.1,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.9,3.3,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.0,3.3,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,1.9,5.3,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),12.0,12.0,,,10.0,14.4,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.7,5.5,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),15.1,15.1,,,12.1,18.8,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.7,3.7,,,3.0,4.6,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.4,4.5,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.0,4.0,,,3.0,5.2,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.2,4.9,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.0,4.0,,,3.3,4.8,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),5.2,5.2,,,4.1,6.7,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.9,4.9,,,3.7,6.5,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.2,4.1,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,2.1,3.9,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.1,6.8,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),13.3,13.3,,,11.0,16.1,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),5.5,5.5,,,4.5,6.8,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),14.1,14.1,,,11.0,17.9,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.7,5.5,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.3,4.2,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.6,3.6,,,2.7,4.9,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.8,4.5,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.5,3.5,,,2.8,4.3,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.7,4.7,,,3.8,5.8,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.4,4.4,,,3.3,5.8,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.0,3.6,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,1.9,3.5,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.5,5.2,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),11.9,11.9,,,9.3,15.1,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.7,4.7,,,3.7,5.9,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),14.9,14.9,,,12.4,17.9,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.1,4.1,,,3.2,5.4,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.0,3.9,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.4,3.4,,,2.4,4.6,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.8,3.7,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.8,3.9,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,3.4,5.1,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.4,4.4,,,3.6,5.2,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,2.0,2.7,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,2.1,3.0,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.5,3.9,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),11.5,11.5,,,10.1,13.1,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.4,4.4,,,3.8,5.2,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),13.8,13.8,,,11.4,16.5,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.8,4.3,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.4,4.4,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.5,3.5,,,2.6,4.5,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.7,4.7,,,2.8,7.9,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),5.3,5.3,,,3.1,9.0,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.5,3.7,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.5,3.9,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.7,5.7,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),4.6,4.6,,,3.8,5.5,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.7,1.7,,,1.2,2.3,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.3,2.5,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,2.9,5.0,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,7.0,10.0,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,3.4,5.1,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),10.7,10.7,,,8.5,13.3,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.9,4.6,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.1,3.9,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.4,4.0,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.6,3.8,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,2.5,3.4,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.7,3.7,,,3.0,4.4,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,3.1,4.7,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,1.9,3.4,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.7,3.1,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.1,3.8,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),10.7,10.7,,,8.2,13.8,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.3,4.3,,,3.7,5.0,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),10.5,10.5,,,8.3,13.3,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.7,3.7,,,2.9,4.6,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.8,2.9,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.8,3.2,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.4,1.4,,,0.9,2.1,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.2,1.2,,,0.7,1.9,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.1,3.0,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,1.8,4.0,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,1.4,4.6,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.8,4.0,Overall,Overall,C1,T3,NH004,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.5,3.7,Overall,Overall,C1,T3,NH004,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,3.1,5.1,Gender,Male,C1,T3,NH004,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,3.3,5.4,Gender,Male,C1,T3,NH004,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,1.9,3.4,Gender,Female,C1,T3,NH004,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.7,3.1,Gender,Female,C1,T3,NH004,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T3,NH004,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.4,0.8,Age,25-44,C1,T3,NH004,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.4,3.8,Age,45-64,C1,T3,NH004,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),11.1,11.1,,,8.9,13.7,Age,65+,C1,T3,NH004,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.8,5.5,Age,35+,C1,T3,NH004,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),13.2,13.2,,,10.2,16.9,Age,75+,C1,T3,NH004,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.1,4.9,Race,Non-Hispanic White,C1,T3,NH004,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.2,3.4,Race,Non-Hispanic Black,C1,T3,NH004,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.3,3.4,Race,Non-Hispanic Black,C1,T3,NH004,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),1.7,1.7,,,1.0,2.9,Race,Non-Hispanic Asian,C1,T3,NH004,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,1.0,2.8,Race,Non-Hispanic Asian,C1,T3,NH004,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,1.2,2.4,Race,Hispanic,C1,T3,NH004,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.1,2.1,,,1.6,2.8,Race,Hispanic,C1,T3,NH004,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,1.8,4.7,Race,Other,C1,T3,NH004,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.6,4.1,Race,Other,C1,T3,NH004,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.7,3.4,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.9,3.7,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.7,4.7,,,3.8,5.9,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,3.3,5.2,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.5,2.7,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.5,2.7,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.7,5.7,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),9.6,9.6,,,8.2,11.4,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.3,4.3,,,3.7,5.0,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),10.8,10.8,,,8.2,14.2,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,3.0,4.1,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,1.1,2.4,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.6,3.1,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.6,3.6,,,3.0,4.4,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.6,4.2,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.2,4.2,,,3.2,5.6,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.7,4.7,,,3.7,6.1,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,1.9,3.6,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.8,3.5,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),0.7,0.7,,,0.4,1.3,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,2.7,5.6,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),11.8,11.8,,,9.0,15.3,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.8,4.8,,,3.8,5.9,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),14.8,14.8,,,10.1,21.2,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.0,4.0,,,3.1,5.0,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.6,3.7,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.1,4.2,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.1,4.9,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,3.2,4.8,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.5,5.5,,,4.5,6.8,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),5.1,5.1,,,4.0,6.5,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.1,3.6,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.0,3.5,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.1,4.1,,,2.9,5.8,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),14.0,14.0,,,11.6,16.9,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),5.5,5.5,,,4.4,6.7,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),14.5,14.5,,,11.0,18.8,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.7,5.8,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.3,3.0,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.5,3.3,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.4,3.4,,,3.0,3.8,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.8,4.0,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.7,4.7,,,3.9,5.7,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),5.0,5.0,,,4.3,5.8,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.4,2.8,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.5,3.1,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.2,4.2,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),12.6,12.6,,,11.1,14.4,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.8,5.4,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),13.3,13.3,,,10.6,16.6,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.0,4.0,,,3.2,4.9,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.3,3.0,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.7,3.4,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.9,3.8,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.3,3.3,,,2.8,3.7,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.9,4.9,,,4.1,5.9,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.8,4.8,,,4.0,5.6,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.7,2.4,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.6,2.2,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.8,4.5,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),11.4,11.4,,,9.3,13.9,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.9,5.2,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),11.8,11.8,,,9.2,15.0,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,3.3,4.4,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.3,1.3,,,0.9,2.0,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.4,1.4,,,1.0,2.1,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.6,3.8,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.5,3.5,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.5,4.5,,,3.8,5.4,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.5,5.7,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.9,1.9,,,1.4,2.5,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.7,1.7,,,1.3,2.3,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.1,4.5,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),10.6,10.6,,,9.3,12.1,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.3,4.3,,,3.6,5.2,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),13.5,13.5,,,10.5,17.2,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.7,3.7,,,3.0,4.7,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.5,2.8,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.8,2.8,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.2,3.9,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.1,3.5,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.7,3.7,,,2.8,4.9,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,2.7,5.4,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.5,2.9,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.8,1.8,,,1.3,2.6,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.3,3.6,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),11.2,11.2,,,8.6,14.4,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.0,4.0,,,3.1,5.2,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),14.1,14.1,,,10.6,18.5,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.4,4.9,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,1.4,2.2,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.5,2.4,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.1,2.1,,,1.2,3.4,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.0,3.1,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.6,1.6,,,0.9,2.9,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.4,3.9,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,1.9,4.3,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,1.8,4.0,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.7,3.7,,,2.9,4.6,Overall,Overall,C1,T4,NH003,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),3.3,3.3,,,2.6,4.2,Overall,Overall,C1,T4,NH003,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),4.3,4.3,,,3.4,5.3,Gender,Male,C1,T4,NH003,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.7,5.7,Gender,Male,C1,T4,NH003,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,1.9,4.2,Gender,Female,C1,T4,NH003,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.6,3.7,Gender,Female,C1,T4,NH003,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T4,NH003,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T4,NH003,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.1,4.5,Age,45-64,C1,T4,NH003,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),13.0,13.0,,,10.4,16.2,Age,65+,C1,T4,NH003,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.9,4.9,,,3.9,6.2,Age,35+,C1,T4,NH003,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),15.7,15.7,,,12.1,20.2,Age,75+,C1,T4,NH003,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,3.5,5.9,Race,Non-Hispanic White,C1,T4,NH003,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.0,3.3,Race,Non-Hispanic Black,C1,T4,NH003,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.0,3.5,Race,Non-Hispanic Black,C1,T4,NH003,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.1,3.1,Race,Non-Hispanic Asian,C1,T4,NH003,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C1,T4,NH003,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,0.9,2.4,Race,Hispanic,C1,T4,NH003,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.3,2.9,Race,Hispanic,C1,T4,NH003,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T4,NH003,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.7,2.6,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.8,2.8,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.0,3.4,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.8,3.1,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.9,1.9,,,1.3,2.7,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.3,2.7,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.0,4.1,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),6.7,6.7,,,5.3,8.4,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.3,3.5,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),10.3,10.3,,,8.0,13.2,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.7,2.9,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,1.5,4.8,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.7,2.9,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.9,3.0,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.0,3.3,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.6,3.1,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.5,3.0,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.7,3.0,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),8.5,8.5,,,6.8,10.5,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.4,4.1,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),10.9,10.9,,,7.7,15.1,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.6,3.2,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.0,4.6,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.7,3.7,,,2.6,5.1,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.1,3.2,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.2,3.2,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.2,4.0,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.0,3.7,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.9,3.3,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.9,3.1,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.4,3.3,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),10.2,10.2,,,8.6,12.0,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,3.0,4.4,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),12.3,12.3,,,10.1,14.9,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.6,3.6,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.4,3.2,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.7,3.7,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.2,3.0,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.2,3.0,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.7,3.7,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.5,3.7,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.8,2.7,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.1,2.1,,,1.6,2.6,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.6,3.4,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),9.5,9.5,,,7.8,11.6,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,3.1,4.2,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),10.9,10.9,,,8.3,14.0,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.3,3.3,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.6,5.0,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),4.2,4.2,,,3.2,5.4,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.9,3.0,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.8,2.9,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.3,3.3,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.2,3.2,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.4,3.1,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.3,2.9,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.9,1.9,,,1.5,2.6,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),9.0,9.0,,,7.0,11.4,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.5,4.1,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),11.1,11.1,,,8.3,14.8,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.5,3.2,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,2.9,4.9,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),4.1,4.1,,,3.2,5.4,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),5.1,5.1,,,3.3,7.9,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),4.1,4.1,,,2.6,6.2,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.6,2.5,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.5,2.3,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.8,2.8,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.7,3.0,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.7,1.7,,,1.3,2.3,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.6,1.6,,,1.2,2.1,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.0,2.0,,,1.4,3.0,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),6.3,6.3,,,4.9,8.1,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.1,3.4,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,6.3,11.2,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.6,3.0,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.1,4.2,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.3,4.3,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.1,3.6,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,2.0,3.2,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.6,3.5,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.6,3.7,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.4,3.8,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.1,3.4,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,1.0,2.2,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),10.5,10.5,,,7.5,14.4,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.8,4.8,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),12.9,12.9,,,9.5,17.4,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.2,3.8,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.1,4.4,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.3,3.3,,,2.3,4.6,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.0,1.0,,,0.7,1.6,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),0.9,0.9,,,0.5,1.4,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.2,2.2,,,1.3,3.8,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.3,3.0,Overall,Overall,C1,T5,NH002,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,2.0,2.8,Overall,Overall,C1,T5,NH002,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.7,3.3,Gender,Male,C1,T5,NH002,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.8,3.4,Gender,Male,C1,T5,NH002,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.2,3.2,Gender,Female,C1,T5,NH002,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,2.0,2.9,Gender,Female,C1,T5,NH002,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T5,NH002,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T5,NH002,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.7,3.0,Age,45-64,C1,T5,NH002,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,7.0,10.1,Age,65+,C1,T5,NH002,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,3.0,4.1,Age,35+,C1,T5,NH002,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),11.1,11.1,,,9.2,13.3,Age,75+,C1,T5,NH002,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.5,3.4,Race,Non-Hispanic White,C1,T5,NH002,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.4,4.7,Race,Non-Hispanic Black,C1,T5,NH002,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),3.5,3.5,,,2.5,4.8,Race,Non-Hispanic Black,C1,T5,NH002,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C1,T5,NH002,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C1,T5,NH002,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,0.9,2.7,Race,Hispanic,C1,T5,NH002,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),1.9,1.9,,,1.2,3.1,Race,Hispanic,C1,T5,NH002,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T5,NH002,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.8,2.9,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.9,3.2,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.8,3.2,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.6,2.8,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.9,3.3,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.9,3.4,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.4,3.5,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),8.7,8.7,,,6.9,10.9,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.5,4.2,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),10.6,10.6,,,8.0,13.9,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.8,3.3,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.5,3.5,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,3.3,4.6,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,2.1,2.8,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.3,3.0,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.2,3.2,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.8,2.8,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.0,3.4,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.1,3.5,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.9,0.9,,,0.5,1.5,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.2,3.4,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),9.0,9.0,,,7.9,10.4,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.8,3.9,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),12.8,12.8,,,10.5,15.5,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,2.1,3.0,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.3,4.8,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),4.0,4.0,,,2.7,5.7,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.2,3.4,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.2,3.4,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.7,2.9,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.4,2.4,,,1.9,3.1,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.1,3.1,,,2.5,3.9,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.5,4.0,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.8,3.5,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),8.8,8.8,,,7.6,10.2,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.9,4.6,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),10.8,10.8,,,9.0,12.9,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.2,3.6,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.6,4.7,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),4.1,4.1,,,3.1,5.5,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.3,3.7,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,2.4,3.5,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.0,3.3,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.7,3.3,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.5,4.4,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.5,4.1,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.1,3.9,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),9.8,9.8,,,8.1,12.0,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.1,4.9,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),14.1,14.1,,,10.8,18.3,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.1,3.1,,,2.3,4.1,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.4,4.5,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,3.0,4.9,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.6,4.0,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.2,3.2,,,2.5,3.9,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.4,3.3,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.3,3.3,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.6,3.6,,,2.6,5.1,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.4,3.4,,,2.5,4.7,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.0,4.2,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),11.3,11.3,,,8.8,14.6,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),4.3,4.3,,,3.4,5.5,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),13.9,13.9,,,9.9,19.3,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.7,4.6,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.3,6.0,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),5.0,5.0,,,3.7,6.7,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.2,3.0,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,2.2,2.9,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,2.0,3.1,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.9,3.2,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.2,3.3,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,2.1,3.1,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.3,1.1,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.1,3.1,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),8.2,8.2,,,6.4,10.5,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,3.0,4.1,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),11.7,11.7,,,9.9,13.8,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.1,3.3,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,3.1,4.6,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),4.0,4.0,,,3.3,4.9,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.2,2.2,,,1.3,4.0,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,1.9,4.6,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.2,3.2,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,2.3,3.5,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.0,3.6,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.5,2.5,,,1.9,3.4,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,2.2,3.4,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.0,3.0,,,2.4,3.8,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.7,2.7,,,2.0,3.7,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),8.9,8.9,,,7.7,10.3,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,3.0,4.7,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),11.5,11.5,,,9.2,14.3,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.6,2.6,,,2.1,3.3,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),4.5,4.5,,,3.5,5.8,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),4.8,4.8,,,3.6,6.2,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.2,3.3,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),1.8,1.8,,,1.0,3.1,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.1,2.1,,,1.6,2.7,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.7,2.7,,,2.2,3.4,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.8,3.8,,,2.4,5.9,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.5,3.5,,,2.0,5.9,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.5,3.3,Overall,Overall,C1,T6,NH005,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.6,2.6,,,2.3,3.0,Overall,Overall,C1,T6,NH005,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.3,2.3,,,1.7,3.1,Gender,Male,C1,T6,NH005,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.4,2.4,,,1.8,3.2,Gender,Male,C1,T6,NH005,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.6,4.2,Gender,Female,C1,T6,NH005,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.9,2.9,,,2.4,3.6,Gender,Female,C1,T6,NH005,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C1,T6,NH005,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C1,T6,NH005,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.5,2.5,,,1.9,3.4,Age,45-64,C1,T6,NH005,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),9.5,9.5,,,8.2,11.0,Age,65+,C1,T6,NH005,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,3.4,4.5,Age,35+,C1,T6,NH005,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),11.2,11.2,,,8.3,15.1,Age,75+,C1,T6,NH005,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),3.2,3.2,,,2.7,3.8,Race,Non-Hispanic White,C1,T6,NH005,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.9,2.9,,,2.2,3.9,Race,Non-Hispanic Black,C1,T6,NH005,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),3.0,3.0,,,2.3,4.0,Race,Non-Hispanic Black,C1,T6,NH005,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),1.7,1.7,,,1.0,2.9,Race,Non-Hispanic Asian,C1,T6,NH005,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C1,T6,NH005,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),1.5,1.5,,,1.0,2.4,Race,Hispanic,C1,T6,NH005,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.0,2.0,,,1.3,3.0,Race,Hispanic,C1,T6,NH005,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Age-Standardized,Percent (%),2.8,2.8,,,1.8,4.4,Race,Other,C1,T6,NH005,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+); NHANES,Crude,Percent (%),2.3,2.3,,,1.3,4.0,Race,Other,C1,T6,NH005,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH101,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T1,NH101,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH101,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH101,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH101,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH101,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH101,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH101,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH101,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH101,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH101,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T1,NH101,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH101,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH101,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH101,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH101,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH101,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH101,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH101,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH101,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH101,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH101,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T1,NH101,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH101,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH101,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH101,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH101,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH101,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH101,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH101,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH101,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T1,NH101,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH101,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH101,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH101,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH101,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH101,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH101,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH101,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH101,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH101,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH101,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),0.2,0.2,,,0.2,0.2,Age,25-44,C2,T1,NH101,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH101,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH101,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH101,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH101,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),0.8,0.8,,,0.4,1.3,Race,Non-Hispanic Black,C2,T1,NH101,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),0.8,0.8,,,0.5,1.3,Race,Non-Hispanic Black,C2,T1,NH101,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH101,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH101,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH101,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH101,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH101,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T1,NH101,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH101,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH101,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH101,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH101,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH101,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH101,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH101,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH101,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T1,NH101,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH101,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH101,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH101,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH101,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T1,NH101,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T1,NH101,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH101,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH101,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH101,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH101,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH101,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH101,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T1,NH101,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH101,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH101,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH101,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH101,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH101,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH101,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T1,NH101,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T1,NH101,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH101,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH101,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of poor Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH101,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH103,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH103,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH103,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH103,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH103,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH103,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH103,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T1,NH103,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH103,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH103,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH103,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH103,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH103,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH103,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH103,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH103,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH103,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH103,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH103,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH103,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH103,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH103,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH103,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH103,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH103,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T1,NH103,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH103,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH103,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH103,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH103,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH103,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH103,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH103,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH103,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH103,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH103,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH103,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH103,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH103,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH103,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH103,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH103,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH103,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH103,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T1,NH103,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH103,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH103,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH103,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH103,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH103,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH103,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH103,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH103,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH103,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH103,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH103,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH103,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH103,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH103,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH103,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH103,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T1,NH103,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH103,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH103,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH103,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH103,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH103,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH103,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH103,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH103,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH103,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T1,NH103,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),5.1,5.1,,,3.8,6.9,Overall,Overall,C2,T1,NH103,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),5.3,5.3,,,3.9,7.0,Overall,Overall,C2,T1,NH103,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),3.9,3.9,,,2.6,5.9,Gender,Male,C2,T1,NH103,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),4.1,4.1,,,2.8,5.9,Gender,Male,C2,T1,NH103,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),6.1,6.1,,,4.0,9.1,Gender,Female,C2,T1,NH103,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),6.5,6.5,,,4.5,9.5,Gender,Female,C2,T1,NH103,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),15.8,15.8,,,9.5,25.1,Age,20-24,C2,T1,NH103,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),6.5,6.5,,,4.5,9.4,Age,25-44,C2,T1,NH103,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH103,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH103,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH103,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH103,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),5.9,5.9,,,4.0,8.5,Race,Non-Hispanic White,C2,T1,NH103,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),6.5,6.5,,,4.5,9.3,Race,Non-Hispanic White,C2,T1,NH103,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH103,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH103,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH103,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH103,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),5.5,5.5,,,4.5,6.9,Overall,Overall,C2,T1,NH103,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),5.2,5.2,,,4.1,6.7,Overall,Overall,C2,T1,NH103,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,2.2,4.8,Gender,Male,C2,T1,NH103,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),3.4,3.4,,,2.4,4.8,Gender,Male,C2,T1,NH103,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),7.6,7.6,,,5.7,9.9,Gender,Female,C2,T1,NH103,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),7.0,7.0,,,5.1,9.5,Gender,Female,C2,T1,NH103,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),10.7,10.7,,,6.1,18.2,Age,20-24,C2,T1,NH103,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,6.1,11.5,Age,25-44,C2,T1,NH103,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH103,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH103,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),3.7,3.7,,,2.8,4.8,Age,35+,C2,T1,NH103,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH103,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),5.7,5.7,,,4.0,8.0,Race,Non-Hispanic White,C2,T1,NH103,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),6.5,6.5,,,4.8,8.9,Race,Non-Hispanic White,C2,T1,NH103,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH103,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T1,NH103,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH103,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH103,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),5.7,5.7,,,4.2,7.7,Overall,Overall,C2,T1,NH103,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),5.9,5.9,,,4.4,7.7,Overall,Overall,C2,T1,NH103,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),4.3,4.3,,,2.9,6.3,Gender,Male,C2,T1,NH103,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),4.1,4.1,,,2.7,6.3,Gender,Male,C2,T1,NH103,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),7.5,7.5,,,5.5,10.2,Gender,Female,C2,T1,NH103,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),7.2,7.2,,,5.2,9.9,Gender,Female,C2,T1,NH103,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),14.8,14.8,,,9.1,23.2,Age,20-24,C2,T1,NH103,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),8.6,8.6,,,6.0,12.1,Age,25-44,C2,T1,NH103,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH103,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH103,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),3.4,3.4,,,2.4,4.8,Age,35+,C2,T1,NH103,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH103,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),5.9,5.9,,,4.0,8.5,Race,Non-Hispanic White,C2,T1,NH103,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),6.5,6.5,,,4.6,9.3,Race,Non-Hispanic White,C2,T1,NH103,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),13.5,13.5,,,10.5,17.1,Race,Non-Hispanic Asian,C2,T1,NH103,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),11.6,11.6,,,9.6,14.1,Race,Non-Hispanic Asian,C2,T1,NH103,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),4.3,4.3,,,2.5,7.3,Race,Hispanic,C2,T1,NH103,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),3.6,3.6,,,2.2,6.0,Race,Hispanic,C2,T1,NH103,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),10.6,10.6,,,7.5,14.9,Race,Other,C2,T1,NH103,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),9.7,9.7,,,7.6,12.3,Race,Other,C2,T1,NH103,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH103,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T1,NH103,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH103,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T1,NH103,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH103,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T1,NH103,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T1,NH103,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T1,NH103,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T1,NH103,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T1,NH103,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T1,NH103,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T1,NH103,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH103,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T1,NH103,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T1,NH103,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T1,NH103,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T1,NH103,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH103,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T1,NH103,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of ideal Cardiovascular Health among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T1,NH103,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH060,Crude,BOC03,AGE03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH060,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH060,Crude,BOC03,AGE03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH060,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH060,Crude,BOC03,AGE03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH060,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH060,Crude,BOC03,AGE03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH060,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH060,Crude,BOC03,AGE03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH060,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),34.7,34.7,,,33.2,36.3,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),51.1,51.1,,,48.9,53.3,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),56.9,56.9,,,53.8,60.1,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),41.1,41.1,,,38.9,43.5,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),28.9,28.9,,,26.4,31.7,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),45.6,45.6,,,42.1,49.1,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,21-24,C2,T10,NH060,Crude,BOC03,AGE03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),14.5,14.5,,,11.9,17.5,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),61.7,61.7,,,58.4,64.8,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),88.0,88.0,,,85.8,90.0,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),62.2,62.2,,,60.3,64.1,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),79.3,79.3,,,73.8,83.9,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),54.6,54.6,,,51.3,57.8,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),34.7,34.7,,,32.6,36.8,Race,Non-Hispanic White,C2,T10,NH060,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),38.9,38.9,,,35.4,42.5,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),52.3,52.3,,,47.9,56.6,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),44.2,44.2,,,37.4,51.3,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),34.0,34.0,,,29.1,39.3,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),34.4,34.4,,,32.2,36.6,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),50.7,50.7,,,47.2,54.1,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),53.2,53.2,,,48.8,57.5,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),40.0,40.0,,,37.4,42.7,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),29.5,29.5,,,26.6,32.5,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),48.3,48.3,,,44.2,52.5,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,21-24,C2,T10,NH060,Crude,BOC03,AGE03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),11.5,11.5,,,9.3,14.1,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),64.8,64.8,,,58.4,70.6,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),88.8,88.8,,,86.6,90.7,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),62.1,62.1,,,58.3,65.8,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),78.8,78.8,,,73.6,83.2,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),52.9,52.9,,,48.8,57.0,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),33.4,33.4,,,30.3,36.7,Race,Non-Hispanic White,C2,T10,NH060,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),39.3,39.3,,,34.8,43.9,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),56.1,56.1,,,51.8,60.2,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),42.3,42.3,,,36.1,48.9,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),31.7,31.7,,,27.3,36.4,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),36.1,36.1,,,32.4,40.0,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),37.5,37.5,,,30.3,45.2,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),45.9,45.9,,,39.5,52.5,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),33.1,33.1,,,28.8,37.6,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH060,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH060,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH060,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH060,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH060,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH060,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH060,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH060,Crude,BOC03,AGE03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH060,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH060,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH060,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH060,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH060,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH060,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH060,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH060,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH060,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH060,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH060,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH060,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH060,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH061,Crude,BOC03,AGE03,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH061,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH061,Crude,BOC03,AGE03,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH061,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH061,Crude,BOC03,AGE03,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH061,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH061,Crude,BOC03,AGE03,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH061,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH061,Crude,BOC03,AGE03,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH061,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),47.3,47.3,,,38.6,56.2,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),62.5,62.5,,,60.0,65.0,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),62.4,62.4,,,58.7,66.0,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),50.4,50.4,,,38.8,61.9,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),43.3,43.3,,,30.4,57.1,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),62.7,62.7,,,60.3,65.0,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,21-24,C2,T10,NH061,Crude,BOC03,AGE03,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),52.7,52.7,,,41.4,63.7,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),59.5,59.5,,,55.4,63.4,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),67.9,67.9,,,64.3,71.3,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),63.0,63.0,,,60.4,65.6,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),75.7,75.7,,,72.7,78.4,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),65.4,65.4,,,62.3,68.4,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),54.7,54.7,,,45.6,63.6,Race,Non-Hispanic White,C2,T10,NH061,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),53.2,53.2,,,48.5,57.8,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),21.9,21.9,,,14.0,32.5,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),53.1,53.1,,,41.0,64.9,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),64.9,64.9,,,61.4,68.2,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),44.6,44.6,,,37.0,52.5,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),44.1,44.1,,,32.9,56.0,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),62.2,62.2,,,59.1,65.2,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),67.7,67.7,,,62.4,72.5,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),46.0,46.0,,,35.7,56.7,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,21-24,C2,T10,NH061,Crude,BOC03,AGE03,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),47.6,47.6,,,35.0,60.5,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),63.0,63.0,,,57.0,68.5,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),70.7,70.7,,,66.9,74.3,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),65.3,65.3,,,61.8,68.7,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),77.6,77.6,,,69.4,84.1,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),67.3,67.3,,,64.1,70.4,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH061,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),42.3,42.3,,,31.8,53.5,Race,Non-Hispanic White,C2,T10,NH061,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),56.5,56.5,,,42.2,69.8,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),62.6,62.6,,,56.7,68.1,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),63.6,63.6,,,57.0,69.8,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),45.9,45.9,,,30.6,62.1,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),28.9,28.9,,,18.9,41.5,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),48.6,48.6,,,40.9,56.3,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),67.0,67.0,,,57.7,75.1,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),47.2,47.2,,,31.7,63.2,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH061,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH061,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH061,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH061,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH061,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH061,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH061,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH061,Crude,BOC03,AGE03,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH061,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH061,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH061,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH061,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH061,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH061,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH061,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH061,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH061,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH061,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH061,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH061,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH063,Crude,BOC03,AGE03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH063,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH063,Crude,BOC03,AGE03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH063,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH063,Crude,BOC03,AGE03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH063,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH063,Crude,BOC03,AGE03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH063,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH063,Crude,BOC03,AGE03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH063,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),13.1,13.1,,,11.8,14.5,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),13.5,13.5,,,12.2,14.8,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),12.3,12.3,,,10.7,14.1,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),12.2,12.2,,,10.5,14.0,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),14.5,14.5,,,13.2,16.0,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),13.8,13.8,,,12.4,15.3,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,21-24,C2,T10,NH063,Crude,BOC03,AGE03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),10.3,10.3,,,9.0,11.9,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),19.3,19.3,,,16.9,21.9,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),13.7,13.7,,,11.3,16.5,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),16.4,16.4,,,14.6,18.2,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),12.1,12.1,,,9.3,15.7,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),13.3,13.3,,,11.8,15.0,Race,Non-Hispanic White,C2,T10,NH063,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),14.1,14.1,,,12.7,15.7,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),10.1,10.1,,,7.9,12.8,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),10.0,10.0,,,7.7,12.8,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),12.1,12.1,,,7.0,20.0,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),12.4,12.4,,,7.2,20.5,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),12.6,12.6,,,11.2,14.1,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),12.9,12.9,,,11.4,14.6,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),11.2,11.2,,,9.7,13.0,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),11.1,11.1,,,9.6,12.8,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),14.6,14.6,,,12.4,17.1,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),13.8,13.8,,,12.0,15.9,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),5.5,5.5,,,3.1,9.7,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),5.5,5.5,,,3.1,9.6,Age,21-24,C2,T10,NH063,Crude,BOC03,AGE03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),8.3,8.3,,,6.8,10.1,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),19.5,19.5,,,16.4,23.0,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),12.5,12.5,,,10.6,14.7,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),15.8,15.8,,,13.8,18.0,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),11.3,11.3,,,8.1,15.7,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),13.9,13.9,,,11.8,16.3,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),13.1,13.1,,,11.3,15.3,Race,Non-Hispanic White,C2,T10,NH063,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),9.7,9.7,,,8.3,11.3,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),9.8,9.8,,,8.3,11.4,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),10.1,10.1,,,7.7,13.0,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),9.8,9.8,,,7.5,12.8,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),12.5,12.5,,,9.7,15.8,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),13.9,13.9,,,11.2,17.1,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),10.1,10.1,,,7.2,14.0,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),10.0,10.0,,,7.2,13.8,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),11.0,11.0,,,10.1,12.0,Overall,Overall,C2,T10,NH063,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,9.9,11.7,Overall,Overall,C2,T10,NH063,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),10.1,10.1,,,9.1,11.3,Gender,Male,C2,T10,NH063,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),10.1,10.1,,,9.0,11.3,Gender,Male,C2,T10,NH063,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),11.8,11.8,,,10.4,13.4,Gender,Female,C2,T10,NH063,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),11.2,11.2,,,9.8,12.7,Gender,Female,C2,T10,NH063,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH063,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,21-24,C2,T10,NH063,Crude,BOC03,AGE03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),9.9,9.9,,,8.4,11.7,Age,25-44,C2,T10,NH063,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),14.3,14.3,,,12.3,16.6,Age,45-64,C2,T10,NH063,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),10.6,10.6,,,8.9,12.7,Age,65+,C2,T10,NH063,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),13.1,13.1,,,11.9,14.5,Age,35+,C2,T10,NH063,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),10.4,10.4,,,7.7,13.8,Age,75+,C2,T10,NH063,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),11.5,11.5,,,10.1,13.0,Race,Non-Hispanic White,C2,T10,NH063,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),11.1,11.1,,,9.8,12.4,Race,Non-Hispanic White,C2,T10,NH063,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),7.6,7.6,,,6.6,8.8,Race,Non-Hispanic Black,C2,T10,NH063,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),7.6,7.6,,,6.5,8.8,Race,Non-Hispanic Black,C2,T10,NH063,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),11.6,11.6,,,9.2,14.5,Race,Non-Hispanic Asian,C2,T10,NH063,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),11.7,11.7,,,9.2,14.7,Race,Non-Hispanic Asian,C2,T10,NH063,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),11.5,11.5,,,9.6,13.7,Race,Hispanic,C2,T10,NH063,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),12.0,12.0,,,10.1,14.3,Race,Hispanic,C2,T10,NH063,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Crude,Percent (%),10.3,10.3,,,8.5,12.6,Race,Other,C2,T10,NH063,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,8.9,13.0,Race,Other,C2,T10,NH063,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH064,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH064,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH064,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH064,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH064,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH064,Crude,BOC03,AGE03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH064,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH064,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH064,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH064,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH064,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH064,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH064,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH064,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH064,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH064,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH064,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH064,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH064,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH064,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH064,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH064,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH064,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH064,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH064,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH064,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH064,Crude,BOC03,AGE03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH064,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH064,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH064,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH064,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH064,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH064,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH064,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH064,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH064,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH064,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH064,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH064,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH064,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH064,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH064,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH064,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH064,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH064,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH064,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH064,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH064,Crude,BOC03,AGE03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH064,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH064,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH064,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH064,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH064,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH064,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH064,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH064,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH064,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH064,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH064,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH064,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH064,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH064,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH064,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH064,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH064,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH064,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH064,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH064,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH064,Crude,BOC03,AGE03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH064,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH064,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH064,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH064,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH064,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH064,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH064,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH064,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH064,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH064,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH064,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH064,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH064,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH064,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH064,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH064,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH064,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH064,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH064,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH064,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH064,Crude,BOC03,AGE03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH064,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH064,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH064,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH064,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH064,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH064,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH064,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH064,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH064,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH064,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH064,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH064,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH064,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH064,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH064,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),18.3,18.3,,,16.2,20.5,Overall,Overall,C2,T10,NH064,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),18.0,18.0,,,16.0,20.1,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),27.9,27.9,,,24.7,31.4,Gender,Male,C2,T10,NH064,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),28.1,28.1,,,24.7,31.8,Gender,Male,C2,T10,NH064,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),9.0,9.0,,,7.3,11.1,Gender,Female,C2,T10,NH064,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),9.3,9.3,,,7.4,11.6,Gender,Female,C2,T10,NH064,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),21.8,21.8,,,15.5,29.8,Age,20-24,C2,T10,NH064,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),21.9,21.9,,,15.0,30.7,Age,21-24,C2,T10,NH064,Crude,BOC03,AGE03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),20.2,20.2,,,17.1,23.5,Age,25-44,C2,T10,NH064,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),17.9,17.9,,,15.8,20.2,Age,45-64,C2,T10,NH064,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),12.0,12.0,,,9.2,15.6,Age,65+,C2,T10,NH064,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),16.7,16.7,,,15.3,18.2,Age,35+,C2,T10,NH064,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),11.7,11.7,,,8.1,16.6,Age,75+,C2,T10,NH064,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),17.6,17.6,,,15.1,20.4,Race,Non-Hispanic White,C2,T10,NH064,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),17.0,17.0,,,15.0,19.3,Race,Non-Hispanic White,C2,T10,NH064,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),15.1,15.1,,,11.4,19.9,Race,Non-Hispanic Black,C2,T10,NH064,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),15.6,15.6,,,11.8,20.3,Race,Non-Hispanic Black,C2,T10,NH064,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH064,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH064,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH064,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH064,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),18.2,18.2,,,11.2,28.3,Race,Other,C2,T10,NH064,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),17.5,17.5,,,11.0,26.6,Race,Other,C2,T10,NH064,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),16.5,16.5,,,13.4,20.1,Overall,Overall,C2,T10,NH064,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),16.4,16.4,,,13.3,20.1,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),24.2,24.2,,,20.6,28.3,Gender,Male,C2,T10,NH064,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),24.0,24.0,,,20.6,27.8,Gender,Male,C2,T10,NH064,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),8.9,8.9,,,6.1,12.7,Gender,Female,C2,T10,NH064,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),9.1,9.1,,,6.4,12.9,Gender,Female,C2,T10,NH064,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),15.9,15.9,,,10.5,23.4,Age,20-24,C2,T10,NH064,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),17.5,17.5,,,12.0,24.7,Age,21-24,C2,T10,NH064,Crude,BOC03,AGE03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),17.3,17.3,,,13.7,21.5,Age,25-44,C2,T10,NH064,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),16.6,16.6,,,11.7,23.0,Age,45-64,C2,T10,NH064,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),14.5,14.5,,,8.8,22.9,Age,65+,C2,T10,NH064,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),16.1,16.1,,,12.7,20.2,Age,35+,C2,T10,NH064,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),16.1,16.1,,,10.8,23.4,Age,75+,C2,T10,NH064,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),16.5,16.5,,,13.2,20.5,Race,Non-Hispanic White,C2,T10,NH064,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),16.4,16.4,,,13.0,20.5,Race,Non-Hispanic White,C2,T10,NH064,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),11.7,11.7,,,9.3,14.6,Race,Non-Hispanic Black,C2,T10,NH064,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),12.0,12.0,,,9.5,15.1,Race,Non-Hispanic Black,C2,T10,NH064,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),12.9,12.9,,,8.5,19.0,Race,Non-Hispanic Asian,C2,T10,NH064,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),12.9,12.9,,,8.5,19.2,Race,Non-Hispanic Asian,C2,T10,NH064,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),19.7,19.7,,,16.1,24.0,Race,Hispanic,C2,T10,NH064,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),19.3,19.3,,,15.8,23.4,Race,Hispanic,C2,T10,NH064,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T10,NH064,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T10,NH064,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),17.4,17.4,,,14.9,20.1,Overall,Overall,C2,T10,NH064,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),17.0,17.0,,,14.8,19.6,Overall,Overall,C2,T10,NH064,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),26.5,26.5,,,22.3,31.2,Gender,Male,C2,T10,NH064,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),26.8,26.8,,,22.5,31.5,Gender,Male,C2,T10,NH064,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.0,11.0,,,7.8,15.2,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),8.0,8.0,,,5.9,10.7,Gender,Female,C2,T10,NH064,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),8.3,8.3,,,6.0,11.3,Gender,Female,C2,T10,NH064,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),13.8,13.8,,,8.2,22.2,Age,20-24,C2,T10,NH064,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),13.3,13.3,,,7.3,23.0,Age,21-24,C2,T10,NH064,Crude,BOC03,AGE03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),20.7,20.7,,,16.7,25.3,Age,25-44,C2,T10,NH064,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),16.3,16.3,,,14.2,18.7,Age,45-64,C2,T10,NH064,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),13.2,13.2,,,11.1,15.6,Age,65+,C2,T10,NH064,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),15.9,15.9,,,14.0,18.1,Age,35+,C2,T10,NH064,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),13.0,13.0,,,8.0,20.6,Age,75+,C2,T10,NH064,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),18.2,18.2,,,15.4,21.3,Race,Non-Hispanic White,C2,T10,NH064,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),19.0,19.0,,,15.8,22.8,Race,Non-Hispanic White,C2,T10,NH064,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),10.4,10.4,,,9.0,12.0,Race,Non-Hispanic Black,C2,T10,NH064,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),10.4,10.4,,,8.9,12.0,Race,Non-Hispanic Black,C2,T10,NH064,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),11.4,11.4,,,7.6,16.8,Race,Non-Hispanic Asian,C2,T10,NH064,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),11.4,11.4,,,7.7,16.7,Race,Non-Hispanic Asian,C2,T10,NH064,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),17.9,17.9,,,15.7,20.4,Race,Hispanic,C2,T10,NH064,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),17.4,17.4,,,15.3,19.6,Race,Hispanic,C2,T10,NH064,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Crude,Percent (%),13.9,13.9,,,9.4,20.0,Race,Other,C2,T10,NH064,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+); NHANES,Age-Standardized,Percent (%),14.0,14.0,,,9.3,20.4,Race,Other,C2,T10,NH064,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH065,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH065,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH065,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH065,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH065,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH065,Crude,BOC03,AGE03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH065,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH065,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH065,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH065,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH065,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH065,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH065,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH065,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH065,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH065,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH065,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH065,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH065,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH065,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH065,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH065,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH065,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH065,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH065,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH065,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH065,Crude,BOC03,AGE03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH065,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH065,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH065,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH065,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH065,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH065,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH065,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH065,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH065,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH065,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH065,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH065,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH065,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH065,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH065,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH065,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH065,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH065,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH065,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH065,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH065,Crude,BOC03,AGE03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH065,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH065,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH065,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH065,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH065,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH065,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH065,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH065,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH065,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH065,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH065,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH065,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH065,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH065,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH065,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH065,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH065,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH065,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH065,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH065,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH065,Crude,BOC03,AGE03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH065,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH065,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH065,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH065,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH065,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH065,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH065,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH065,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH065,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH065,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH065,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH065,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH065,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH065,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH065,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH065,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH065,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH065,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH065,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH065,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH065,Crude,BOC03,AGE03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH065,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH065,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH065,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH065,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH065,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH065,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH065,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH065,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH065,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH065,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH065,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH065,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH065,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH065,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH065,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),11.6,11.6,,,10.3,13.0,Overall,Overall,C2,T10,NH065,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),11.7,11.7,,,10.5,13.0,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),14.1,14.1,,,11.9,16.6,Gender,Male,C2,T10,NH065,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),14.0,14.0,,,11.9,16.5,Gender,Male,C2,T10,NH065,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),9.4,9.4,,,7.8,11.3,Gender,Female,C2,T10,NH065,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),8.9,8.9,,,7.3,10.8,Gender,Female,C2,T10,NH065,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH065,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,21-24,C2,T10,NH065,Crude,BOC03,AGE03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),10.6,10.6,,,8.4,13.2,Age,25-44,C2,T10,NH065,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),14.1,14.1,,,11.9,16.7,Age,45-64,C2,T10,NH065,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),11.7,11.7,,,8.7,15.5,Age,65+,C2,T10,NH065,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),12.8,12.8,,,11.8,13.9,Age,35+,C2,T10,NH065,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),10.1,10.1,,,7.5,13.5,Age,75+,C2,T10,NH065,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),11.7,11.7,,,10.2,13.3,Race,Non-Hispanic White,C2,T10,NH065,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),11.2,11.2,,,9.6,13.1,Race,Non-Hispanic White,C2,T10,NH065,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),5.2,5.2,,,3.4,7.7,Race,Non-Hispanic Black,C2,T10,NH065,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),5.3,5.3,,,3.6,7.7,Race,Non-Hispanic Black,C2,T10,NH065,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH065,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH065,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH065,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH065,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T10,NH065,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T10,NH065,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),11.6,11.6,,,9.0,14.8,Overall,Overall,C2,T10,NH065,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),11.8,11.8,,,9.1,15.2,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),15.6,15.6,,,12.3,19.5,Gender,Male,C2,T10,NH065,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),15.8,15.8,,,12.4,20.0,Gender,Male,C2,T10,NH065,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),8.1,8.1,,,5.8,11.2,Gender,Female,C2,T10,NH065,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),7.8,7.8,,,5.6,10.8,Gender,Female,C2,T10,NH065,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH065,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),6.7,6.7,,,3.9,11.2,Age,21-24,C2,T10,NH065,Crude,BOC03,AGE03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),12.0,12.0,,,8.1,17.6,Age,25-44,C2,T10,NH065,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),12.3,12.3,,,8.9,16.8,Age,45-64,C2,T10,NH065,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),13.2,13.2,,,9.2,18.7,Age,65+,C2,T10,NH065,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),13.3,13.3,,,10.5,16.8,Age,35+,C2,T10,NH065,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),11.6,11.6,,,7.2,18.2,Age,75+,C2,T10,NH065,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),12.5,12.5,,,9.1,16.9,Race,Non-Hispanic White,C2,T10,NH065,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),12.0,12.0,,,8.7,16.3,Race,Non-Hispanic White,C2,T10,NH065,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),6.2,6.2,,,4.2,9.2,Race,Non-Hispanic Black,C2,T10,NH065,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),6.1,6.1,,,4.1,9.0,Race,Non-Hispanic Black,C2,T10,NH065,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),11.3,11.3,,,8.8,14.3,Race,Non-Hispanic Asian,C2,T10,NH065,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),11.1,11.1,,,8.7,14.1,Race,Non-Hispanic Asian,C2,T10,NH065,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),13.4,13.4,,,10.5,17.1,Race,Hispanic,C2,T10,NH065,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),12.9,12.9,,,9.4,17.5,Race,Hispanic,C2,T10,NH065,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),12.3,12.3,,,6.8,21.2,Race,Other,C2,T10,NH065,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),12.5,12.5,,,7.3,20.8,Race,Other,C2,T10,NH065,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),12.4,12.4,,,11.0,14.0,Overall,Overall,C2,T10,NH065,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),12.3,12.3,,,11.0,13.8,Overall,Overall,C2,T10,NH065,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),15.8,15.8,,,13.9,17.8,Gender,Male,C2,T10,NH065,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),15.7,15.7,,,13.8,17.9,Gender,Male,C2,T10,NH065,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),9.2,9.2,,,7.1,11.7,Gender,Female,C2,T10,NH065,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),8.9,8.9,,,6.9,11.3,Gender,Female,C2,T10,NH065,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),4.6,4.6,,,2.5,8.2,Age,20-24,C2,T10,NH065,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,21-24,C2,T10,NH065,Crude,BOC03,AGE03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),12.9,12.9,,,10.8,15.5,Age,25-44,C2,T10,NH065,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),15.0,15.0,,,12.1,18.5,Age,45-64,C2,T10,NH065,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),10.0,10.0,,,7.2,13.9,Age,65+,C2,T10,NH065,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),13.7,13.7,,,11.9,15.8,Age,35+,C2,T10,NH065,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),10.2,10.2,,,7.3,14.1,Age,75+,C2,T10,NH065,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),13.6,13.6,,,11.6,15.9,Race,Non-Hispanic White,C2,T10,NH065,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),13.6,13.6,,,11.7,15.8,Race,Non-Hispanic White,C2,T10,NH065,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),3.8,3.8,,,2.2,6.5,Race,Non-Hispanic Black,C2,T10,NH065,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),3.8,3.8,,,2.3,6.4,Race,Non-Hispanic Black,C2,T10,NH065,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,7.5,15.1,Race,Non-Hispanic Asian,C2,T10,NH065,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),10.8,10.8,,,7.5,15.3,Race,Non-Hispanic Asian,C2,T10,NH065,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),13.8,13.8,,,10.8,17.6,Race,Hispanic,C2,T10,NH065,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),14.1,14.1,,,10.7,18.2,Race,Hispanic,C2,T10,NH065,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Age-Standardized,Percent (%),11.5,11.5,,,7.3,17.6,Race,Other,C2,T10,NH065,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+); NHANES,Crude,Percent (%),11.6,11.6,,,7.3,18.0,Race,Other,C2,T10,NH065,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH066,Crude,BOC03,AGE03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH066,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),12.1,12.1,,,8.3,17.3,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH066,Crude,BOC03,AGE03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH066,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),11.2,11.2,,,9.8,12.8,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH066,Crude,BOC03,AGE03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH066,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH066,Crude,BOC03,AGE03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.7,11.7,,,10.2,13.4,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH066,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH066,Crude,BOC03,AGE03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH066,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),67.8,67.8,,,65.9,69.6,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),69.3,69.3,,,67.1,71.4,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),66.3,66.3,,,63.4,69.1,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),65.6,65.6,,,63.4,67.8,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.3,12.3,,,10.9,13.9,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),70.0,70.0,,,67.6,72.2,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),72.2,72.2,,,69.8,74.4,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),29.5,29.5,,,24.5,35.2,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),32.7,32.7,,,27.5,38.4,Age,21-24,C2,T10,NH066,Crude,BOC03,AGE03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),56.8,56.8,,,53.4,60.2,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),81.0,81.0,,,77.6,84.0,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),91.2,91.2,,,89.4,92.8,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),79.7,79.7,,,77.0,82.1,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),90.1,90.1,,,86.7,92.7,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),73.9,73.9,,,71.9,75.9,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),70.5,70.5,,,68.7,72.3,Race,Non-Hispanic White,C2,T10,NH066,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),65.9,65.9,,,62.0,69.6,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),65.1,65.1,,,61.1,68.8,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),66.7,66.7,,,60.5,72.3,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),68.9,68.9,,,63.2,74.0,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),69.3,69.3,,,67.3,71.3,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),71.0,71.0,,,68.2,73.7,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),67.8,67.8,,,64.9,70.7,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),66.9,66.9,,,65.0,68.8,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),71.6,71.6,,,68.8,74.2,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),74.0,74.0,,,70.6,77.1,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),34.0,34.0,,,26.6,42.2,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),34.5,34.5,,,24.7,45.7,Age,21-24,C2,T10,NH066,Crude,BOC03,AGE03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),58.8,58.8,,,55.1,62.4,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),81.6,81.6,,,78.4,84.5,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),92.7,92.7,,,90.6,94.4,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),80.9,80.9,,,78.5,83.0,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),91.8,91.8,,,89.8,93.5,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),75.2,75.2,,,72.2,78.0,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),71.8,71.8,,,69.0,74.4,Race,Non-Hispanic White,C2,T10,NH066,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),71.8,71.8,,,66.6,76.5,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),71.6,71.6,,,65.3,77.2,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),69.3,69.3,,,64.9,73.4,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),70.5,70.5,,,66.9,73.9,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),12.3,12.3,,,10.8,14.0,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),59.0,59.0,,,55.9,62.0,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),53.8,53.8,,,49.6,57.8,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),65.7,65.7,,,59.6,71.4,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),66.5,66.5,,,61.7,71.0,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),72.9,72.9,,,71.4,74.3,Overall,Overall,C2,T10,NH066,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),74.6,74.6,,,72.9,76.3,Overall,Overall,C2,T10,NH066,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),71.0,71.0,,,67.9,74.0,Gender,Male,C2,T10,NH066,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),69.9,69.9,,,67.1,72.6,Gender,Male,C2,T10,NH066,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),75.9,75.9,,,74.3,77.4,Gender,Female,C2,T10,NH066,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),78.1,78.1,,,76.4,79.7,Gender,Female,C2,T10,NH066,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),37.2,37.2,,,30.8,44.0,Age,20-24,C2,T10,NH066,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),38.4,38.4,,,31.8,45.5,Age,21-24,C2,T10,NH066,Crude,BOC03,AGE03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),63.5,63.5,,,61.2,65.8,Age,25-44,C2,T10,NH066,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),85.3,85.3,,,83.6,86.9,Age,45-64,C2,T10,NH066,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),93.3,93.3,,,91.3,94.9,Age,65+,C2,T10,NH066,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),83.7,83.7,,,82.9,84.6,Age,35+,C2,T10,NH066,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),95.5,95.5,,,92.5,97.4,Age,75+,C2,T10,NH066,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),78.4,78.4,,,76.3,80.3,Race,Non-Hispanic White,C2,T10,NH066,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),75.0,75.0,,,72.9,77.0,Race,Non-Hispanic White,C2,T10,NH066,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),72.7,72.7,,,69.1,76.0,Race,Non-Hispanic Black,C2,T10,NH066,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),72.8,72.8,,,68.1,77.0,Race,Non-Hispanic Black,C2,T10,NH066,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),74.9,74.9,,,70.7,78.6,Race,Non-Hispanic Asian,C2,T10,NH066,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),74.9,74.9,,,70.5,78.8,Race,Non-Hispanic Asian,C2,T10,NH066,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),64.7,64.7,,,61.8,67.4,Race,Hispanic,C2,T10,NH066,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),60.3,60.3,,,56.7,63.8,Race,Hispanic,C2,T10,NH066,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Crude,Percent (%),72.9,72.9,,,68.4,76.9,Race,Other,C2,T10,NH066,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+); NHANES,Age-Standardized,Percent (%),73.8,73.8,,,69.8,77.4,Race,Other,C2,T10,NH066,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH067,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH067,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH067,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH067,Crude,BOC03,AGE03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH067,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH067,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH067,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH067,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH067,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH067,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH067,Crude,BOC03,AGE03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH067,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH067,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH067,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH067,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH067,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH067,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH067,Crude,BOC03,AGE03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH067,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH067,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH067,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH067,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH067,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH067,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH067,Crude,BOC03,AGE03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH067,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH067,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH067,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH067,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Male,C2,T10,NH067,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH067,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,21-24,C2,T10,NH067,Crude,BOC03,AGE03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T10,NH067,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH067,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH067,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Other,C2,T10,NH067,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T10,NH067,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T10,NH067,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T10,NH067,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,21-24,C2,T10,NH067,Crude,BOC03,AGE03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T10,NH067,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T10,NH067,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH067,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH067,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T10,NH067,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T10,NH067,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T10,NH067,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T10,NH067,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,21-24,C2,T10,NH067,Crude,BOC03,AGE03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T10,NH067,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T10,NH067,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T10,NH067,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH067,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T10,NH067,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T10,NH067,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T10,NH067,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T10,NH067,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T10,NH067,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T10,NH067,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T10,NH067,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH067,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,21-24,C2,T10,NH067,Crude,BOC03,AGE03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T10,NH067,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T10,NH067,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T10,NH067,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T10,NH067,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T10,NH067,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T10,NH067,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T10,NH067,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T10,NH067,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T10,NH067,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T10,NH067,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T10,NH067,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH067,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH067,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age-Standardized,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T10,NH067,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Crude,Mean (mg/dL),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T10,NH067,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),17.3,17.3,,,15.3,19.4,Overall,Overall,C2,T10,NH301,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),17.7,17.7,,,15.8,19.8,Overall,Overall,C2,T10,NH301,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),17.2,17.2,,,15.1,19.6,Gender,Male,C2,T10,NH301,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),16.7,16.7,,,14.8,18.9,Gender,Male,C2,T10,NH301,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),17.8,17.8,,,15.2,20.8,Gender,Female,C2,T10,NH301,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),17.9,17.9,,,15.5,20.6,Gender,Female,C2,T10,NH301,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),5.2,5.2,,,3.1,8.8,Age,20-24,C2,T10,NH301,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),13.6,13.6,,,10.9,16.8,Age,25-44,C2,T10,NH301,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),22.3,22.3,,,19.7,25.1,Age,45-64,C2,T10,NH301,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),25.6,25.6,,,23.6,27.7,Age,65+,C2,T10,NH301,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),21.2,21.2,,,18.5,24.2,Age,35+,C2,T10,NH301,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),20.7,20.7,,,18.0,23.7,Age,75+,C2,T10,NH301,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),18.7,18.7,,,16.5,21.1,Race,Non-Hispanic White,C2,T10,NH301,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.6,18.6,,,16.4,21.0,Race,Non-Hispanic White,C2,T10,NH301,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.7,13.7,,,11.4,16.5,Race,Non-Hispanic Black,C2,T10,NH301,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),12.4,12.4,,,10.2,14.8,Race,Non-Hispanic Black,C2,T10,NH301,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH301,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH301,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH301,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH301,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),16.3,16.3,,,10.8,23.8,Race,Other,C2,T10,NH301,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.9,15.9,,,11.2,22.2,Race,Other,C2,T10,NH301,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),16.2,16.2,,,14.6,17.9,Overall,Overall,C2,T10,NH301,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.2,16.2,,,14.6,17.8,Overall,Overall,C2,T10,NH301,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),16.3,16.3,,,13.8,19.1,Gender,Male,C2,T10,NH301,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.8,15.8,,,13.4,18.4,Gender,Male,C2,T10,NH301,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),16.1,16.1,,,14.5,17.9,Gender,Female,C2,T10,NH301,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.0,16.0,,,14.5,17.6,Gender,Female,C2,T10,NH301,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH301,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),12.8,12.8,,,10.8,15.2,Age,25-44,C2,T10,NH301,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),22.7,22.7,,,19.7,26.2,Age,45-64,C2,T10,NH301,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),19.4,19.4,,,16.1,23.2,Age,65+,C2,T10,NH301,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),19.6,19.6,,,17.5,21.8,Age,35+,C2,T10,NH301,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),19.7,19.7,,,16.4,23.5,Age,75+,C2,T10,NH301,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.0,16.0,,,13.9,18.3,Race,Non-Hispanic White,C2,T10,NH301,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),16.5,16.5,,,14.2,19.0,Race,Non-Hispanic White,C2,T10,NH301,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),14.3,14.3,,,11.1,18.3,Race,Non-Hispanic Black,C2,T10,NH301,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.7,15.7,,,12.3,19.8,Race,Non-Hispanic Black,C2,T10,NH301,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH301,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH301,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH301,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH301,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),22.0,22.0,,,14.8,31.2,Race,Other,C2,T10,NH301,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),23.4,23.4,,,16.0,32.9,Race,Other,C2,T10,NH301,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),16.9,16.9,,,15.7,18.1,Overall,Overall,C2,T10,NH301,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.6,16.6,,,15.5,17.9,Overall,Overall,C2,T10,NH301,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),16.5,16.5,,,15.1,18.0,Gender,Male,C2,T10,NH301,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.3,16.3,,,14.8,17.9,Gender,Male,C2,T10,NH301,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),17.2,17.2,,,15.0,19.8,Gender,Female,C2,T10,NH301,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.7,16.7,,,14.6,18.9,Gender,Female,C2,T10,NH301,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),4.7,4.7,,,2.8,7.7,Age,20-24,C2,T10,NH301,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),14.4,14.4,,,12.8,16.2,Age,25-44,C2,T10,NH301,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),22.2,22.2,,,20.0,24.7,Age,45-64,C2,T10,NH301,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),18.4,18.4,,,16.7,20.3,Age,65+,C2,T10,NH301,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),19.9,19.9,,,18.3,21.5,Age,35+,C2,T10,NH301,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),17.1,17.1,,,14.4,20.2,Age,75+,C2,T10,NH301,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),17.8,17.8,,,16.4,19.3,Race,Non-Hispanic White,C2,T10,NH301,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),17.2,17.2,,,15.8,18.6,Race,Non-Hispanic White,C2,T10,NH301,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),7.2,7.2,,,5.8,8.9,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),12.9,12.9,,,10.7,15.4,Race,Non-Hispanic Black,C2,T10,NH301,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.4,13.4,,,10.9,16.2,Race,Non-Hispanic Black,C2,T10,NH301,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH301,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH301,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH301,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH301,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.8,14.8,,,10.7,20.3,Race,Other,C2,T10,NH301,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),14.9,14.9,,,10.7,20.5,Race,Other,C2,T10,NH301,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.3,15.3,,,13.9,16.7,Overall,Overall,C2,T10,NH301,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),15.6,15.6,,,14.1,17.1,Overall,Overall,C2,T10,NH301,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),14.0,14.0,,,12.1,16.1,Gender,Male,C2,T10,NH301,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.8,13.8,,,11.9,15.9,Gender,Male,C2,T10,NH301,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),17.1,17.1,,,15.6,18.7,Gender,Female,C2,T10,NH301,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.5,16.5,,,15.1,18.0,Gender,Female,C2,T10,NH301,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),4.1,4.1,,,2.4,6.8,Age,20-24,C2,T10,NH301,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),13.5,13.5,,,11.0,16.5,Age,25-44,C2,T10,NH301,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),20.9,20.9,,,18.2,23.9,Age,45-64,C2,T10,NH301,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),15.1,15.1,,,12.2,18.5,Age,65+,C2,T10,NH301,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),18.0,18.0,,,16.0,20.1,Age,35+,C2,T10,NH301,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),12.8,12.8,,,8.7,18.5,Age,75+,C2,T10,NH301,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.0,16.0,,,14.1,18.2,Race,Non-Hispanic White,C2,T10,NH301,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),16.6,16.6,,,14.6,18.7,Race,Non-Hispanic White,C2,T10,NH301,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),10.1,10.1,,,8.9,11.5,Race,Non-Hispanic Black,C2,T10,NH301,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.4,10.4,,,9.1,11.8,Race,Non-Hispanic Black,C2,T10,NH301,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH301,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH301,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH301,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH301,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),17.8,17.8,,,11.3,26.9,Race,Other,C2,T10,NH301,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.0,18.0,,,11.4,27.3,Race,Other,C2,T10,NH301,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),14.5,14.5,,,13.0,16.2,Overall,Overall,C2,T10,NH301,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.2,14.2,,,12.6,15.9,Overall,Overall,C2,T10,NH301,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),13.6,13.6,,,11.7,15.7,Gender,Male,C2,T10,NH301,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.3,13.3,,,11.3,15.6,Gender,Male,C2,T10,NH301,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),15.4,15.4,,,13.4,17.7,Gender,Female,C2,T10,NH301,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.7,14.7,,,12.8,16.9,Gender,Female,C2,T10,NH301,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH301,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),11.1,11.1,,,9.2,13.3,Age,25-44,C2,T10,NH301,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),19.7,19.7,,,16.8,23.0,Age,45-64,C2,T10,NH301,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),15.5,15.5,,,13.3,18.0,Age,65+,C2,T10,NH301,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),17.2,17.2,,,15.5,19.0,Age,35+,C2,T10,NH301,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),16.9,16.9,,,13.7,20.8,Age,75+,C2,T10,NH301,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),15.1,15.1,,,13.3,17.2,Race,Non-Hispanic White,C2,T10,NH301,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.5,14.5,,,12.5,16.7,Race,Non-Hispanic White,C2,T10,NH301,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),12.3,12.3,,,9.6,15.5,Race,Non-Hispanic Black,C2,T10,NH301,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.6,12.6,,,10.1,15.7,Race,Non-Hispanic Black,C2,T10,NH301,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH301,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH301,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH301,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH301,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),14.2,14.2,,,10.1,19.6,Race,Other,C2,T10,NH301,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.6,13.6,,,9.8,18.5,Race,Other,C2,T10,NH301,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),13.5,13.5,,,12.2,14.8,Overall,Overall,C2,T10,NH301,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.1,13.1,,,11.8,14.5,Overall,Overall,C2,T10,NH301,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),12.3,12.3,,,10.7,14.1,Gender,Male,C2,T10,NH301,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.2,12.2,,,10.5,14.0,Gender,Male,C2,T10,NH301,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),14.5,14.5,,,13.2,16.0,Gender,Female,C2,T10,NH301,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.8,13.8,,,12.4,15.3,Gender,Female,C2,T10,NH301,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH301,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),10.3,10.3,,,9.0,11.9,Age,25-44,C2,T10,NH301,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),19.3,19.3,,,16.9,21.9,Age,45-64,C2,T10,NH301,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),13.7,13.7,,,11.3,16.5,Age,65+,C2,T10,NH301,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),16.4,16.4,,,14.6,18.2,Age,35+,C2,T10,NH301,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),12.1,12.1,,,9.3,15.7,Age,75+,C2,T10,NH301,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),14.1,14.1,,,12.7,15.7,Race,Non-Hispanic White,C2,T10,NH301,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.3,13.3,,,11.8,15.0,Race,Non-Hispanic White,C2,T10,NH301,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.1,10.1,,,7.9,12.8,Race,Non-Hispanic Black,C2,T10,NH301,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),10.0,10.0,,,7.7,12.8,Race,Non-Hispanic Black,C2,T10,NH301,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH301,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH301,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH301,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH301,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),12.1,12.1,,,7.0,20.0,Race,Other,C2,T10,NH301,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.4,12.4,,,7.2,20.5,Race,Other,C2,T10,NH301,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),12.9,12.9,,,11.4,14.6,Overall,Overall,C2,T10,NH301,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.6,12.6,,,11.2,14.1,Overall,Overall,C2,T10,NH301,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),11.1,11.1,,,9.6,12.8,Gender,Male,C2,T10,NH301,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),11.2,11.2,,,9.7,13.0,Gender,Male,C2,T10,NH301,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),14.6,14.6,,,12.4,17.1,Gender,Female,C2,T10,NH301,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.8,13.8,,,12.0,15.9,Gender,Female,C2,T10,NH301,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),5.5,5.5,,,3.1,9.7,Age,20-24,C2,T10,NH301,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),8.3,8.3,,,6.8,10.1,Age,25-44,C2,T10,NH301,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),19.5,19.5,,,16.4,23.0,Age,45-64,C2,T10,NH301,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),12.5,12.5,,,10.6,14.7,Age,65+,C2,T10,NH301,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),15.8,15.8,,,13.8,18.0,Age,35+,C2,T10,NH301,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),11.3,11.3,,,8.1,15.7,Age,75+,C2,T10,NH301,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),13.9,13.9,,,11.8,16.3,Race,Non-Hispanic White,C2,T10,NH301,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.1,13.1,,,11.3,15.3,Race,Non-Hispanic White,C2,T10,NH301,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),9.7,9.7,,,8.3,11.3,Race,Non-Hispanic Black,C2,T10,NH301,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),9.8,9.8,,,8.3,11.4,Race,Non-Hispanic Black,C2,T10,NH301,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.1,10.1,,,7.7,13.0,Race,Non-Hispanic Asian,C2,T10,NH301,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),9.8,9.8,,,7.5,12.8,Race,Non-Hispanic Asian,C2,T10,NH301,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),12.5,12.5,,,9.7,15.8,Race,Hispanic,C2,T10,NH301,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.9,13.9,,,11.2,17.1,Race,Hispanic,C2,T10,NH301,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),10.1,10.1,,,7.2,14.0,Race,Other,C2,T10,NH301,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.0,10.0,,,7.2,13.8,Race,Other,C2,T10,NH301,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,9.9,11.7,Overall,Overall,C2,T10,NH301,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),11.0,11.0,,,10.1,12.0,Overall,Overall,C2,T10,NH301,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),10.1,10.1,,,9.0,11.3,Gender,Male,C2,T10,NH301,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.1,10.1,,,9.1,11.3,Gender,Male,C2,T10,NH301,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),11.2,11.2,,,9.8,12.7,Gender,Female,C2,T10,NH301,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),11.8,11.8,,,10.4,13.4,Gender,Female,C2,T10,NH301,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T10,NH301,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),9.9,9.9,,,8.4,11.7,Age,25-44,C2,T10,NH301,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),14.3,14.3,,,12.3,16.6,Age,45-64,C2,T10,NH301,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),10.6,10.6,,,8.9,12.7,Age,65+,C2,T10,NH301,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),13.1,13.1,,,11.9,14.5,Age,35+,C2,T10,NH301,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),10.4,10.4,,,7.7,13.8,Age,75+,C2,T10,NH301,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),11.5,11.5,,,10.1,13.0,Race,Non-Hispanic White,C2,T10,NH301,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),11.1,11.1,,,9.8,12.4,Race,Non-Hispanic White,C2,T10,NH301,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),7.6,7.6,,,6.6,8.8,Race,Non-Hispanic Black,C2,T10,NH301,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),7.6,7.6,,,6.5,8.8,Race,Non-Hispanic Black,C2,T10,NH301,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),11.7,11.7,,,9.2,14.7,Race,Non-Hispanic Asian,C2,T10,NH301,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),11.6,11.6,,,9.2,14.5,Race,Non-Hispanic Asian,C2,T10,NH301,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),11.5,11.5,,,9.6,13.7,Race,Hispanic,C2,T10,NH301,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.0,12.0,,,10.1,14.3,Race,Hispanic,C2,T10,NH301,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Crude,Percent (%),10.3,10.3,,,8.5,12.6,Race,Other,C2,T10,NH301,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,8.9,13.0,Race,Other,C2,T10,NH301,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),46.0,46.0,,,43.8,48.3,Overall,Overall,C2,T10,NH303,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),44.8,44.8,,,42.8,46.9,Overall,Overall,C2,T10,NH303,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),43.6,43.6,,,40.8,46.4,Gender,Male,C2,T10,NH303,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),45.4,45.4,,,42.6,48.3,Gender,Male,C2,T10,NH303,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),46.6,46.6,,,43.9,49.3,Gender,Female,C2,T10,NH303,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.4,46.4,,,44.2,48.6,Gender,Female,C2,T10,NH303,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),81.2,81.2,,,75.7,85.7,Age,20-24,C2,T10,NH303,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),57.3,57.3,,,53.9,60.6,Age,25-44,C2,T10,NH303,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),28.3,28.3,,,25.3,31.6,Age,45-64,C2,T10,NH303,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),26.3,26.3,,,23.8,29.1,Age,65+,C2,T10,NH303,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),35.8,35.8,,,32.3,39.5,Age,35+,C2,T10,NH303,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),34.5,34.5,,,30.9,38.4,Age,75+,C2,T10,NH303,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),42.7,42.7,,,39.9,45.6,Race,Non-Hispanic White,C2,T10,NH303,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),43.0,43.0,,,40.3,45.7,Race,Non-Hispanic White,C2,T10,NH303,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),54.4,54.4,,,51.1,57.7,Race,Non-Hispanic Black,C2,T10,NH303,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.1,13.1,,,10.8,15.8,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),57.8,57.8,,,54.0,61.5,Race,Non-Hispanic Black,C2,T10,NH303,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH303,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH303,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH303,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH303,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),45.8,45.8,,,37.6,54.2,Race,Other,C2,T10,NH303,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),44.6,44.6,,,36.8,52.7,Race,Other,C2,T10,NH303,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),47.4,47.4,,,45.1,49.7,Overall,Overall,C2,T10,NH303,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),47.5,47.5,,,44.8,50.3,Overall,Overall,C2,T10,NH303,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),46.4,46.4,,,43.6,49.3,Gender,Male,C2,T10,NH303,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.7,46.7,,,44.2,49.1,Gender,Male,C2,T10,NH303,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),48.8,48.8,,,45.6,52.1,Gender,Female,C2,T10,NH303,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),48.6,48.6,,,44.9,52.3,Gender,Female,C2,T10,NH303,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),78.7,78.7,,,75.3,81.8,Age,20-24,C2,T10,NH303,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),56.6,56.6,,,53.0,60.3,Age,25-44,C2,T10,NH303,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),35.4,35.4,,,32.4,38.4,Age,45-64,C2,T10,NH303,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),29.6,29.6,,,25.7,33.8,Age,65+,C2,T10,NH303,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),38.6,38.6,,,36.1,41.2,Age,35+,C2,T10,NH303,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),31.3,31.3,,,26.7,36.2,Age,75+,C2,T10,NH303,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),45.5,45.5,,,42.4,48.8,Race,Non-Hispanic White,C2,T10,NH303,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.8,46.8,,,44.2,49.4,Race,Non-Hispanic White,C2,T10,NH303,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),51.4,51.4,,,47.0,55.9,Race,Non-Hispanic Black,C2,T10,NH303,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),53.6,53.6,,,49.6,57.6,Race,Non-Hispanic Black,C2,T10,NH303,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH303,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH303,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH303,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH303,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),40.0,40.0,,,32.1,48.5,Race,Other,C2,T10,NH303,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),36.1,36.1,,,29.7,43.0,Race,Other,C2,T10,NH303,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),45.0,45.0,,,43.0,47.0,Overall,Overall,C2,T10,NH303,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),44.5,44.5,,,42.1,46.9,Overall,Overall,C2,T10,NH303,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),43.8,43.8,,,41.0,46.7,Gender,Male,C2,T10,NH303,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),43.7,43.7,,,41.1,46.3,Gender,Male,C2,T10,NH303,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.6,46.6,,,44.0,49.3,Gender,Female,C2,T10,NH303,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),45.1,45.1,,,41.7,48.5,Gender,Female,C2,T10,NH303,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),80.2,80.2,,,75.7,84.1,Age,20-24,C2,T10,NH303,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),53.8,53.8,,,51.4,56.1,Age,25-44,C2,T10,NH303,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),32.8,32.8,,,28.7,37.1,Age,45-64,C2,T10,NH303,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),26.9,26.9,,,24.4,29.5,Age,65+,C2,T10,NH303,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),35.3,35.3,,,32.5,38.2,Age,35+,C2,T10,NH303,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),32.4,32.4,,,28.0,37.2,Age,75+,C2,T10,NH303,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),42.1,42.1,,,39.2,45.0,Race,Non-Hispanic White,C2,T10,NH303,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),44.1,44.1,,,41.8,46.5,Race,Non-Hispanic White,C2,T10,NH303,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),52.3,52.3,,,50.4,54.1,Race,Non-Hispanic Black,C2,T10,NH303,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),53.8,53.8,,,51.9,55.8,Race,Non-Hispanic Black,C2,T10,NH303,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH303,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH303,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH303,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH303,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),52.2,52.2,,,43.0,61.3,Race,Other,C2,T10,NH303,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),50.8,50.8,,,41.2,60.3,Race,Other,C2,T10,NH303,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.7,46.7,,,44.5,49.0,Overall,Overall,C2,T10,NH303,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),45.7,45.7,,,42.9,48.5,Overall,Overall,C2,T10,NH303,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),47.0,47.0,,,43.6,50.4,Gender,Male,C2,T10,NH303,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),47.3,47.3,,,44.6,50.0,Gender,Male,C2,T10,NH303,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.7,46.7,,,44.0,49.3,Gender,Female,C2,T10,NH303,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),44.4,44.4,,,41.3,47.6,Gender,Female,C2,T10,NH303,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),82.4,82.4,,,78.2,86.0,Age,20-24,C2,T10,NH303,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),57.4,57.4,,,54.0,60.8,Age,25-44,C2,T10,NH303,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),31.6,31.6,,,27.8,35.6,Age,45-64,C2,T10,NH303,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),30.4,30.4,,,26.8,34.2,Age,65+,C2,T10,NH303,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),37.2,37.2,,,34.6,39.9,Age,35+,C2,T10,NH303,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),34.0,34.0,,,29.6,38.6,Age,75+,C2,T10,NH303,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),43.8,43.8,,,40.7,46.8,Race,Non-Hispanic White,C2,T10,NH303,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.3,46.3,,,43.8,48.8,Race,Non-Hispanic White,C2,T10,NH303,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),53.5,53.5,,,49.4,57.5,Race,Non-Hispanic Black,C2,T10,NH303,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),54.4,54.4,,,51.0,57.7,Race,Non-Hispanic Black,C2,T10,NH303,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH303,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH303,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH303,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T10,NH303,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),45.5,45.5,,,37.6,53.6,Race,Other,C2,T10,NH303,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),44.1,44.1,,,38.5,49.8,Race,Other,C2,T10,NH303,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.1,46.1,,,44.3,47.9,Overall,Overall,C2,T10,NH303,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),45.1,45.1,,,42.8,47.4,Overall,Overall,C2,T10,NH303,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),46.1,46.1,,,43.1,49.2,Gender,Male,C2,T10,NH303,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.5,46.5,,,43.9,49.1,Gender,Male,C2,T10,NH303,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.1,46.1,,,43.6,48.6,Gender,Female,C2,T10,NH303,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),44.1,44.1,,,41.3,47.0,Gender,Female,C2,T10,NH303,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),78.2,78.2,,,70.7,84.1,Age,20-24,C2,T10,NH303,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),56.3,56.3,,,53.5,59.1,Age,25-44,C2,T10,NH303,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),33.0,33.0,,,29.2,37.0,Age,45-64,C2,T10,NH303,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),30.1,30.1,,,27.3,33.1,Age,65+,C2,T10,NH303,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),36.7,36.7,,,34.1,39.3,Age,35+,C2,T10,NH303,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),35.5,35.5,,,29.7,41.7,Age,75+,C2,T10,NH303,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),43.4,43.4,,,40.5,46.4,Race,Non-Hispanic White,C2,T10,NH303,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),45.8,45.8,,,43.4,48.2,Race,Non-Hispanic White,C2,T10,NH303,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),51.1,51.1,,,48.0,54.2,Race,Non-Hispanic Black,C2,T10,NH303,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),52.2,52.2,,,48.8,55.5,Race,Non-Hispanic Black,C2,T10,NH303,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH303,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH303,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH303,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH303,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),41.1,41.1,,,30.5,52.7,Race,Other,C2,T10,NH303,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),40.4,40.4,,,31.7,49.8,Race,Other,C2,T10,NH303,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),47.3,47.3,,,45.5,49.1,Overall,Overall,C2,T10,NH303,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),46.0,46.0,,,44.2,47.8,Overall,Overall,C2,T10,NH303,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),46.0,46.0,,,44.1,47.8,Gender,Male,C2,T10,NH303,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.6,46.6,,,44.6,48.5,Gender,Male,C2,T10,NH303,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),48.3,48.3,,,45.3,51.3,Gender,Female,C2,T10,NH303,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),46.0,46.0,,,43.0,49.1,Gender,Female,C2,T10,NH303,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),79.5,79.5,,,74.5,83.8,Age,20-24,C2,T10,NH303,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),59.1,59.1,,,57.0,61.1,Age,25-44,C2,T10,NH303,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),31.2,31.2,,,28.0,34.6,Age,45-64,C2,T10,NH303,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),31.2,31.2,,,26.3,36.6,Age,65+,C2,T10,NH303,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),36.5,36.5,,,34.0,39.1,Age,35+,C2,T10,NH303,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),33.7,33.7,,,29.1,38.7,Age,75+,C2,T10,NH303,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),43.6,43.6,,,41.3,45.9,Race,Non-Hispanic White,C2,T10,NH303,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.9,46.9,,,44.5,49.2,Race,Non-Hispanic White,C2,T10,NH303,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),50.3,50.3,,,46.8,53.8,Race,Non-Hispanic Black,C2,T10,NH303,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),51.3,51.3,,,46.7,55.9,Race,Non-Hispanic Black,C2,T10,NH303,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH303,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T10,NH303,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH303,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T10,NH303,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),55.5,55.5,,,47.6,63.1,Race,Other,C2,T10,NH303,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),54.5,54.5,,,46.4,62.3,Race,Other,C2,T10,NH303,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.2,46.2,,,44.6,47.7,Overall,Overall,C2,T10,NH303,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),44.4,44.4,,,42.0,46.8,Overall,Overall,C2,T10,NH303,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),45.9,45.9,,,43.4,48.4,Gender,Male,C2,T10,NH303,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.8,46.8,,,45.0,48.6,Gender,Male,C2,T10,NH303,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),45.8,45.8,,,43.5,48.0,Gender,Female,C2,T10,NH303,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),43.0,43.0,,,40.0,46.0,Gender,Female,C2,T10,NH303,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),80.3,80.3,,,73.2,85.9,Age,20-24,C2,T10,NH303,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),61.6,61.6,,,59.3,63.8,Age,25-44,C2,T10,NH303,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),28.3,28.3,,,25.5,31.4,Age,45-64,C2,T10,NH303,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),24.1,24.1,,,21.7,26.6,Age,65+,C2,T10,NH303,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),33.5,33.5,,,31.6,35.4,Age,35+,C2,T10,NH303,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),27.9,27.9,,,25.1,30.9,Age,75+,C2,T10,NH303,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),41.2,41.2,,,38.7,43.8,Race,Non-Hispanic White,C2,T10,NH303,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),45.5,45.5,,,43.4,47.5,Race,Non-Hispanic White,C2,T10,NH303,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),50.0,50.0,,,47.5,52.5,Race,Non-Hispanic Black,C2,T10,NH303,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),50.7,50.7,,,48.0,53.5,Race,Non-Hispanic Black,C2,T10,NH303,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),49.7,49.7,,,43.1,56.3,Race,Non-Hispanic Asian,C2,T10,NH303,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),48.1,48.1,,,42.4,53.7,Race,Non-Hispanic Asian,C2,T10,NH303,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.8,46.8,,,43.9,49.7,Race,Hispanic,C2,T10,NH303,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),51.7,51.7,,,48.3,55.1,Race,Hispanic,C2,T10,NH303,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),49.6,49.6,,,43.6,55.6,Race,Other,C2,T10,NH303,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),48.4,48.4,,,43.6,53.3,Race,Other,C2,T10,NH303,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),50.2,50.2,,,46.9,53.5,Overall,Overall,C2,T10,NH303,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),48.3,48.3,,,44.9,51.8,Overall,Overall,C2,T10,NH303,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),48.7,48.7,,,44.5,53.0,Gender,Male,C2,T10,NH303,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),49.6,49.6,,,45.5,53.7,Gender,Male,C2,T10,NH303,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),51.0,51.0,,,47.4,54.7,Gender,Female,C2,T10,NH303,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),48.0,48.0,,,44.2,51.7,Gender,Female,C2,T10,NH303,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),85.7,85.7,,,81.2,89.2,Age,20-24,C2,T10,NH303,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),63.1,63.1,,,58.5,67.5,Age,25-44,C2,T10,NH303,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),35.2,35.2,,,31.7,38.8,Age,45-64,C2,T10,NH303,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),26.9,26.9,,,22.1,32.3,Age,65+,C2,T10,NH303,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),37.9,37.9,,,35.1,40.8,Age,35+,C2,T10,NH303,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),27.5,27.5,,,23.6,31.7,Age,75+,C2,T10,NH303,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),44.5,44.5,,,40.4,48.8,Race,Non-Hispanic White,C2,T10,NH303,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),48.5,48.5,,,44.2,52.8,Race,Non-Hispanic White,C2,T10,NH303,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),56.9,56.9,,,54.1,59.8,Race,Non-Hispanic Black,C2,T10,NH303,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),57.0,57.0,,,53.6,60.4,Race,Non-Hispanic Black,C2,T10,NH303,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),49.6,49.6,,,44.3,54.9,Race,Non-Hispanic Asian,C2,T10,NH303,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),49.1,49.1,,,44.9,53.3,Race,Non-Hispanic Asian,C2,T10,NH303,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),51.5,51.5,,,48.6,54.4,Race,Hispanic,C2,T10,NH303,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),56.0,56.0,,,52.9,59.1,Race,Hispanic,C2,T10,NH303,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Crude,Percent (%),54.4,54.4,,,49.8,58.9,Race,Other,C2,T10,NH303,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal cholesterol status among US adults (20+); NHANES,Age-Standardized,Percent (%),52.3,52.3,,,48.2,56.3,Race,Other,C2,T10,NH303,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),8.2,8.2,,,6.9,9.6,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),8.4,8.4,,,7.2,9.9,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),8.7,8.7,,,7.2,10.4,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.5,9.5,,,7.9,11.5,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),7.7,7.7,,,6.3,9.4,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),7.5,7.5,,,6.2,9.1,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),3.1,3.1,,,2.0,4.7,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.9,12.9,,,10.6,15.6,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),20.0,20.0,,,16.9,23.5,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.6,11.6,,,9.8,13.6,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),18.0,18.0,,,13.2,23.9,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),6.9,6.9,,,5.6,8.5,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.5,12.5,,,10.6,14.7,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),15.2,15.2,,,13.3,17.3,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),15.8,15.8,,,8.6,27.1,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),8.9,8.9,,,7.8,10.1,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),8.8,8.8,,,7.7,9.9,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),9.6,9.6,,,8.2,11.3,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.1,10.1,,,8.6,12.0,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),7.9,7.9,,,6.9,9.1,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),7.7,7.7,,,6.7,8.9,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),4.1,4.1,,,2.9,5.8,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.9,11.9,,,9.5,14.8,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),20.8,20.8,,,19.2,22.4,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.8,11.8,,,10.5,13.2,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),20.0,20.0,,,16.5,24.0,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),7.1,7.1,,,6.2,8.2,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),7.5,7.5,,,6.7,8.5,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),14.9,14.9,,,12.8,17.1,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),14.9,14.9,,,8.5,24.9,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.9,16.9,,,9.5,28.2,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),9.9,9.9,,,8.7,11.1,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.7,9.7,,,8.6,10.8,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.7,10.7,,,9.4,12.1,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.4,10.4,,,9.0,11.9,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),9.4,9.4,,,8.2,10.7,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),8.8,8.8,,,7.7,10.0,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),3.9,3.9,,,2.9,5.1,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.8,13.8,,,11.8,16.2,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),22.3,22.3,,,19.3,25.5,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.4,13.4,,,11.9,15.0,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),17.8,17.8,,,15.0,21.1,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),8.9,8.9,,,7.7,10.3,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),8.1,8.1,,,7.0,9.4,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.5,12.5,,,10.7,14.5,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),13.7,13.7,,,11.6,16.1,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),14.2,14.2,,,10.1,19.7,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),15.4,15.4,,,10.7,21.5,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),9.7,9.7,,,8.4,11.1,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.3,9.3,,,8.4,10.3,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.5,9.5,,,8.2,11.1,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),9.5,9.5,,,7.8,11.4,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),9.8,9.8,,,8.4,11.6,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.0,9.0,,,7.8,10.4,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),4.7,4.7,,,3.6,6.0,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.2,12.2,,,10.0,14.8,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),21.6,21.6,,,19.3,24.2,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.8,12.8,,,11.3,14.6,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),20.1,20.1,,,17.2,23.3,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),8.3,8.3,,,6.8,10.2,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),7.4,7.4,,,6.4,8.6,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.5,15.5,,,12.5,19.0,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.7,16.7,,,14.4,19.3,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.2,11.2,,,9.3,13.4,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.3,10.3,,,8.7,12.2,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),4.0,4.0,,,3.3,4.9,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.7,15.7,,,13.3,18.6,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),27.4,27.4,,,23.0,32.2,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.6,15.6,,,13.6,17.9,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),26.0,26.0,,,21.8,30.8,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.6,10.6,,,8.5,13.2,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.5,9.5,,,7.6,11.7,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),19.2,19.2,,,17.0,21.5,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),20.1,20.1,,,18.1,22.3,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.8,12.8,,,8.3,19.1,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),13.3,13.3,,,9.7,18.0,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.6,11.6,,,10.4,12.8,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.9,10.9,,,9.8,12.1,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.6,12.6,,,10.9,14.4,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),12.2,12.2,,,10.6,14.0,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.6,10.6,,,9.5,11.9,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.6,9.6,,,8.5,10.9,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),4.1,4.1,,,3.2,5.3,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.2,15.2,,,13.1,17.6,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),26.9,26.9,,,23.8,30.2,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.5,15.5,,,13.9,17.2,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),26.4,26.4,,,22.6,30.6,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.3,10.3,,,8.7,12.1,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),8.9,8.9,,,7.6,10.4,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.4,16.4,,,14.0,19.0,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),17.2,17.2,,,15.8,18.7,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.9,12.9,,,9.4,17.4,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),15.6,15.6,,,11.8,20.3,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.7,11.7,,,10.4,13.1,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.9,10.9,,,9.7,12.2,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),12.1,12.1,,,10.2,14.2,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.5,12.5,,,10.4,15.0,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),10.9,10.9,,,9.4,12.5,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.8,9.8,,,8.5,11.3,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),5.4,5.4,,,4.2,6.9,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.3,15.3,,,13.1,17.7,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),24.5,24.5,,,21.9,27.3,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.7,15.7,,,13.9,17.8,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),25.8,25.8,,,22.0,29.9,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),8.3,8.3,,,7.2,9.5,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),9.7,9.7,,,8.3,11.4,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),18.2,18.2,,,14.7,22.2,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),19.0,19.0,,,15.8,22.6,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.8,13.8,,,10.9,17.3,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),14.7,14.7,,,12.2,17.7,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.4,13.4,,,11.0,16.2,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.7,16.7,,,14.0,19.8,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.5,15.5,,,10.9,21.7,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.3,16.3,,,12.3,21.3,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.1,12.1,,,11.2,13.1,Overall,Overall,C2,T11,NH070,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),11.2,11.2,,,10.3,12.2,Overall,Overall,C2,T11,NH070,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.0,13.0,,,11.7,14.4,Gender,Male,C2,T11,NH070,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),12.4,12.4,,,11.2,13.6,Gender,Male,C2,T11,NH070,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.3,11.3,,,10.1,12.7,Gender,Female,C2,T11,NH070,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),10.3,10.3,,,9.1,11.6,Gender,Female,C2,T11,NH070,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T11,NH070,Crude,BOC03,AGE01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),4.8,4.8,,,4.1,5.7,Age,25-44,C2,T11,NH070,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.4,16.4,,,14.1,19.0,Age,45-64,C2,T11,NH070,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),25.0,25.0,,,22.3,28.0,Age,65+,C2,T11,NH070,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.5,16.5,,,15.2,17.8,Age,35+,C2,T11,NH070,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),24.9,24.9,,,20.6,29.8,Age,75+,C2,T11,NH070,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),11.3,11.3,,,10.0,12.8,Race,Non-Hispanic White,C2,T11,NH070,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),9.6,9.6,,,8.3,11.1,Race,Non-Hispanic White,C2,T11,NH070,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),16.4,16.4,,,14.6,18.4,Race,Non-Hispanic Black,C2,T11,NH070,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),16.3,16.3,,,14.1,18.8,Race,Non-Hispanic Black,C2,T11,NH070,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),15.3,15.3,,,12.1,19.0,Race,Non-Hispanic Asian,C2,T11,NH070,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),15.5,15.5,,,13.2,18.1,Race,Non-Hispanic Asian,C2,T11,NH070,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),12.3,12.3,,,10.7,14.0,Race,Hispanic,C2,T11,NH070,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),15.6,15.6,,,14.1,17.2,Race,Hispanic,C2,T11,NH070,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Crude,Percent (%),13.0,13.0,,,10.4,16.2,Race,Other,C2,T11,NH070,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+); NHANES,Age-Standardized,Percent (%),14.1,14.1,,,11.5,17.2,Race,Other,C2,T11,NH070,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),10.3,10.3,,,8.4,12.7,Overall,Overall,C2,T11,NH401,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,8.6,13.4,Overall,Overall,C2,T11,NH401,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),11.7,11.7,,,9.1,15.0,Gender,Male,C2,T11,NH401,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),10.5,10.5,,,8.4,13.0,Gender,Male,C2,T11,NH401,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),10.2,10.2,,,7.8,13.3,Gender,Female,C2,T11,NH401,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.2,10.2,,,7.8,13.3,Gender,Female,C2,T11,NH401,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH401,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),3.3,3.3,,,1.9,5.9,Age,25-44,C2,T11,NH401,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),15.8,15.8,,,12.2,20.2,Age,45-64,C2,T11,NH401,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),26.7,26.7,,,22.0,32.0,Age,65+,C2,T11,NH401,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),14.1,14.1,,,11.3,17.5,Age,35+,C2,T11,NH401,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),25.0,25.0,,,17.4,34.5,Age,75+,C2,T11,NH401,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),9.0,9.0,,,6.7,12.0,Race,Non-Hispanic White,C2,T11,NH401,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),8.7,8.7,,,6.3,11.9,Race,Non-Hispanic White,C2,T11,NH401,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),15.6,15.6,,,12.2,19.8,Race,Non-Hispanic Black,C2,T11,NH401,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),20.0,20.0,,,16.5,24.1,Race,Non-Hispanic Black,C2,T11,NH401,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH401,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH401,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH401,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH401,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T11,NH401,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),22.0,22.0,,,12.0,36.7,Race,Other,C2,T11,NH401,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),11.1,11.1,,,9.3,13.0,Overall,Overall,C2,T11,NH401,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),11.8,11.8,,,10.3,13.5,Overall,Overall,C2,T11,NH401,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),12.2,12.2,,,9.7,15.3,Gender,Male,C2,T11,NH401,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.4,13.4,,,11.0,16.0,Gender,Male,C2,T11,NH401,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),9.9,9.9,,,8.0,12.3,Gender,Female,C2,T11,NH401,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.3,10.3,,,8.4,12.5,Gender,Female,C2,T11,NH401,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH401,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),5.6,5.6,,,3.3,9.4,Age,25-44,C2,T11,NH401,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),14.6,14.6,,,11.4,18.5,Age,45-64,C2,T11,NH401,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),27.9,27.9,,,25.5,30.5,Age,65+,C2,T11,NH401,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),14.7,14.7,,,12.8,16.8,Age,35+,C2,T11,NH401,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),23.6,23.6,,,18.3,29.8,Age,75+,C2,T11,NH401,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.0,10.0,,,8.7,11.5,Race,Non-Hispanic White,C2,T11,NH401,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),10.0,10.0,,,8.5,11.6,Race,Non-Hispanic White,C2,T11,NH401,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),17.4,17.4,,,13.5,22.0,Race,Non-Hispanic Black,C2,T11,NH401,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),14.8,14.8,,,11.1,19.5,Race,Non-Hispanic Black,C2,T11,NH401,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH401,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH401,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH401,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH401,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T11,NH401,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T11,NH401,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),11.4,11.4,,,9.7,13.4,Overall,Overall,C2,T11,NH401,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),11.3,11.3,,,9.6,13.3,Overall,Overall,C2,T11,NH401,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),11.8,11.8,,,9.3,14.9,Gender,Male,C2,T11,NH401,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.3,12.3,,,9.8,15.3,Gender,Male,C2,T11,NH401,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),11.0,11.0,,,9.4,12.9,Gender,Female,C2,T11,NH401,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.4,10.4,,,8.9,12.2,Gender,Female,C2,T11,NH401,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH401,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),4.3,4.3,,,3.0,6.1,Age,25-44,C2,T11,NH401,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),15.4,15.4,,,12.4,19.1,Age,45-64,C2,T11,NH401,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),26.7,26.7,,,22.0,32.1,Age,65+,C2,T11,NH401,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),15.2,15.2,,,12.8,17.9,Age,35+,C2,T11,NH401,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),23.6,23.6,,,18.2,29.9,Age,75+,C2,T11,NH401,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),9.6,9.6,,,7.5,12.2,Race,Non-Hispanic White,C2,T11,NH401,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),9.0,9.0,,,7.1,11.3,Race,Non-Hispanic White,C2,T11,NH401,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),18.1,18.1,,,14.4,22.5,Race,Non-Hispanic Black,C2,T11,NH401,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),20.0,20.0,,,16.6,23.8,Race,Non-Hispanic Black,C2,T11,NH401,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH401,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH401,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH401,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH401,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),16.1,16.1,,,10.1,24.7,Race,Other,C2,T11,NH401,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),17.4,17.4,,,11.2,26.0,Race,Other,C2,T11,NH401,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),13.0,13.0,,,11.0,15.2,Overall,Overall,C2,T11,NH401,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.1,13.1,,,11.8,14.6,Overall,Overall,C2,T11,NH401,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),11.8,11.8,,,9.6,14.3,Gender,Male,C2,T11,NH401,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.3,12.3,,,10.6,14.1,Gender,Male,C2,T11,NH401,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),14.2,14.2,,,11.4,17.5,Gender,Female,C2,T11,NH401,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.8,13.8,,,11.4,16.5,Gender,Female,C2,T11,NH401,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH401,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),6.5,6.5,,,4.3,9.8,Age,25-44,C2,T11,NH401,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),15.6,15.6,,,12.8,18.9,Age,45-64,C2,T11,NH401,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),30.4,30.4,,,26.1,35.2,Age,65+,C2,T11,NH401,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),17.0,17.0,,,14.6,19.7,Age,35+,C2,T11,NH401,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),27.8,27.8,,,20.4,36.7,Age,75+,C2,T11,NH401,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),11.4,11.4,,,9.2,14.0,Race,Non-Hispanic White,C2,T11,NH401,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,9.3,12.6,Race,Non-Hispanic White,C2,T11,NH401,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),21.6,21.6,,,17.9,25.8,Race,Non-Hispanic Black,C2,T11,NH401,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),32.4,32.4,,,28.8,36.1,Age,75+,C2,T13,NH072,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),24.2,24.2,,,21.5,27.2,Race,Non-Hispanic Black,C2,T11,NH401,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH401,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH401,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH401,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH401,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T11,NH401,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.4,14.4,,,8.0,24.5,Race,Other,C2,T11,NH401,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),15.3,15.3,,,12.6,18.4,Overall,Overall,C2,T11,NH401,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.2,15.2,,,12.5,18.3,Overall,Overall,C2,T11,NH401,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),16.8,16.8,,,14.5,19.5,Gender,Male,C2,T11,NH401,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),17.5,17.5,,,14.9,20.5,Gender,Male,C2,T11,NH401,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),13.9,13.9,,,10.0,19.0,Gender,Female,C2,T11,NH401,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.4,13.4,,,9.9,17.8,Gender,Female,C2,T11,NH401,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH401,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),5.4,5.4,,,4.0,7.2,Age,25-44,C2,T11,NH401,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),19.8,19.8,,,16.2,23.9,Age,45-64,C2,T11,NH401,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),37.2,37.2,,,27.8,47.7,Age,65+,C2,T11,NH401,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),20.2,20.2,,,16.4,24.6,Age,35+,C2,T11,NH401,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),34.6,34.6,,,25.7,44.8,Age,75+,C2,T11,NH401,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),14.2,14.2,,,10.4,19.0,Race,Non-Hispanic White,C2,T11,NH401,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.2,13.2,,,9.9,17.4,Race,Non-Hispanic White,C2,T11,NH401,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),24.4,24.4,,,20.3,29.1,Race,Non-Hispanic Black,C2,T11,NH401,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.9,26.9,,,23.4,30.6,Race,Non-Hispanic Black,C2,T11,NH401,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH401,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH401,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T11,NH401,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T11,NH401,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T11,NH401,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.1,15.1,,,8.2,26.2,Race,Other,C2,T11,NH401,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),15.2,15.2,,,13.4,17.1,Overall,Overall,C2,T11,NH401,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.5,14.5,,,12.6,16.6,Overall,Overall,C2,T11,NH401,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),17.5,17.5,,,14.6,20.7,Gender,Male,C2,T11,NH401,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),17.1,17.1,,,14.3,20.3,Gender,Male,C2,T11,NH401,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),13.1,13.1,,,11.5,14.9,Gender,Female,C2,T11,NH401,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.3,12.3,,,10.7,14.1,Gender,Female,C2,T11,NH401,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH401,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),4.3,4.3,,,2.8,6.5,Age,25-44,C2,T11,NH401,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),19.8,19.8,,,15.8,24.4,Age,45-64,C2,T11,NH401,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),36.6,36.6,,,32.1,41.5,Age,65+,C2,T11,NH401,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),20.3,20.3,,,17.9,22.9,Age,35+,C2,T11,NH401,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),35.1,35.1,,,27.4,43.7,Age,75+,C2,T11,NH401,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),13.5,13.5,,,11.3,16.0,Race,Non-Hispanic White,C2,T11,NH401,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),11.9,11.9,,,10.0,14.2,Race,Non-Hispanic White,C2,T11,NH401,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),21.2,21.2,,,19.0,23.5,Race,Non-Hispanic Black,C2,T11,NH401,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),21.8,21.8,,,19.1,24.7,Race,Non-Hispanic Black,C2,T11,NH401,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH401,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH401,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T11,NH401,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T11,NH401,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),21.1,21.1,,,16.2,27.0,Race,Other,C2,T11,NH401,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),20.4,20.4,,,14.4,28.1,Race,Other,C2,T11,NH401,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),15.7,15.7,,,13.5,18.2,Overall,Overall,C2,T11,NH401,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.1,15.1,,,13.0,17.4,Overall,Overall,C2,T11,NH401,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),16.6,16.6,,,14.1,19.5,Gender,Male,C2,T11,NH401,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.0,16.0,,,13.6,18.7,Gender,Male,C2,T11,NH401,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),14.8,14.8,,,12.3,17.7,Gender,Female,C2,T11,NH401,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.1,14.1,,,11.8,16.8,Gender,Female,C2,T11,NH401,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH401,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),4.9,4.9,,,3.1,7.6,Age,25-44,C2,T11,NH401,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),20.6,20.6,,,17.1,24.5,Age,45-64,C2,T11,NH401,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),38.6,38.6,,,31.9,45.7,Age,65+,C2,T11,NH401,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),20.9,20.9,,,17.8,24.4,Age,35+,C2,T11,NH401,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),45.5,45.5,,,37.2,53.9,Age,75+,C2,T11,NH401,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),13.5,13.5,,,10.7,16.9,Race,Non-Hispanic White,C2,T11,NH401,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.1,12.1,,,9.8,14.9,Race,Non-Hispanic White,C2,T11,NH401,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),26.6,26.6,,,22.3,31.3,Race,Non-Hispanic Black,C2,T11,NH401,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.5,26.5,,,22.5,31.0,Race,Non-Hispanic Black,C2,T11,NH401,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.6,18.6,,,14.8,23.2,Race,Non-Hispanic Asian,C2,T11,NH401,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),16.3,16.3,,,12.4,21.0,Race,Non-Hispanic Asian,C2,T11,NH401,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),16.4,16.4,,,12.0,22.1,Race,Hispanic,C2,T11,NH401,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),21.5,21.5,,,17.1,26.6,Race,Hispanic,C2,T11,NH401,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),20.8,20.8,,,16.8,25.4,Race,Other,C2,T11,NH401,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),20.4,20.4,,,14.0,28.8,Race,Other,C2,T11,NH401,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),17.3,17.3,,,14.9,20.1,Overall,Overall,C2,T11,NH401,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.1,16.1,,,14.3,18.1,Overall,Overall,C2,T11,NH401,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),19.4,19.4,,,16.3,23.1,Gender,Male,C2,T11,NH401,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.4,18.4,,,16.1,21.0,Gender,Male,C2,T11,NH401,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),15.4,15.4,,,13.2,17.8,Gender,Female,C2,T11,NH401,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.1,14.1,,,12.3,16.1,Gender,Female,C2,T11,NH401,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH401,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),5.4,5.4,,,3.8,7.5,Age,25-44,C2,T11,NH401,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),23.8,23.8,,,19.4,28.9,Age,45-64,C2,T11,NH401,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),35.7,35.7,,,30.7,41.0,Age,65+,C2,T11,NH401,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),22.8,22.8,,,20.0,25.8,Age,35+,C2,T11,NH401,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),36.8,36.8,,,29.6,44.5,Age,75+,C2,T11,NH401,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.8,14.8,,,12.1,17.8,Race,Non-Hispanic White,C2,T11,NH401,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),16.9,16.9,,,13.8,20.7,Race,Non-Hispanic White,C2,T11,NH401,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),22.6,22.6,,,19.8,25.5,Race,Non-Hispanic Black,C2,T11,NH401,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),21.8,21.8,,,19.9,23.7,Race,Non-Hispanic Black,C2,T11,NH401,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.8,18.8,,,14.5,24.1,Race,Non-Hispanic Asian,C2,T11,NH401,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),17.6,17.6,,,12.4,24.3,Race,Non-Hispanic Asian,C2,T11,NH401,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),15.7,15.7,,,12.9,19.0,Race,Hispanic,C2,T11,NH401,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),20.0,20.0,,,17.1,23.4,Race,Hispanic,C2,T11,NH401,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.6,18.6,,,14.0,24.3,Race,Other,C2,T11,NH401,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),17.2,17.2,,,12.2,23.7,Race,Other,C2,T11,NH401,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),89.9,89.9,,,87.1,92.1,Overall,Overall,C2,T11,NH403,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),90.3,90.3,,,88.0,92.2,Overall,Overall,C2,T11,NH403,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),90.3,90.3,,,87.5,92.5,Gender,Male,C2,T11,NH403,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),89.2,89.2,,,85.8,91.8,Gender,Male,C2,T11,NH403,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),90.4,90.4,,,87.4,92.7,Gender,Female,C2,T11,NH403,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),90.4,90.4,,,87.3,92.8,Gender,Female,C2,T11,NH403,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH403,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T11,NH403,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),85.4,85.4,,,80.8,89.0,Age,45-64,C2,T11,NH403,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),73.2,73.2,,,68.0,77.9,Age,65+,C2,T11,NH403,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),86.6,86.6,,,83.1,89.5,Age,35+,C2,T11,NH403,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),75.1,75.1,,,65.4,82.7,Age,75+,C2,T11,NH403,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),92.1,92.1,,,88.4,94.7,Race,Non-Hispanic White,C2,T11,NH403,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),91.8,91.8,,,88.4,94.3,Race,Non-Hispanic White,C2,T11,NH403,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),80.3,80.3,,,76.8,83.5,Race,Non-Hispanic Black,C2,T11,NH403,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),84.6,84.6,,,80.8,87.8,Race,Non-Hispanic Black,C2,T11,NH403,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH403,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH403,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH403,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH403,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),78.7,78.7,,,64.8,88.1,Race,Other,C2,T11,NH403,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T11,NH403,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),89.3,89.3,,,87.2,91.1,Overall,Overall,C2,T11,NH403,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),88.6,88.6,,,86.7,90.2,Overall,Overall,C2,T11,NH403,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),87.5,87.5,,,85.1,89.6,Gender,Male,C2,T11,NH403,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),88.8,88.8,,,86.0,91.0,Gender,Male,C2,T11,NH403,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),89.5,89.5,,,86.9,91.6,Gender,Female,C2,T11,NH403,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),89.8,89.8,,,87.3,91.9,Gender,Female,C2,T11,NH403,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH403,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),94.3,94.3,,,90.5,96.7,Age,25-44,C2,T11,NH403,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),86.0,86.0,,,81.9,89.3,Age,45-64,C2,T11,NH403,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),73.6,73.6,,,70.7,76.3,Age,65+,C2,T11,NH403,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),85.9,85.9,,,83.7,87.8,Age,35+,C2,T11,NH403,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),76.1,76.1,,,69.3,81.9,Age,75+,C2,T11,NH403,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),90.7,90.7,,,89.1,92.0,Race,Non-Hispanic White,C2,T11,NH403,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),90.6,90.6,,,89.2,91.9,Race,Non-Hispanic White,C2,T11,NH403,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),80.9,80.9,,,76.6,84.5,Race,Non-Hispanic Black,C2,T11,NH403,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),83.7,83.7,,,78.6,87.8,Race,Non-Hispanic Black,C2,T11,NH403,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH403,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH403,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH403,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH403,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T11,NH403,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T11,NH403,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),88.3,88.3,,,86.4,90.0,Overall,Overall,C2,T11,NH403,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),88.3,88.3,,,86.2,90.1,Overall,Overall,C2,T11,NH403,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),87.5,87.5,,,85.0,89.7,Gender,Male,C2,T11,NH403,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),88.1,88.1,,,85.2,90.5,Gender,Male,C2,T11,NH403,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),89.0,89.0,,,87.1,90.7,Gender,Female,C2,T11,NH403,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),88.4,88.4,,,86.2,90.3,Gender,Female,C2,T11,NH403,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH403,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),96.3,96.3,,,94.3,97.6,Age,25-44,C2,T11,NH403,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),83.7,83.7,,,80.4,86.5,Age,45-64,C2,T11,NH403,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),71.2,71.2,,,65.8,76.1,Age,65+,C2,T11,NH403,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),84.2,84.2,,,81.4,86.6,Age,35+,C2,T11,NH403,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),75.1,75.1,,,68.5,80.7,Age,75+,C2,T11,NH403,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),89.8,89.8,,,87.4,91.9,Race,Non-Hispanic White,C2,T11,NH403,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),90.5,90.5,,,88.3,92.3,Race,Non-Hispanic White,C2,T11,NH403,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),81.0,81.0,,,76.3,84.9,Race,Non-Hispanic Black,C2,T11,NH403,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),78.9,78.9,,,74.8,82.6,Race,Non-Hispanic Black,C2,T11,NH403,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH403,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH403,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH403,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH403,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),84.6,84.6,,,76.4,90.3,Race,Other,C2,T11,NH403,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),86.2,86.2,,,78.5,91.5,Race,Other,C2,T11,NH403,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),86.4,86.4,,,85.0,87.7,Overall,Overall,C2,T11,NH403,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),86.5,86.5,,,84.5,88.3,Overall,Overall,C2,T11,NH403,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),87.9,87.9,,,86.1,89.6,Gender,Male,C2,T11,NH403,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),88.5,88.5,,,86.2,90.4,Gender,Male,C2,T11,NH403,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),85.1,85.1,,,82.4,87.3,Gender,Female,C2,T11,NH403,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),84.6,84.6,,,81.4,87.3,Gender,Female,C2,T11,NH403,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH403,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),93.9,93.9,,,91.2,95.8,Age,25-44,C2,T11,NH403,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),83.0,83.0,,,79.6,85.9,Age,45-64,C2,T11,NH403,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),68.5,68.5,,,64.3,72.4,Age,65+,C2,T11,NH403,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),82.4,82.4,,,80.0,84.6,Age,35+,C2,T11,NH403,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),74.0,74.0,,,67.1,79.8,Age,75+,C2,T11,NH403,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),89.1,89.1,,,87.5,90.6,Race,Non-Hispanic White,C2,T11,NH403,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),88.6,88.6,,,86.2,90.7,Race,Non-Hispanic White,C2,T11,NH403,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),77.3,77.3,,,73.2,80.9,Race,Non-Hispanic Black,C2,T11,NH403,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),74.5,74.5,,,71.2,77.6,Race,Non-Hispanic Black,C2,T11,NH403,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH403,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH403,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH403,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T11,NH403,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),81.0,81.0,,,72.7,87.3,Race,Other,C2,T11,NH403,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),85.5,85.5,,,78.2,90.6,Race,Other,C2,T11,NH403,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),83.5,83.5,,,79.9,86.5,Overall,Overall,C2,T11,NH403,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),83.6,83.6,,,80.1,86.6,Overall,Overall,C2,T11,NH403,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),83.2,83.2,,,80.8,85.3,Gender,Male,C2,T11,NH403,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),82.5,82.5,,,80.0,84.7,Gender,Male,C2,T11,NH403,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),84.5,84.5,,,79.1,88.7,Gender,Female,C2,T11,NH403,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),83.8,83.8,,,77.5,88.5,Gender,Female,C2,T11,NH403,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH403,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),94.9,94.9,,,92.6,96.5,Age,25-44,C2,T11,NH403,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),78.1,78.1,,,73.0,82.4,Age,45-64,C2,T11,NH403,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),59.0,59.0,,,50.3,67.3,Age,65+,C2,T11,NH403,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),78.1,78.1,,,73.1,82.4,Age,35+,C2,T11,NH403,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),61.1,61.1,,,53.7,68.0,Age,75+,C2,T11,NH403,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),85.7,85.7,,,80.8,89.5,Race,Non-Hispanic White,C2,T11,NH403,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),84.5,84.5,,,79.0,88.8,Race,Non-Hispanic White,C2,T11,NH403,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),74.4,74.4,,,69.5,78.8,Race,Non-Hispanic Black,C2,T11,NH403,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),72.0,72.0,,,68.3,75.4,Race,Non-Hispanic Black,C2,T11,NH403,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH403,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH403,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T11,NH403,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T11,NH403,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T11,NH403,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),80.6,80.6,,,69.5,88.3,Race,Other,C2,T11,NH403,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),84.0,84.0,,,82.0,85.7,Overall,Overall,C2,T11,NH403,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),83.2,83.2,,,81.4,84.9,Overall,Overall,C2,T11,NH403,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),82.1,82.1,,,79.0,84.8,Gender,Male,C2,T11,NH403,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),81.7,81.7,,,78.5,84.6,Gender,Male,C2,T11,NH403,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),85.5,85.5,,,83.7,87.2,Gender,Female,C2,T11,NH403,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),84.6,84.6,,,82.6,86.3,Gender,Female,C2,T11,NH403,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH403,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),94.9,94.9,,,92.6,96.6,Age,25-44,C2,T11,NH403,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),78.6,78.6,,,74.6,82.2,Age,45-64,C2,T11,NH403,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),58.7,58.7,,,53.7,63.6,Age,65+,C2,T11,NH403,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),77.6,77.6,,,75.2,79.9,Age,35+,C2,T11,NH403,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),59.3,59.3,,,51.8,66.4,Age,75+,C2,T11,NH403,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),86.7,86.7,,,84.3,88.8,Race,Non-Hispanic White,C2,T11,NH403,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),85.0,85.0,,,82.2,87.4,Race,Non-Hispanic White,C2,T11,NH403,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),75.6,75.6,,,72.3,78.7,Race,Non-Hispanic Black,C2,T11,NH403,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),76.4,76.4,,,73.7,78.9,Race,Non-Hispanic Black,C2,T11,NH403,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH403,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T11,NH403,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T11,NH403,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T11,NH403,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),76.8,76.8,,,70.1,82.3,Race,Other,C2,T11,NH403,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),77.5,77.5,,,69.1,84.1,Race,Other,C2,T11,NH403,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),83.2,83.2,,,80.4,85.7,Overall,Overall,C2,T11,NH403,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),83.9,83.9,,,81.4,86.2,Overall,Overall,C2,T11,NH403,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),82.8,82.8,,,80.3,85.1,Gender,Male,C2,T11,NH403,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),82.1,82.1,,,79.2,84.7,Gender,Male,C2,T11,NH403,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),85.0,85.0,,,81.9,87.8,Gender,Female,C2,T11,NH403,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),84.4,84.4,,,80.8,87.3,Gender,Female,C2,T11,NH403,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH403,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),95.3,95.3,,,92.9,96.9,Age,25-44,C2,T11,NH403,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),78.5,78.5,,,74.6,82.0,Age,45-64,C2,T11,NH403,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),56.3,56.3,,,48.0,64.2,Age,65+,C2,T11,NH403,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),77.5,77.5,,,73.8,80.9,Age,35+,C2,T11,NH403,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),52.7,52.7,,,42.9,62.2,Age,75+,C2,T11,NH403,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),87.3,87.3,,,84.7,89.6,Race,Non-Hispanic White,C2,T11,NH403,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),85.8,85.8,,,82.5,88.6,Race,Non-Hispanic White,C2,T11,NH403,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),70.2,70.2,,,65.3,74.7,Race,Non-Hispanic Black,C2,T11,NH403,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),70.3,70.3,,,65.8,74.5,Race,Non-Hispanic Black,C2,T11,NH403,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),80.6,80.6,,,75.0,85.2,Race,Non-Hispanic Asian,C2,T11,NH403,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),82.9,82.9,,,77.0,87.5,Race,Non-Hispanic Asian,C2,T11,NH403,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),77.1,77.1,,,72.3,81.3,Race,Hispanic,C2,T11,NH403,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),83.0,83.0,,,77.5,87.3,Race,Hispanic,C2,T11,NH403,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),76.6,76.6,,,68.9,82.9,Race,Other,C2,T11,NH403,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),76.8,76.8,,,63.9,86.1,Race,Other,C2,T11,NH403,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),83.3,83.3,,,81.4,84.9,Overall,Overall,C2,T11,NH403,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),81.9,81.9,,,79.2,84.3,Overall,Overall,C2,T11,NH403,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),81.7,81.7,,,79.5,83.8,Gender,Male,C2,T11,NH403,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),80.6,80.6,,,77.4,83.5,Gender,Male,C2,T11,NH403,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),83.0,83.0,,,80.1,85.5,Gender,Female,C2,T11,NH403,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),84.6,84.6,,,82.3,86.6,Gender,Female,C2,T11,NH403,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T11,NH403,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),94.8,94.8,,,92.6,96.4,Age,25-44,C2,T11,NH403,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),75.4,75.4,,,70.5,79.7,Age,45-64,C2,T11,NH403,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),60.3,60.3,,,54.5,65.8,Age,65+,C2,T11,NH403,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),75.8,75.8,,,72.7,78.7,Age,35+,C2,T11,NH403,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),59.9,59.9,,,52.0,67.3,Age,75+,C2,T11,NH403,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),82.7,82.7,,,79.0,85.8,Race,Non-Hispanic White,C2,T11,NH403,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),85.1,85.1,,,82.4,87.5,Race,Non-Hispanic White,C2,T11,NH403,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),75.8,75.8,,,73.1,78.2,Race,Non-Hispanic Black,C2,T11,NH403,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),75.0,75.0,,,71.6,78.1,Race,Non-Hispanic Black,C2,T11,NH403,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),81.5,81.5,,,73.7,87.4,Race,Non-Hispanic Asian,C2,T11,NH403,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),80.2,80.2,,,74.7,84.7,Race,Non-Hispanic Asian,C2,T11,NH403,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),77.9,77.9,,,74.2,81.1,Race,Hispanic,C2,T11,NH403,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),82.8,82.8,,,78.8,86.1,Race,Hispanic,C2,T11,NH403,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Age-Standardized,Percent (%),79.9,79.9,,,73.5,85.1,Race,Other,C2,T11,NH403,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and fasting glucose status among US adults (20+); NHANES,Crude,Percent (%),82.0,82.0,,,74.1,87.9,Race,Other,C2,T11,NH403,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH073,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH073,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH073,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH073,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),68.2,68.2,,,64.6,71.6,Gender,Female,C2,T12,NH501,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH073,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),79.6,79.6,,,76.5,82.3,Gender,Male,C2,T12,NH501,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH073,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH073,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),79.8,79.8,,,76.4,82.7,Gender,Male,C2,T12,NH501,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T12,NH073,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH073,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH073,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH073,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH073,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T12,NH073,Crude,BOC03,AGE01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH073,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH073,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH073,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH073,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH073,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH073,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH073,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T12,NH073,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T12,NH073,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH073,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH073,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age-Standardized,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Crude,Mean (mg/day),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH073,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH501,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH501,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH501,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH501,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH501,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH501,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T12,NH501,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH501,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH501,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH501,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH501,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH501,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH501,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH501,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH501,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH501,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH501,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH501,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH501,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH501,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH501,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH501,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH501,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH501,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH501,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH501,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH501,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH501,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),72.1,72.1,,,69.0,75.1,Gender,Female,C2,T12,NH501,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T12,NH501,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH501,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH501,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH501,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH501,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH501,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH501,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH501,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH501,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH501,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH501,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH501,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH501,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH501,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH501,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH501,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),76.1,76.1,,,73.8,78.2,Overall,Overall,C2,T12,NH501,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),75.9,75.9,,,73.3,78.3,Overall,Overall,C2,T12,NH501,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),72.7,72.7,,,69.9,75.4,Gender,Female,C2,T12,NH501,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),89.0,89.0,,,84.0,92.6,Age,20-24,C2,T12,NH501,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),82.1,82.1,,,78.9,84.9,Age,25-44,C2,T12,NH501,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),72.3,72.3,,,67.6,76.6,Age,45-64,C2,T12,NH501,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),61.5,61.5,,,56.4,66.2,Age,65+,C2,T12,NH501,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),72.1,72.1,,,69.1,74.9,Age,35+,C2,T12,NH501,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),57.6,57.6,,,52.3,62.7,Age,75+,C2,T12,NH501,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),77.1,77.1,,,74.3,79.8,Race,Non-Hispanic White,C2,T12,NH501,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),76.1,76.1,,,72.7,79.1,Race,Non-Hispanic White,C2,T12,NH501,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),78.1,78.1,,,73.1,82.3,Race,Non-Hispanic Black,C2,T12,NH501,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),79.1,79.1,,,73.9,83.6,Race,Non-Hispanic Black,C2,T12,NH501,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH501,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH501,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH501,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH501,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),60.0,60.0,,,52.3,67.2,Race,Other,C2,T12,NH501,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),59.0,59.0,,,51.6,66.0,Race,Other,C2,T12,NH501,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),73.7,73.7,,,71.2,76.1,Overall,Overall,C2,T12,NH501,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),73.4,73.4,,,70.9,75.8,Overall,Overall,C2,T12,NH501,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),78.7,78.7,,,75.9,81.3,Gender,Male,C2,T12,NH501,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),78.9,78.9,,,76.1,81.3,Gender,Male,C2,T12,NH501,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),69.2,69.2,,,65.9,72.3,Gender,Female,C2,T12,NH501,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),83.8,83.8,,,78.3,88.1,Age,20-24,C2,T12,NH501,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),80.4,80.4,,,76.8,83.6,Age,25-44,C2,T12,NH501,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),68.7,68.7,,,65.7,71.5,Age,45-64,C2,T12,NH501,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),62.2,62.2,,,57.5,66.7,Age,65+,C2,T12,NH501,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),69.6,69.6,,,66.6,72.4,Age,35+,C2,T12,NH501,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),59.1,59.1,,,52.3,65.5,Age,75+,C2,T12,NH501,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),72.9,72.9,,,69.8,75.7,Race,Non-Hispanic White,C2,T12,NH501,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),74.0,74.0,,,70.8,77.0,Race,Non-Hispanic White,C2,T12,NH501,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),76.5,76.5,,,72.0,80.5,Race,Non-Hispanic Black,C2,T12,NH501,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),77.1,77.1,,,71.7,81.8,Race,Non-Hispanic Black,C2,T12,NH501,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH501,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH501,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH501,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH501,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),59.6,59.6,,,50.2,68.3,Race,Other,C2,T12,NH501,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),58.0,58.0,,,48.3,67.1,Race,Other,C2,T12,NH501,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),73.7,73.7,,,71.1,76.1,Overall,Overall,C2,T12,NH501,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),73.6,73.6,,,71.1,75.9,Overall,Overall,C2,T12,NH501,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),75.6,75.6,,,72.0,78.9,Gender,Male,C2,T12,NH501,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),76.0,76.0,,,72.4,79.2,Gender,Male,C2,T12,NH501,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),71.4,71.4,,,68.8,73.9,Gender,Female,C2,T12,NH501,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),71.8,71.8,,,69.1,74.4,Gender,Female,C2,T12,NH501,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),81.4,81.4,,,73.3,87.5,Age,20-24,C2,T12,NH501,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),81.6,81.6,,,77.1,85.4,Age,25-44,C2,T12,NH501,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),68.3,68.3,,,64.9,71.5,Age,45-64,C2,T12,NH501,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),61.3,61.3,,,58.3,64.3,Age,65+,C2,T12,NH501,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),70.1,70.1,,,67.6,72.5,Age,35+,C2,T12,NH501,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),60.0,60.0,,,55.3,64.5,Age,75+,C2,T12,NH501,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),73.5,73.5,,,70.4,76.4,Race,Non-Hispanic White,C2,T12,NH501,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),74.3,74.3,,,71.1,77.2,Race,Non-Hispanic White,C2,T12,NH501,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),78.4,78.4,,,75.4,81.1,Race,Non-Hispanic Black,C2,T12,NH501,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),79.2,79.2,,,76.6,81.5,Race,Non-Hispanic Black,C2,T12,NH501,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH501,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH501,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH501,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH501,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),53.1,53.1,,,41.7,64.1,Race,Other,C2,T12,NH501,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),52.5,52.5,,,41.1,63.6,Race,Other,C2,T12,NH501,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),70.6,70.6,,,67.7,73.4,Overall,Overall,C2,T12,NH501,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),70.3,70.3,,,67.7,72.8,Overall,Overall,C2,T12,NH501,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),74.8,74.8,,,71.2,78.2,Gender,Male,C2,T12,NH501,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),74.8,74.8,,,71.0,78.3,Gender,Male,C2,T12,NH501,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),66.7,66.7,,,63.3,69.9,Gender,Female,C2,T12,NH501,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),66.0,66.0,,,62.9,68.9,Gender,Female,C2,T12,NH501,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),81.2,81.2,,,73.7,87.0,Age,20-24,C2,T12,NH501,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),76.2,76.2,,,72.6,79.4,Age,25-44,C2,T12,NH501,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),66.9,66.9,,,63.7,69.9,Age,45-64,C2,T12,NH501,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),58.4,58.4,,,54.0,62.6,Age,65+,C2,T12,NH501,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),67.2,67.2,,,64.5,69.8,Age,35+,C2,T12,NH501,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),59.0,59.0,,,54.9,63.0,Age,75+,C2,T12,NH501,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),69.8,69.8,,,66.8,72.6,Race,Non-Hispanic White,C2,T12,NH501,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),71.1,71.1,,,67.6,74.3,Race,Non-Hispanic White,C2,T12,NH501,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),74.6,74.6,,,70.0,78.6,Race,Non-Hispanic Black,C2,T12,NH501,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),74.9,74.9,,,70.5,78.9,Race,Non-Hispanic Black,C2,T12,NH501,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH501,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH501,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH501,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH501,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),55.9,55.9,,,46.6,64.9,Race,Other,C2,T12,NH501,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),53.3,53.3,,,43.4,63.0,Race,Other,C2,T12,NH501,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),72.6,72.6,,,69.3,75.6,Overall,Overall,C2,T12,NH501,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),72.1,72.1,,,68.9,75.1,Overall,Overall,C2,T12,NH501,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),75.2,75.2,,,72.8,77.5,Gender,Male,C2,T12,NH501,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),75.2,75.2,,,72.8,77.6,Gender,Male,C2,T12,NH501,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),70.0,70.0,,,65.1,74.4,Gender,Female,C2,T12,NH501,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),69.1,69.1,,,64.4,73.5,Gender,Female,C2,T12,NH501,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),85.3,85.3,,,81.1,88.6,Age,20-24,C2,T12,NH501,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),78.5,78.5,,,74.4,82.1,Age,25-44,C2,T12,NH501,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),69.1,69.1,,,65.2,72.7,Age,45-64,C2,T12,NH501,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),57.4,57.4,,,52.2,62.5,Age,65+,C2,T12,NH501,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),68.6,68.6,,,64.5,72.4,Age,35+,C2,T12,NH501,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),56.7,56.7,,,50.9,62.3,Age,75+,C2,T12,NH501,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),72.7,72.7,,,68.7,76.4,Race,Non-Hispanic White,C2,T12,NH501,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),74.1,74.1,,,69.9,77.9,Race,Non-Hispanic White,C2,T12,NH501,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),73.4,73.4,,,68.4,77.9,Race,Non-Hispanic Black,C2,T12,NH501,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),73.8,73.8,,,68.4,78.6,Race,Non-Hispanic Black,C2,T12,NH501,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),49.1,49.1,,,44.1,54.1,Race,Non-Hispanic Asian,C2,T12,NH501,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),48.7,48.7,,,44.0,53.4,Race,Non-Hispanic Asian,C2,T12,NH501,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),73.4,73.4,,,69.5,77.0,Race,Hispanic,C2,T12,NH501,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),75.6,75.6,,,71.7,79.1,Race,Hispanic,C2,T12,NH501,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),57.7,57.7,,,51.7,63.4,Race,Other,C2,T12,NH501,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),57.1,57.1,,,50.9,63.0,Race,Other,C2,T12,NH501,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH501,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH501,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH501,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH501,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH501,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH501,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T12,NH501,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH501,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH501,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH501,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH501,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH501,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH501,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH501,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH501,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH501,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T12,NH501,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T12,NH501,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH501,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH501,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH501,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH501,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH503,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH503,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T12,NH503,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH503,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH503,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH503,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH503,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH503,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH503,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH503,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH503,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH503,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH503,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH503,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T12,NH503,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH503,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH503,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH503,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH503,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH503,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH503,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH503,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH503,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH503,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH503,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.3,1.0,Overall,Overall,C2,T12,NH503,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH503,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T12,NH503,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH503,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH503,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH503,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH503,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH503,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH503,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH503,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH503,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH503,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),0.4,0.4,,,0.2,0.6,Overall,Overall,C2,T12,NH503,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH503,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),0.3,0.3,,,0.2,0.5,Gender,Male,C2,T12,NH503,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),0.3,0.3,,,0.2,0.5,Gender,Male,C2,T12,NH503,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T12,NH503,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH503,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH503,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH503,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH503,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH503,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH503,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH503,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH503,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T12,NH503,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),0.6,0.6,,,0.3,1.0,Overall,Overall,C2,T12,NH503,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.3,1.0,Overall,Overall,C2,T12,NH503,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T12,NH503,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH503,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH503,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),0.9,0.9,,,0.5,1.5,Age,65+,C2,T12,NH503,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH503,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH503,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH503,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH503,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH503,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH503,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),0.5,0.5,,,0.3,0.9,Overall,Overall,C2,T12,NH503,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),0.5,0.5,,,0.3,0.9,Overall,Overall,C2,T12,NH503,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),32.3,32.3,,,28.7,36.2,Age,75+,C2,T13,NH072,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T12,NH503,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH503,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH503,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH503,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH503,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH503,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH503,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T12,NH503,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH503,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH503,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),0.6,0.6,,,0.3,1.0,Overall,Overall,C2,T12,NH503,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),0.6,0.6,,,0.3,0.9,Gender,Female,C2,T12,NH503,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),0.5,0.5,,,0.3,0.9,Gender,Female,C2,T12,NH503,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T12,NH503,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH503,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH503,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),1.2,1.2,,,0.7,2.1,Age,65+,C2,T12,NH503,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),0.8,0.8,,,0.4,1.3,Age,35+,C2,T12,NH503,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH503,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),0.4,0.4,,,0.2,0.7,Race,Non-Hispanic Black,C2,T12,NH503,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T12,NH503,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T12,NH503,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH503,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH503,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH503,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T12,NH503,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T12,NH503,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T12,NH503,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T12,NH503,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T12,NH503,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T12,NH503,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T12,NH503,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T12,NH503,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T12,NH503,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T12,NH503,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T12,NH503,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T12,NH503,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T12,NH503,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH503,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T12,NH503,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T12,NH503,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),30.2,30.2,,,27.2,33.3,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),29.9,29.9,,,27.0,32.9,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),26.5,26.5,,,23.7,29.6,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),26.9,26.9,,,24.0,30.1,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),33.2,33.2,,,29.9,36.8,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.2,33.2,,,29.8,36.7,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),18.6,18.6,,,14.1,24.2,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),28.2,28.2,,,24.9,31.8,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.6,35.6,,,30.7,40.9,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.8,30.8,,,27.0,34.9,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.5,32.5,,,28.7,36.4,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),23.2,23.2,,,18.9,28.1,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),28.4,28.4,,,24.9,32.2,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),28.3,28.3,,,24.8,32.2,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),39.5,39.5,,,36.2,42.8,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),39.1,39.1,,,35.8,42.5,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.0,30.0,,,20.6,41.4,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),28.2,28.2,,,19.2,39.4,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),30.0,30.0,,,27.9,32.2,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.0,30.0,,,27.9,32.2,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),27.2,27.2,,,25.1,29.3,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),27.1,27.1,,,25.1,29.3,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,29.9,35.6,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.7,32.7,,,30.0,35.6,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),24.0,24.0,,,17.9,31.3,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),27.9,27.9,,,25.3,30.7,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.2,35.2,,,31.8,38.8,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),28.1,28.1,,,25.6,30.7,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.3,32.3,,,29.5,35.2,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),18.9,18.9,,,14.7,24.0,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.0,30.0,,,27.7,32.4,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),29.6,29.6,,,27.1,32.1,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),38.5,38.5,,,35.0,42.1,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),37.8,37.8,,,34.2,41.6,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),31.9,31.9,,,29.5,34.3,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.0,32.0,,,29.7,34.4,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.8,30.8,,,28.4,33.4,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),30.8,30.8,,,28.3,33.4,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.9,32.9,,,29.6,36.4,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.1,33.1,,,29.9,36.6,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),25.4,25.4,,,21.2,30.0,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),31.5,31.5,,,28.6,34.5,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.7,35.7,,,31.6,39.9,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),29.7,29.7,,,26.5,33.2,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),34.3,34.3,,,31.9,36.7,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),23.5,23.5,,,19.5,28.1,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.8,30.8,,,28.4,33.4,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),30.4,30.4,,,27.9,33.0,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),44.6,44.6,,,40.5,48.8,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),44.6,44.6,,,40.4,48.9,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),18.5,18.5,,,11.1,29.3,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),18.6,18.6,,,12.0,27.7,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),33.9,33.9,,,31.2,36.7,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),34.2,34.2,,,31.4,37.1,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.9,32.9,,,28.9,37.2,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,28.9,36.8,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),35.0,35.0,,,32.3,37.9,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.5,35.5,,,32.7,38.3,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),24.1,24.1,,,16.9,33.0,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.9,32.9,,,28.7,37.4,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),40.3,40.3,,,35.8,44.8,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),30.4,30.4,,,27.5,33.5,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),36.6,36.6,,,33.7,39.5,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),24.7,24.7,,,20.5,29.5,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.2,33.2,,,30.1,36.5,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.5,32.5,,,29.3,35.8,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),45.7,45.7,,,42.4,49.2,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),45.3,45.3,,,41.7,49.0,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),25.9,25.9,,,18.0,35.6,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),25.2,25.2,,,18.1,33.9,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),33.6,33.6,,,31.4,35.8,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.7,33.7,,,31.5,35.9,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.0,32.0,,,29.2,34.9,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.0,32.0,,,29.4,34.8,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),35.2,35.2,,,33.0,37.5,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.3,35.3,,,33.1,37.5,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),26.2,26.2,,,19.6,34.1,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.8,32.8,,,29.3,36.6,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),37.3,37.3,,,34.2,40.6,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),31.9,31.9,,,28.9,34.9,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.6,35.6,,,33.3,38.1,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),26.2,26.2,,,22.5,30.3,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),32.5,32.5,,,29.3,36.0,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.2,32.2,,,28.7,35.8,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),43.9,43.9,,,39.9,47.9,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),43.8,43.8,,,39.8,47.9,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),19.9,19.9,,,11.8,31.5,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),19.5,19.5,,,11.6,31.0,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),35.6,35.6,,,33.8,37.4,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.8,35.8,,,34.0,37.6,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.3,35.3,,,31.9,38.8,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),35.2,35.2,,,31.9,38.7,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),35.8,35.8,,,34.1,37.6,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),36.2,36.2,,,34.4,38.1,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),23.2,23.2,,,17.3,30.4,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),34.9,34.9,,,32.6,37.4,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),39.0,39.0,,,36.2,41.9,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),37.4,37.4,,,34.3,40.7,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),38.4,38.4,,,36.6,40.2,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),28.8,28.8,,,24.9,33.1,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),34.7,34.7,,,32.4,37.1,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),34.1,34.1,,,31.8,36.5,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),49.4,49.4,,,44.9,53.9,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),49.5,49.5,,,44.8,54.3,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),20.0,20.0,,,16.0,24.7,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),19.7,19.7,,,15.7,24.5,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),34.9,34.9,,,32.2,37.7,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.1,35.1,,,32.4,38.0,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.7,33.7,,,31.1,36.4,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),33.5,33.5,,,30.9,36.3,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),36.1,36.1,,,32.8,39.6,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),36.5,36.5,,,33.1,40.1,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),25.2,25.2,,,20.5,30.6,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),34.4,34.4,,,31.4,37.4,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),39.4,39.4,,,34.8,44.2,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.4,33.4,,,29.5,37.6,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),37.1,37.1,,,34.1,40.1,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),28.7,28.7,,,24.4,33.4,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),33.4,33.4,,,29.9,37.1,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),32.6,32.6,,,29.2,36.2,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),47.8,47.8,,,44.6,51.1,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),47.8,47.8,,,44.6,51.1,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),10.9,10.9,,,8.4,14.1,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,8.3,14.0,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),42.0,42.0,,,38.5,45.5,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),42.5,42.5,,,39.2,45.8,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),19.2,19.2,,,14.7,24.6,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),18.9,18.9,,,14.5,24.4,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),37.9,37.9,,,36.3,39.6,Overall,Overall,C2,T13,NH071,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),37.7,37.7,,,36.0,39.6,Overall,Overall,C2,T13,NH071,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),35.0,35.0,,,33.0,37.2,Gender,Male,C2,T13,NH071,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.2,35.2,,,33.2,37.2,Gender,Male,C2,T13,NH071,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),40.5,40.5,,,37.9,43.2,Gender,Female,C2,T13,NH071,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),40.4,40.4,,,37.7,43.1,Gender,Female,C2,T13,NH071,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),25.3,25.3,,,20.9,30.3,Age,20-24,C2,T13,NH071,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),39.1,39.1,,,36.7,41.6,Age,25-44,C2,T13,NH071,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),41.1,41.1,,,37.0,45.4,Age,45-64,C2,T13,NH071,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),35.9,35.9,,,32.0,40.0,Age,65+,C2,T13,NH071,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),40.2,40.2,,,37.9,42.6,Age,35+,C2,T13,NH071,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),29.3,29.3,,,25.1,33.9,Age,75+,C2,T13,NH071,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),37.1,37.1,,,35.0,39.2,Race,Non-Hispanic White,C2,T13,NH071,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),36.4,36.4,,,34.2,38.6,Race,Non-Hispanic White,C2,T13,NH071,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),48.4,48.4,,,44.4,52.4,Race,Non-Hispanic Black,C2,T13,NH071,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),48.5,48.5,,,44.6,52.4,Race,Non-Hispanic Black,C2,T13,NH071,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),12.7,12.7,,,10.4,15.4,Race,Non-Hispanic Asian,C2,T13,NH071,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),12.6,12.6,,,10.2,15.4,Race,Non-Hispanic Asian,C2,T13,NH071,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),42.7,42.7,,,38.5,46.9,Race,Hispanic,C2,T13,NH071,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),42.6,42.6,,,38.5,46.8,Race,Hispanic,C2,T13,NH071,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Age-Standardized,Percent (%),20.7,20.7,,,16.7,25.5,Race,Other,C2,T13,NH071,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+); NHANES,Crude,Percent (%),21.2,21.2,,,16.9,26.1,Race,Other,C2,T13,NH071,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),34.2,34.2,,,31.3,37.2,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),33.9,33.9,,,30.9,37.0,Overall,Overall,C2,T13,NH072,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),31.8,31.8,,,28.9,34.9,Gender,Male,C2,T13,NH072,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),32.4,32.4,,,29.4,35.5,Gender,Male,C2,T13,NH072,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),35.9,35.9,,,31.7,40.3,Gender,Female,C2,T13,NH072,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),35.8,35.8,,,31.6,40.3,Gender,Female,C2,T13,NH072,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),50.7,50.7,,,45.0,56.4,Age,20-24,C2,T13,NH072,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),35.0,35.0,,,30.9,39.3,Age,25-44,C2,T13,NH072,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),29.9,29.9,,,25.6,34.4,Age,45-64,C2,T13,NH072,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),29.5,29.5,,,25.8,33.6,Age,65+,C2,T13,NH072,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),30.7,30.7,,,27.2,34.5,Age,35+,C2,T13,NH072,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),35.9,35.9,,,32.6,39.4,Age,75+,C2,T13,NH072,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),35.4,35.4,,,31.2,39.7,Race,Non-Hispanic White,C2,T13,NH072,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),35.5,35.5,,,31.3,39.9,Race,Non-Hispanic White,C2,T13,NH072,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),29.2,29.2,,,27.4,31.1,Race,Non-Hispanic Black,C2,T13,NH072,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),30.5,30.5,,,28.3,32.8,Race,Non-Hispanic Black,C2,T13,NH072,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH072,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH072,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH072,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH072,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),46.8,46.8,,,38.1,55.8,Race,Other,C2,T13,NH072,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),47.4,47.4,,,39.4,55.6,Race,Other,C2,T13,NH072,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,31.5,34.0,Overall,Overall,C2,T13,NH072,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),32.8,32.8,,,31.5,34.2,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),29.5,29.5,,,27.8,31.4,Gender,Male,C2,T13,NH072,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),29.5,29.5,,,27.8,31.3,Gender,Male,C2,T13,NH072,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),35.9,35.9,,,33.7,38.2,Gender,Female,C2,T13,NH072,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),36.0,36.0,,,33.7,38.4,Gender,Female,C2,T13,NH072,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),47.7,47.7,,,41.2,54.3,Age,20-24,C2,T13,NH072,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),35.4,35.4,,,32.4,38.5,Age,25-44,C2,T13,NH072,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),26.7,26.7,,,24.4,29.2,Age,45-64,C2,T13,NH072,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),29.0,29.0,,,25.4,32.8,Age,65+,C2,T13,NH072,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),29.3,29.3,,,27.6,31.1,Age,35+,C2,T13,NH072,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),34.6,34.6,,,27.0,43.0,Age,75+,C2,T13,NH072,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),33.8,33.8,,,32.2,35.5,Race,Non-Hispanic White,C2,T13,NH072,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),34.4,34.4,,,32.9,35.9,Race,Non-Hispanic White,C2,T13,NH072,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),26.1,26.1,,,23.3,29.1,Race,Non-Hispanic Black,C2,T13,NH072,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),27.2,27.2,,,24.1,30.4,Race,Non-Hispanic Black,C2,T13,NH072,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH072,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH072,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH072,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH072,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),42.0,42.0,,,34.4,50.1,Race,Other,C2,T13,NH072,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),42.6,42.6,,,34.7,50.8,Race,Other,C2,T13,NH072,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),32.4,32.4,,,30.1,34.7,Overall,Overall,C2,T13,NH072,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),32.1,32.1,,,30.0,34.3,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),28.1,28.1,,,25.7,30.7,Gender,Male,C2,T13,NH072,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),28.2,28.2,,,25.6,30.8,Gender,Male,C2,T13,NH072,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),36.5,36.5,,,32.6,40.5,Gender,Female,C2,T13,NH072,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),35.9,35.9,,,32.2,39.9,Gender,Female,C2,T13,NH072,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),45.9,45.9,,,40.3,51.6,Age,20-24,C2,T13,NH072,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),35.1,35.1,,,32.5,37.7,Age,25-44,C2,T13,NH072,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),26.2,26.2,,,23.1,29.7,Age,45-64,C2,T13,NH072,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),29.3,29.3,,,25.7,33.1,Age,65+,C2,T13,NH072,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),28.5,28.5,,,26.2,30.9,Age,35+,C2,T13,NH072,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),33.8,33.8,,,30.1,37.8,Age,75+,C2,T13,NH072,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),33.2,33.2,,,30.3,36.2,Race,Non-Hispanic White,C2,T13,NH072,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),34.1,34.1,,,31.2,37.2,Race,Non-Hispanic White,C2,T13,NH072,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),22.8,22.8,,,20.0,25.7,Race,Non-Hispanic Black,C2,T13,NH072,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),23.0,23.0,,,20.2,25.9,Race,Non-Hispanic Black,C2,T13,NH072,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH072,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH072,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH072,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH072,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),45.6,45.6,,,38.6,52.8,Race,Other,C2,T13,NH072,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),45.8,45.8,,,39.3,52.4,Race,Other,C2,T13,NH072,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),31.4,31.4,,,29.1,33.8,Overall,Overall,C2,T13,NH072,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),31.1,31.1,,,28.7,33.6,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),25.7,25.7,,,22.8,28.7,Gender,Male,C2,T13,NH072,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),25.7,25.7,,,23.2,28.5,Gender,Male,C2,T13,NH072,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),36.9,36.9,,,33.9,40.0,Gender,Female,C2,T13,NH072,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),36.4,36.4,,,33.4,39.5,Gender,Female,C2,T13,NH072,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),45.8,45.8,,,39.4,52.3,Age,20-24,C2,T13,NH072,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),33.5,33.5,,,29.4,37.9,Age,25-44,C2,T13,NH072,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),25.1,25.1,,,22.5,27.9,Age,45-64,C2,T13,NH072,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),30.0,30.0,,,27.3,32.8,Age,65+,C2,T13,NH072,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),27.9,27.9,,,25.8,30.2,Age,35+,C2,T13,NH072,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),36.7,36.7,,,32.1,41.5,Age,75+,C2,T13,NH072,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),32.0,32.0,,,28.9,35.3,Race,Non-Hispanic White,C2,T13,NH072,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),33.0,33.0,,,29.7,36.4,Race,Non-Hispanic White,C2,T13,NH072,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),22.7,22.7,,,19.8,26.0,Race,Non-Hispanic Black,C2,T13,NH072,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),22.7,22.7,,,19.5,26.3,Race,Non-Hispanic Black,C2,T13,NH072,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH072,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH072,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH072,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH072,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),46.8,46.8,,,38.3,55.6,Race,Other,C2,T13,NH072,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),48.2,48.2,,,40.5,56.0,Race,Other,C2,T13,NH072,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),30.5,30.5,,,28.7,32.4,Overall,Overall,C2,T13,NH072,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),30.3,30.3,,,28.5,32.1,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),27.0,27.0,,,25.2,29.0,Gender,Male,C2,T13,NH072,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),27.1,27.1,,,25.2,29.1,Gender,Male,C2,T13,NH072,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),33.7,33.7,,,30.9,36.6,Gender,Female,C2,T13,NH072,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),33.4,33.4,,,30.7,36.2,Gender,Female,C2,T13,NH072,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),42.8,42.8,,,37.5,48.3,Age,20-24,C2,T13,NH072,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),31.7,31.7,,,28.8,34.7,Age,25-44,C2,T13,NH072,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),26.8,26.8,,,23.7,30.1,Age,45-64,C2,T13,NH072,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),27.8,27.8,,,24.4,31.6,Age,65+,C2,T13,NH072,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),27.0,27.0,,,24.7,29.4,Age,35+,C2,T13,NH072,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),30.3,30.3,,,27.8,32.8,Age,75+,C2,T13,NH072,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),30.9,30.9,,,28.4,33.6,Race,Non-Hispanic White,C2,T13,NH072,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),31.7,31.7,,,29.1,34.5,Race,Non-Hispanic White,C2,T13,NH072,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),24.6,24.6,,,22.2,27.2,Race,Non-Hispanic Black,C2,T13,NH072,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),24.8,24.8,,,22.3,27.4,Race,Non-Hispanic Black,C2,T13,NH072,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH072,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH072,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH072,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH072,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),50.3,50.3,,,42.6,58.1,Race,Other,C2,T13,NH072,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),50.9,50.9,,,43.4,58.3,Race,Other,C2,T13,NH072,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),29.5,29.5,,,27.2,32.0,Overall,Overall,C2,T13,NH072,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),29.2,29.2,,,26.8,31.7,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),25.0,25.0,,,21.5,28.8,Gender,Male,C2,T13,NH072,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),25.2,25.2,,,21.8,28.8,Gender,Male,C2,T13,NH072,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),33.9,33.9,,,31.6,36.3,Gender,Female,C2,T13,NH072,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),33.1,33.1,,,30.9,35.4,Gender,Female,C2,T13,NH072,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),47.1,47.1,,,37.8,56.6,Age,20-24,C2,T13,NH072,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),31.9,31.9,,,29.2,34.6,Age,25-44,C2,T13,NH072,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),23.4,23.4,,,20.4,26.7,Age,45-64,C2,T13,NH072,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),25.9,25.9,,,23.8,28.1,Age,65+,C2,T13,NH072,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),25.2,25.2,,,23.4,27.1,Age,35+,C2,T13,NH072,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),30.2,30.2,,,27.3,33.2,Race,Non-Hispanic White,C2,T13,NH072,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),31.4,31.4,,,28.4,34.5,Race,Non-Hispanic White,C2,T13,NH072,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),21.9,21.9,,,19.6,24.3,Race,Non-Hispanic Black,C2,T13,NH072,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),22.0,22.0,,,19.4,24.7,Race,Non-Hispanic Black,C2,T13,NH072,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH072,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH072,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH072,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH072,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),44.1,44.1,,,36.7,51.7,Race,Other,C2,T13,NH072,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),44.3,44.3,,,37.4,51.4,Race,Other,C2,T13,NH072,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),29.8,29.8,,,27.1,32.6,Overall,Overall,C2,T13,NH072,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),29.3,29.3,,,26.5,32.3,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),27.6,27.6,,,24.6,30.9,Gender,Male,C2,T13,NH072,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),27.9,27.9,,,25.3,30.8,Gender,Male,C2,T13,NH072,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),31.4,31.4,,,28.3,34.8,Gender,Female,C2,T13,NH072,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),30.9,30.9,,,27.8,34.2,Gender,Female,C2,T13,NH072,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),46.8,46.8,,,38.9,54.8,Age,20-24,C2,T13,NH072,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),31.0,31.0,,,26.7,35.7,Age,25-44,C2,T13,NH072,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),23.5,23.5,,,20.7,26.6,Age,45-64,C2,T13,NH072,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),28.2,28.2,,,24.6,32.0,Age,65+,C2,T13,NH072,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),25.8,25.8,,,24.0,27.7,Age,35+,C2,T13,NH072,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),29.9,29.9,,,26.4,33.5,Race,Non-Hispanic White,C2,T13,NH072,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),31.1,31.1,,,27.7,34.7,Race,Non-Hispanic White,C2,T13,NH072,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),21.9,21.9,,,19.3,24.6,Race,Non-Hispanic Black,C2,T13,NH072,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),21.7,21.7,,,19.2,24.5,Race,Non-Hispanic Black,C2,T13,NH072,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),58.0,58.0,,,53.7,62.1,Race,Non-Hispanic Asian,C2,T13,NH072,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),57.6,57.6,,,53.9,61.3,Race,Non-Hispanic Asian,C2,T13,NH072,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),21.1,21.1,,,18.1,24.4,Race,Hispanic,C2,T13,NH072,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),21.8,21.8,,,18.6,25.4,Race,Hispanic,C2,T13,NH072,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),49.4,49.4,,,46.1,52.6,Race,Other,C2,T13,NH072,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),48.9,48.9,,,46.5,51.2,Race,Other,C2,T13,NH072,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),28.2,28.2,,,26.6,29.9,Overall,Overall,C2,T13,NH072,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),27.8,27.8,,,26.2,29.5,Overall,Overall,C2,T13,NH072,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),24.7,24.7,,,22.5,27.0,Gender,Male,C2,T13,NH072,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),24.9,24.9,,,22.8,27.2,Gender,Male,C2,T13,NH072,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),31.4,31.4,,,29.0,33.9,Gender,Female,C2,T13,NH072,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),30.8,30.8,,,28.5,33.2,Gender,Female,C2,T13,NH072,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),45.5,45.5,,,40.2,50.9,Age,20-24,C2,T13,NH072,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),28.4,28.4,,,26.3,30.7,Age,25-44,C2,T13,NH072,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),23.4,23.4,,,21.2,25.8,Age,45-64,C2,T13,NH072,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),26.0,26.0,,,23.5,28.7,Age,65+,C2,T13,NH072,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),24.4,24.4,,,22.9,26.1,Age,35+,C2,T13,NH072,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),28.9,28.9,,,24.4,33.9,Age,75+,C2,T13,NH072,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),28.1,28.1,,,26.5,29.7,Race,Non-Hispanic White,C2,T13,NH072,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),29.3,29.3,,,27.7,30.9,Race,Non-Hispanic White,C2,T13,NH072,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),22.0,22.0,,,19.2,25.2,Race,Non-Hispanic Black,C2,T13,NH072,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),21.9,21.9,,,19.1,25.0,Race,Non-Hispanic Black,C2,T13,NH072,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),53.6,53.6,,,50.1,57.1,Race,Non-Hispanic Asian,C2,T13,NH072,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),53.6,53.6,,,50.1,57.0,Race,Non-Hispanic Asian,C2,T13,NH072,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),20.7,20.7,,,17.5,24.3,Race,Hispanic,C2,T13,NH072,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),21.4,21.4,,,18.0,25.4,Race,Hispanic,C2,T13,NH072,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Crude,Percent (%),46.0,46.0,,,41.1,50.9,Race,Other,C2,T13,NH072,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Prevalence of healthy weight among US adults (20+); NHANES,Age-Standardized,Percent (%),46.1,46.1,,,41.4,50.8,Race,Other,C2,T13,NH072,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),30.2,30.2,,,27.2,33.3,Overall,Overall,C2,T13,NH601,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),29.9,29.9,,,27.0,32.9,Overall,Overall,C2,T13,NH601,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),26.5,26.5,,,23.7,29.6,Gender,Male,C2,T13,NH601,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.9,26.9,,,24.0,30.1,Gender,Male,C2,T13,NH601,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),33.2,33.2,,,29.9,36.8,Gender,Female,C2,T13,NH601,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),33.2,33.2,,,29.8,36.7,Gender,Female,C2,T13,NH601,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),18.6,18.6,,,14.1,24.2,Age,20-24,C2,T13,NH601,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),28.2,28.2,,,24.9,31.8,Age,25-44,C2,T13,NH601,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),35.6,35.6,,,30.7,40.9,Age,45-64,C2,T13,NH601,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),30.8,30.8,,,27.0,34.9,Age,65+,C2,T13,NH601,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),32.5,32.5,,,28.7,36.4,Age,35+,C2,T13,NH601,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),23.2,23.2,,,18.9,28.1,Age,75+,C2,T13,NH601,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),28.4,28.4,,,24.9,32.2,Race,Non-Hispanic White,C2,T13,NH601,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),28.3,28.3,,,24.8,32.2,Race,Non-Hispanic White,C2,T13,NH601,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),39.5,39.5,,,36.2,42.8,Race,Non-Hispanic Black,C2,T13,NH601,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),39.1,39.1,,,35.8,42.5,Race,Non-Hispanic Black,C2,T13,NH601,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH601,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH601,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH601,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH601,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),30.0,30.0,,,20.6,41.4,Race,Other,C2,T13,NH601,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),28.2,28.2,,,19.2,39.4,Race,Other,C2,T13,NH601,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),30.0,30.0,,,27.9,32.2,Overall,Overall,C2,T13,NH601,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),30.0,30.0,,,27.9,32.2,Overall,Overall,C2,T13,NH601,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),27.2,27.2,,,25.1,29.3,Gender,Male,C2,T13,NH601,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),27.1,27.1,,,25.1,29.3,Gender,Male,C2,T13,NH601,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,29.9,35.6,Gender,Female,C2,T13,NH601,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),32.7,32.7,,,30.0,35.6,Gender,Female,C2,T13,NH601,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),24.0,24.0,,,17.9,31.3,Age,20-24,C2,T13,NH601,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),27.9,27.9,,,25.3,30.7,Age,25-44,C2,T13,NH601,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),35.2,35.2,,,31.8,38.8,Age,45-64,C2,T13,NH601,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),28.1,28.1,,,25.6,30.7,Age,65+,C2,T13,NH601,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),32.3,32.3,,,29.5,35.2,Age,35+,C2,T13,NH601,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),18.9,18.9,,,14.7,24.0,Age,75+,C2,T13,NH601,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),30.0,30.0,,,27.7,32.4,Race,Non-Hispanic White,C2,T13,NH601,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),29.6,29.6,,,27.1,32.1,Race,Non-Hispanic White,C2,T13,NH601,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),38.5,38.5,,,35.0,42.1,Race,Non-Hispanic Black,C2,T13,NH601,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),37.8,37.8,,,34.2,41.6,Race,Non-Hispanic Black,C2,T13,NH601,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH601,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH601,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH601,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH601,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T13,NH601,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T13,NH601,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),32.0,32.0,,,29.7,34.4,Overall,Overall,C2,T13,NH601,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),31.9,31.9,,,29.5,34.3,Overall,Overall,C2,T13,NH601,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),30.8,30.8,,,28.3,33.4,Gender,Male,C2,T13,NH601,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),30.8,30.8,,,28.4,33.4,Gender,Male,C2,T13,NH601,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),33.1,33.1,,,29.9,36.6,Gender,Female,C2,T13,NH601,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),32.9,32.9,,,29.6,36.4,Gender,Female,C2,T13,NH601,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),25.4,25.4,,,21.2,30.0,Age,20-24,C2,T13,NH601,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),31.5,31.5,,,28.6,34.5,Age,25-44,C2,T13,NH601,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),35.7,35.7,,,31.6,39.9,Age,45-64,C2,T13,NH601,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),29.7,29.7,,,26.5,33.2,Age,65+,C2,T13,NH601,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),34.3,34.3,,,31.9,36.7,Age,35+,C2,T13,NH601,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),23.5,23.5,,,19.5,28.1,Age,75+,C2,T13,NH601,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),30.8,30.8,,,28.4,33.4,Race,Non-Hispanic White,C2,T13,NH601,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),30.4,30.4,,,27.9,33.0,Race,Non-Hispanic White,C2,T13,NH601,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),44.6,44.6,,,40.5,48.8,Race,Non-Hispanic Black,C2,T13,NH601,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),44.6,44.6,,,40.4,48.9,Race,Non-Hispanic Black,C2,T13,NH601,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH601,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH601,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH601,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH601,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),18.5,18.5,,,11.1,29.3,Race,Other,C2,T13,NH601,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.6,18.6,,,12.0,27.7,Race,Other,C2,T13,NH601,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),33.9,33.9,,,31.2,36.7,Overall,Overall,C2,T13,NH601,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),34.2,34.2,,,31.4,37.1,Overall,Overall,C2,T13,NH601,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),32.9,32.9,,,28.9,37.2,Gender,Male,C2,T13,NH601,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,28.9,36.8,Gender,Male,C2,T13,NH601,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),35.0,35.0,,,32.3,37.9,Gender,Female,C2,T13,NH601,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),35.5,35.5,,,32.7,38.3,Gender,Female,C2,T13,NH601,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),24.1,24.1,,,16.9,33.0,Age,20-24,C2,T13,NH601,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),32.9,32.9,,,28.7,37.4,Age,25-44,C2,T13,NH601,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),40.3,40.3,,,35.8,44.8,Age,45-64,C2,T13,NH601,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),30.4,30.4,,,27.5,33.5,Age,65+,C2,T13,NH601,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),36.6,36.6,,,33.7,39.5,Age,35+,C2,T13,NH601,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),24.7,24.7,,,20.5,29.5,Age,75+,C2,T13,NH601,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),33.2,33.2,,,30.1,36.5,Race,Non-Hispanic White,C2,T13,NH601,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),32.5,32.5,,,29.3,35.8,Race,Non-Hispanic White,C2,T13,NH601,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),45.7,45.7,,,42.4,49.2,Race,Non-Hispanic Black,C2,T13,NH601,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),45.3,45.3,,,41.7,49.0,Race,Non-Hispanic Black,C2,T13,NH601,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH601,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH601,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH601,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH601,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),25.9,25.9,,,18.0,35.6,Race,Other,C2,T13,NH601,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),25.2,25.2,,,18.1,33.9,Race,Other,C2,T13,NH601,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),33.6,33.6,,,31.4,35.8,Overall,Overall,C2,T13,NH601,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),33.7,33.7,,,31.5,35.9,Overall,Overall,C2,T13,NH601,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),32.0,32.0,,,29.2,34.9,Gender,Male,C2,T13,NH601,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),32.0,32.0,,,29.4,34.8,Gender,Male,C2,T13,NH601,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),35.2,35.2,,,33.0,37.5,Gender,Female,C2,T13,NH601,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),35.3,35.3,,,33.1,37.5,Gender,Female,C2,T13,NH601,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),26.2,26.2,,,19.6,34.1,Age,20-24,C2,T13,NH601,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),32.8,32.8,,,29.3,36.6,Age,25-44,C2,T13,NH601,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),37.3,37.3,,,34.2,40.6,Age,45-64,C2,T13,NH601,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),31.9,31.9,,,28.9,34.9,Age,65+,C2,T13,NH601,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),35.6,35.6,,,33.3,38.1,Age,35+,C2,T13,NH601,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),26.2,26.2,,,22.5,30.3,Age,75+,C2,T13,NH601,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),32.5,32.5,,,29.3,36.0,Race,Non-Hispanic White,C2,T13,NH601,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),32.2,32.2,,,28.7,35.8,Race,Non-Hispanic White,C2,T13,NH601,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),43.9,43.9,,,39.9,47.9,Race,Non-Hispanic Black,C2,T13,NH601,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),43.8,43.8,,,39.8,47.9,Race,Non-Hispanic Black,C2,T13,NH601,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH601,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH601,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH601,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH601,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),19.9,19.9,,,11.8,31.5,Race,Other,C2,T13,NH601,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),19.5,19.5,,,11.6,31.0,Race,Other,C2,T13,NH601,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),35.6,35.6,,,33.8,37.4,Overall,Overall,C2,T13,NH601,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),35.8,35.8,,,34.0,37.6,Overall,Overall,C2,T13,NH601,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),35.3,35.3,,,31.9,38.8,Gender,Male,C2,T13,NH601,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),35.2,35.2,,,31.9,38.7,Gender,Male,C2,T13,NH601,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),35.8,35.8,,,34.1,37.6,Gender,Female,C2,T13,NH601,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),36.2,36.2,,,34.4,38.1,Gender,Female,C2,T13,NH601,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),23.2,23.2,,,17.3,30.4,Age,20-24,C2,T13,NH601,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),34.9,34.9,,,32.6,37.4,Age,25-44,C2,T13,NH601,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),39.0,39.0,,,36.2,41.9,Age,45-64,C2,T13,NH601,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),37.4,37.4,,,34.3,40.7,Age,65+,C2,T13,NH601,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),38.4,38.4,,,36.6,40.2,Age,35+,C2,T13,NH601,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),28.8,28.8,,,24.9,33.1,Age,75+,C2,T13,NH601,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),34.7,34.7,,,32.4,37.1,Race,Non-Hispanic White,C2,T13,NH601,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),34.1,34.1,,,31.8,36.5,Race,Non-Hispanic White,C2,T13,NH601,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),49.4,49.4,,,44.9,53.9,Race,Non-Hispanic Black,C2,T13,NH601,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),49.5,49.5,,,44.8,54.3,Race,Non-Hispanic Black,C2,T13,NH601,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH601,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH601,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH601,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH601,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),20.0,20.0,,,16.0,24.7,Race,Other,C2,T13,NH601,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),19.7,19.7,,,15.7,24.5,Race,Other,C2,T13,NH601,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),34.9,34.9,,,32.2,37.7,Overall,Overall,C2,T13,NH601,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),35.1,35.1,,,32.4,38.0,Overall,Overall,C2,T13,NH601,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),33.7,33.7,,,31.1,36.4,Gender,Male,C2,T13,NH601,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),33.5,33.5,,,30.9,36.3,Gender,Male,C2,T13,NH601,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),36.1,36.1,,,32.8,39.6,Gender,Female,C2,T13,NH601,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),36.5,36.5,,,33.1,40.1,Gender,Female,C2,T13,NH601,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),25.2,25.2,,,20.5,30.6,Age,20-24,C2,T13,NH601,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),34.4,34.4,,,31.4,37.4,Age,25-44,C2,T13,NH601,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),39.4,39.4,,,34.8,44.2,Age,45-64,C2,T13,NH601,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),33.4,33.4,,,29.5,37.6,Age,65+,C2,T13,NH601,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),37.1,37.1,,,34.1,40.1,Age,35+,C2,T13,NH601,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),28.7,28.7,,,24.4,33.4,Age,75+,C2,T13,NH601,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),33.4,33.4,,,29.9,37.1,Race,Non-Hispanic White,C2,T13,NH601,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),32.6,32.6,,,29.2,36.2,Race,Non-Hispanic White,C2,T13,NH601,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),47.8,47.8,,,44.6,51.1,Race,Non-Hispanic Black,C2,T13,NH601,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),47.8,47.8,,,44.6,51.1,Race,Non-Hispanic Black,C2,T13,NH601,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),10.9,10.9,,,8.4,14.1,Race,Non-Hispanic Asian,C2,T13,NH601,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),10.8,10.8,,,8.3,14.0,Race,Non-Hispanic Asian,C2,T13,NH601,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),42.0,42.0,,,38.5,45.5,Race,Hispanic,C2,T13,NH601,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),42.5,42.5,,,39.2,45.8,Race,Hispanic,C2,T13,NH601,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),19.2,19.2,,,14.7,24.6,Race,Other,C2,T13,NH601,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),18.9,18.9,,,14.5,24.4,Race,Other,C2,T13,NH601,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),37.9,37.9,,,36.3,39.6,Overall,Overall,C2,T13,NH601,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),37.7,37.7,,,36.0,39.6,Overall,Overall,C2,T13,NH601,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),35.0,35.0,,,33.0,37.2,Gender,Male,C2,T13,NH601,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),35.2,35.2,,,33.2,37.2,Gender,Male,C2,T13,NH601,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),40.5,40.5,,,37.9,43.2,Gender,Female,C2,T13,NH601,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),40.4,40.4,,,37.7,43.1,Gender,Female,C2,T13,NH601,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),25.3,25.3,,,20.9,30.3,Age,20-24,C2,T13,NH601,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),39.1,39.1,,,36.7,41.6,Age,25-44,C2,T13,NH601,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),41.1,41.1,,,37.0,45.4,Age,45-64,C2,T13,NH601,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),35.9,35.9,,,32.0,40.0,Age,65+,C2,T13,NH601,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),40.2,40.2,,,37.9,42.6,Age,35+,C2,T13,NH601,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),29.3,29.3,,,25.1,33.9,Age,75+,C2,T13,NH601,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),37.1,37.1,,,35.0,39.2,Race,Non-Hispanic White,C2,T13,NH601,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),36.4,36.4,,,34.2,38.6,Race,Non-Hispanic White,C2,T13,NH601,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),48.4,48.4,,,44.4,52.4,Race,Non-Hispanic Black,C2,T13,NH601,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),48.5,48.5,,,44.6,52.4,Race,Non-Hispanic Black,C2,T13,NH601,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),12.7,12.7,,,10.4,15.4,Race,Non-Hispanic Asian,C2,T13,NH601,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.6,12.6,,,10.2,15.4,Race,Non-Hispanic Asian,C2,T13,NH601,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),42.7,42.7,,,38.5,46.9,Race,Hispanic,C2,T13,NH601,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),42.6,42.6,,,38.5,46.8,Race,Hispanic,C2,T13,NH601,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),20.7,20.7,,,16.7,25.5,Race,Other,C2,T13,NH601,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI status among US adults (20+); NHANES,Crude,Percent (%),21.2,21.2,,,16.9,26.1,Race,Other,C2,T13,NH601,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),36.4,36.4,,,33.1,39.7,Overall,Overall,C2,T13,NH603,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),36.0,36.0,,,32.8,39.3,Overall,Overall,C2,T13,NH603,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),33.1,33.1,,,29.9,36.5,Gender,Male,C2,T13,NH603,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),33.8,33.8,,,30.6,37.2,Gender,Male,C2,T13,NH603,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),38.8,38.8,,,34.3,43.5,Gender,Female,C2,T13,NH603,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),38.7,38.7,,,34.2,43.4,Gender,Female,C2,T13,NH603,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),54.7,54.7,,,49.1,60.2,Age,20-24,C2,T13,NH603,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),37.7,37.7,,,32.9,42.8,Age,25-44,C2,T13,NH603,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),30.7,30.7,,,26.3,35.6,Age,45-64,C2,T13,NH603,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),31.5,31.5,,,28.3,34.9,Age,65+,C2,T13,NH603,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),32.4,32.4,,,28.6,36.5,Age,35+,C2,T13,NH603,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),38.3,38.3,,,35.1,41.6,Age,75+,C2,T13,NH603,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),38.0,38.0,,,33.5,42.9,Race,Non-Hispanic White,C2,T13,NH603,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),38.2,38.2,,,33.5,43.0,Race,Non-Hispanic White,C2,T13,NH603,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),30.4,30.4,,,28.5,32.4,Race,Non-Hispanic Black,C2,T13,NH603,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),31.7,31.7,,,29.4,34.2,Race,Non-Hispanic Black,C2,T13,NH603,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH603,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH603,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH603,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH603,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),47.4,47.4,,,38.6,56.3,Race,Other,C2,T13,NH603,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),47.9,47.9,,,40.0,56.0,Race,Other,C2,T13,NH603,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),34.7,34.7,,,33.5,35.8,Overall,Overall,C2,T13,NH603,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),34.8,34.8,,,33.5,36.1,Overall,Overall,C2,T13,NH603,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),30.5,30.5,,,29.0,32.1,Gender,Male,C2,T13,NH603,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),30.5,30.5,,,29.0,32.1,Gender,Male,C2,T13,NH603,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),38.8,38.8,,,36.7,40.9,Gender,Female,C2,T13,NH603,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),38.8,38.8,,,36.6,41.1,Gender,Female,C2,T13,NH603,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),51.3,51.3,,,43.3,59.3,Age,20-24,C2,T13,NH603,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),37.7,37.7,,,34.5,41.1,Age,25-44,C2,T13,NH603,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),27.6,27.6,,,25.0,30.3,Age,45-64,C2,T13,NH603,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),31.1,31.1,,,27.5,35.0,Age,65+,C2,T13,NH603,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),30.5,30.5,,,28.8,32.3,Age,35+,C2,T13,NH603,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),36.8,36.8,,,29.1,45.2,Age,75+,C2,T13,NH603,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),35.6,35.6,,,33.9,37.4,Race,Non-Hispanic White,C2,T13,NH603,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),36.3,36.3,,,34.6,37.9,Race,Non-Hispanic White,C2,T13,NH603,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),28.5,28.5,,,25.5,31.8,Race,Non-Hispanic Black,C2,T13,NH603,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),29.7,29.7,,,26.3,33.2,Race,Non-Hispanic Black,C2,T13,NH603,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH603,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH603,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH603,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH603,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),45.8,45.8,,,39.7,51.9,Race,Other,C2,T13,NH603,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),45.7,45.7,,,38.9,52.6,Race,Other,C2,T13,NH603,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),34.1,34.1,,,32.0,36.3,Overall,Overall,C2,T13,NH603,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),33.8,33.8,,,31.8,35.9,Overall,Overall,C2,T13,NH603,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),29.5,29.5,,,27.0,32.1,Gender,Male,C2,T13,NH603,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),29.6,29.6,,,27.0,32.3,Gender,Male,C2,T13,NH603,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),38.5,38.5,,,34.9,42.4,Gender,Female,C2,T13,NH603,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),37.9,37.9,,,34.3,41.7,Gender,Female,C2,T13,NH603,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),51.0,51.0,,,44.7,57.3,Age,20-24,C2,T13,NH603,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),37.0,37.0,,,34.3,39.9,Age,25-44,C2,T13,NH603,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),27.1,27.1,,,24.2,30.3,Age,45-64,C2,T13,NH603,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),30.0,30.0,,,26.4,33.9,Age,65+,C2,T13,NH603,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),29.5,29.5,,,27.5,31.6,Age,35+,C2,T13,NH603,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),34.9,34.9,,,31.2,38.9,Age,75+,C2,T13,NH603,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),35.0,35.0,,,32.1,37.9,Race,Non-Hispanic White,C2,T13,NH603,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),36.1,36.1,,,33.1,39.1,Race,Non-Hispanic White,C2,T13,NH603,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),24.0,24.0,,,21.1,27.2,Race,Non-Hispanic Black,C2,T13,NH603,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),24.2,24.2,,,21.3,27.5,Race,Non-Hispanic Black,C2,T13,NH603,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH603,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH603,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH603,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH603,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),49.7,49.7,,,41.4,58.1,Race,Other,C2,T13,NH603,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),49.7,49.7,,,42.1,57.2,Race,Other,C2,T13,NH603,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),33.3,33.3,,,30.9,35.9,Overall,Overall,C2,T13,NH603,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),33.0,33.0,,,30.5,35.6,Overall,Overall,C2,T13,NH603,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),26.9,26.9,,,24.1,30.0,Gender,Male,C2,T13,NH603,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),27.0,27.0,,,24.4,29.9,Gender,Male,C2,T13,NH603,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),39.5,39.5,,,36.1,42.9,Gender,Female,C2,T13,NH603,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),38.8,38.8,,,35.6,42.2,Gender,Female,C2,T13,NH603,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),50.8,50.8,,,44.2,57.4,Age,20-24,C2,T13,NH603,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),35.0,35.0,,,30.7,39.6,Age,25-44,C2,T13,NH603,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),26.5,26.5,,,24.1,29.1,Age,45-64,C2,T13,NH603,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),31.8,31.8,,,29.0,34.8,Age,65+,C2,T13,NH603,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),29.4,29.4,,,27.4,31.6,Age,35+,C2,T13,NH603,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),39.2,39.2,,,34.5,44.0,Age,75+,C2,T13,NH603,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),34.0,34.0,,,30.9,37.4,Race,Non-Hispanic White,C2,T13,NH603,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),35.1,35.1,,,31.7,38.6,Race,Non-Hispanic White,C2,T13,NH603,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),24.1,24.1,,,21.0,27.5,Race,Non-Hispanic Black,C2,T13,NH603,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),24.0,24.0,,,20.7,27.7,Race,Non-Hispanic Black,C2,T13,NH603,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH603,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH603,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH603,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T13,NH603,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),49.5,49.5,,,40.0,59.0,Race,Other,C2,T13,NH603,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),50.5,50.5,,,42.4,58.6,Race,Other,C2,T13,NH603,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),32.2,32.2,,,30.4,34.1,Overall,Overall,C2,T13,NH603,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),31.9,31.9,,,30.2,33.7,Overall,Overall,C2,T13,NH603,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),28.0,28.0,,,26.2,29.9,Gender,Male,C2,T13,NH603,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),28.1,28.1,,,26.2,30.0,Gender,Male,C2,T13,NH603,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),36.0,36.0,,,33.3,38.9,Gender,Female,C2,T13,NH603,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),35.7,35.7,,,33.0,38.4,Gender,Female,C2,T13,NH603,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),46.6,46.6,,,40.4,53.0,Age,20-24,C2,T13,NH603,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),32.9,32.9,,,30.0,36.0,Age,25-44,C2,T13,NH603,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),28.5,28.5,,,25.4,31.7,Age,45-64,C2,T13,NH603,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),29.2,29.2,,,25.7,32.8,Age,65+,C2,T13,NH603,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),28.4,28.4,,,26.1,30.7,Age,35+,C2,T13,NH603,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),32.0,32.0,,,29.7,34.4,Age,75+,C2,T13,NH603,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),32.7,32.7,,,30.1,35.4,Race,Non-Hispanic White,C2,T13,NH603,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),33.6,33.6,,,31.0,36.3,Race,Non-Hispanic White,C2,T13,NH603,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.7,26.7,,,24.3,29.3,Race,Non-Hispanic Black,C2,T13,NH603,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),26.9,26.9,,,24.5,29.4,Race,Non-Hispanic Black,C2,T13,NH603,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH603,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH603,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH603,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH603,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),52.6,52.6,,,45.4,59.6,Race,Other,C2,T13,NH603,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),51.8,51.8,,,44.3,59.3,Race,Other,C2,T13,NH603,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),31.0,31.0,,,28.5,33.7,Overall,Overall,C2,T13,NH603,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),31.4,31.4,,,28.9,34.1,Overall,Overall,C2,T13,NH603,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.2,26.2,,,22.9,29.9,Gender,Male,C2,T13,NH603,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),26.0,26.0,,,22.6,29.9,Gender,Male,C2,T13,NH603,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),35.7,35.7,,,33.3,38.3,Gender,Female,C2,T13,NH603,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),36.5,36.5,,,33.9,39.2,Gender,Female,C2,T13,NH603,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),50.8,50.8,,,41.4,60.1,Age,20-24,C2,T13,NH603,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),33.3,33.3,,,30.4,36.4,Age,25-44,C2,T13,NH603,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),25.3,25.3,,,22.0,28.9,Age,45-64,C2,T13,NH603,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),27.5,27.5,,,25.3,29.9,Age,65+,C2,T13,NH603,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),26.8,26.8,,,25.0,28.8,Age,35+,C2,T13,NH603,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),33.8,33.8,,,30.5,37.2,Age,75+,C2,T13,NH603,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),32.2,32.2,,,29.0,35.4,Race,Non-Hispanic White,C2,T13,NH603,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),33.4,33.4,,,30.1,36.8,Race,Non-Hispanic White,C2,T13,NH603,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),23.6,23.6,,,20.9,26.6,Race,Non-Hispanic Black,C2,T13,NH603,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),23.7,23.7,,,20.7,27.1,Race,Non-Hispanic Black,C2,T13,NH603,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH603,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T13,NH603,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH603,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T13,NH603,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),47.3,47.3,,,40.3,54.4,Race,Other,C2,T13,NH603,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),47.4,47.4,,,40.6,54.4,Race,Other,C2,T13,NH603,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),31.5,31.5,,,28.6,34.6,Overall,Overall,C2,T13,NH603,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),31.0,31.0,,,27.9,34.4,Overall,Overall,C2,T13,NH603,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),28.4,28.4,,,25.2,31.7,Gender,Male,C2,T13,NH603,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),28.7,28.7,,,26.0,31.6,Gender,Male,C2,T13,NH603,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),34.2,34.2,,,30.7,37.8,Gender,Female,C2,T13,NH603,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),33.5,33.5,,,30.1,37.2,Gender,Female,C2,T13,NH603,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),52.2,52.2,,,44.8,59.5,Age,20-24,C2,T13,NH603,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),32.6,32.6,,,27.9,37.7,Age,25-44,C2,T13,NH603,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),24.2,24.2,,,21.4,27.2,Age,45-64,C2,T13,NH603,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),30.3,30.3,,,26.4,34.5,Age,65+,C2,T13,NH603,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),27.0,27.0,,,25.0,29.1,Age,35+,C2,T13,NH603,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),35.0,35.0,,,31.6,38.5,Age,75+,C2,T13,NH603,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),31.5,31.5,,,27.8,35.4,Race,Non-Hispanic White,C2,T13,NH603,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),32.8,32.8,,,29.2,36.5,Race,Non-Hispanic White,C2,T13,NH603,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),23.8,23.8,,,20.8,27.2,Race,Non-Hispanic Black,C2,T13,NH603,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),23.7,23.7,,,20.7,27.1,Race,Non-Hispanic Black,C2,T13,NH603,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),61.8,61.8,,,57.6,65.9,Race,Non-Hispanic Asian,C2,T13,NH603,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),61.4,61.4,,,57.9,64.7,Race,Non-Hispanic Asian,C2,T13,NH603,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),22.1,22.1,,,18.9,25.5,Race,Hispanic,C2,T13,NH603,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),22.9,22.9,,,19.5,26.7,Race,Hispanic,C2,T13,NH603,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),52.7,52.7,,,48.9,56.5,Race,Other,C2,T13,NH603,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),52.1,52.1,,,49.2,54.9,Race,Other,C2,T13,NH603,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),29.8,29.8,,,28.2,31.4,Overall,Overall,C2,T13,NH603,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),29.3,29.3,,,27.8,31.0,Overall,Overall,C2,T13,NH603,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),26.0,26.0,,,24.0,28.2,Gender,Male,C2,T13,NH603,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.3,26.3,,,24.2,28.4,Gender,Male,C2,T13,NH603,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),33.1,33.1,,,30.7,35.5,Gender,Female,C2,T13,NH603,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),32.5,32.5,,,30.2,34.9,Gender,Female,C2,T13,NH603,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),50.4,50.4,,,43.7,57.1,Age,20-24,C2,T13,NH603,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),29.3,29.3,,,27.0,31.7,Age,25-44,C2,T13,NH603,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),24.5,24.5,,,22.3,26.8,Age,45-64,C2,T13,NH603,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),27.9,27.9,,,25.3,30.7,Age,65+,C2,T13,NH603,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),25.6,25.6,,,24.1,27.2,Age,35+,C2,T13,NH603,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),30.5,30.5,,,26.1,35.4,Age,75+,C2,T13,NH603,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),29.4,29.4,,,27.9,31.0,Race,Non-Hispanic White,C2,T13,NH603,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),30.7,30.7,,,29.0,32.4,Race,Non-Hispanic White,C2,T13,NH603,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),23.8,23.8,,,21.1,26.8,Race,Non-Hispanic Black,C2,T13,NH603,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),23.7,23.7,,,21.0,26.5,Race,Non-Hispanic Black,C2,T13,NH603,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),58.3,58.3,,,54.0,62.5,Race,Non-Hispanic Asian,C2,T13,NH603,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),58.3,58.3,,,54.3,62.1,Race,Non-Hispanic Asian,C2,T13,NH603,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),21.3,21.3,,,18.0,24.9,Race,Hispanic,C2,T13,NH603,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),22.0,22.0,,,18.5,25.9,Race,Hispanic,C2,T13,NH603,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Crude,Percent (%),50.0,50.0,,,44.5,55.6,Race,Other,C2,T13,NH603,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI status among US adults (20+); NHANES,Age-Standardized,Percent (%),50.2,50.2,,,44.9,55.5,Race,Other,C2,T13,NH603,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH701,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH701,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH701,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH701,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH701,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH701,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T14,NH701,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T14,NH701,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T14,NH701,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T14,NH701,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T14,NH701,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T14,NH701,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH701,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH701,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH701,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH701,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH701,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH701,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH701,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH701,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH701,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH701,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH701,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH701,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH701,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH701,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH701,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH701,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T14,NH701,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T14,NH701,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T14,NH701,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T14,NH701,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T14,NH701,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T14,NH701,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH701,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH701,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH701,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH701,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH701,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH701,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH701,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH701,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH701,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH701,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH701,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH701,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH701,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH701,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH701,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH701,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T14,NH701,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T14,NH701,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T14,NH701,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T14,NH701,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T14,NH701,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T14,NH701,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH701,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH701,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH701,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH701,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH701,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH701,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH701,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH701,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH701,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH701,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH701,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH701,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH701,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH701,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH701,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH701,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T14,NH701,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T14,NH701,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T14,NH701,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T14,NH701,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T14,NH701,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T14,NH701,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH701,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH701,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH701,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH701,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH701,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH701,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH701,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH701,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH701,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH701,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),48.9,48.9,,,43.8,54.1,Overall,Overall,C2,T14,NH701,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),49.4,49.4,,,44.0,54.8,Overall,Overall,C2,T14,NH701,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),45.7,45.7,,,39.5,52.1,Gender,Male,C2,T14,NH701,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),45.6,45.6,,,39.6,51.8,Gender,Male,C2,T14,NH701,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),52.0,52.0,,,47.4,56.5,Gender,Female,C2,T14,NH701,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),52.9,52.9,,,47.8,57.9,Gender,Female,C2,T14,NH701,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),33.8,33.8,,,29.8,38.1,Age,20-24,C2,T14,NH701,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),41.3,41.3,,,36.6,46.2,Age,25-44,C2,T14,NH701,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),54.7,54.7,,,46.7,62.4,Age,45-64,C2,T14,NH701,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),64.4,64.4,,,58.0,70.3,Age,65+,C2,T14,NH701,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),54.0,54.0,,,47.8,60.0,Age,35+,C2,T14,NH701,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),71.7,71.7,,,65.5,77.3,Age,75+,C2,T14,NH701,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),46.1,46.1,,,37.8,54.6,Race,Non-Hispanic White,C2,T14,NH701,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),44.6,44.6,,,36.6,52.9,Race,Non-Hispanic White,C2,T14,NH701,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),58.1,58.1,,,55.3,60.9,Race,Non-Hispanic Black,C2,T14,NH701,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),57.2,57.2,,,53.8,60.5,Race,Non-Hispanic Black,C2,T14,NH701,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH701,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH701,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T14,NH701,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T14,NH701,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),49.8,49.8,,,41.2,58.5,Race,Other,C2,T14,NH701,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),50.1,50.1,,,42.8,57.4,Race,Other,C2,T14,NH701,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),47.8,47.8,,,45.6,50.1,Overall,Overall,C2,T14,NH701,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),48.3,48.3,,,45.9,50.7,Overall,Overall,C2,T14,NH701,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),44.2,44.2,,,41.5,46.9,Gender,Male,C2,T14,NH701,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),44.0,44.0,,,41.5,46.6,Gender,Male,C2,T14,NH701,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),51.6,51.6,,,48.9,54.3,Gender,Female,C2,T14,NH701,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),52.2,52.2,,,49.4,55.0,Gender,Female,C2,T14,NH701,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),35.8,35.8,,,30.7,41.2,Age,20-24,C2,T14,NH701,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),43.4,43.4,,,40.6,46.2,Age,25-44,C2,T14,NH701,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),49.8,49.8,,,46.4,53.2,Age,45-64,C2,T14,NH701,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),61.8,61.8,,,58.3,65.3,Age,65+,C2,T14,NH701,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),51.7,51.7,,,49.5,53.8,Age,35+,C2,T14,NH701,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),69.0,69.0,,,64.0,73.6,Age,75+,C2,T14,NH701,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),44.5,44.5,,,40.8,48.2,Race,Non-Hispanic White,C2,T14,NH701,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),43.1,43.1,,,39.4,46.8,Race,Non-Hispanic White,C2,T14,NH701,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),59.2,59.2,,,56.0,62.4,Race,Non-Hispanic Black,C2,T14,NH701,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),58.9,58.9,,,55.3,62.4,Race,Non-Hispanic Black,C2,T14,NH701,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH701,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH701,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T14,NH701,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T14,NH701,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),47.2,47.2,,,41.0,53.5,Race,Other,C2,T14,NH701,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),47.8,47.8,,,41.7,54.0,Race,Other,C2,T14,NH701,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),44.3,44.3,,,40.4,48.2,Overall,Overall,C2,T14,NH701,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),45.2,45.2,,,40.8,49.6,Overall,Overall,C2,T14,NH701,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),43.0,43.0,,,38.1,48.0,Gender,Male,C2,T14,NH701,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),42.5,42.5,,,38.3,46.8,Gender,Male,C2,T14,NH701,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),46.0,46.0,,,41.4,50.7,Gender,Female,C2,T14,NH701,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),47.2,47.2,,,42.3,52.2,Gender,Female,C2,T14,NH701,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),29.7,29.7,,,22.6,37.9,Age,20-24,C2,T14,NH701,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),37.3,37.3,,,32.9,42.1,Age,25-44,C2,T14,NH701,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),49.2,49.2,,,43.5,55.0,Age,45-64,C2,T14,NH701,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),60.6,60.6,,,56.0,65.1,Age,65+,C2,T14,NH701,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),49.9,49.9,,,45.2,54.6,Age,35+,C2,T14,NH701,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),68.4,68.4,,,62.1,74.0,Age,75+,C2,T14,NH701,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),42.3,42.3,,,36.8,48.0,Race,Non-Hispanic White,C2,T14,NH701,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),40.0,40.0,,,35.3,44.9,Race,Non-Hispanic White,C2,T14,NH701,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),52.2,52.2,,,47.5,56.9,Race,Non-Hispanic Black,C2,T14,NH701,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),51.9,51.9,,,47.0,56.8,Race,Non-Hispanic Black,C2,T14,NH701,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),41.2,41.2,,,36.0,46.7,Race,Non-Hispanic Asian,C2,T14,NH701,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),30.4,30.4,,,25.8,35.3,Race,Non-Hispanic White,C2,T15,NH074,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),42.1,42.1,,,37.2,47.1,Race,Non-Hispanic Asian,C2,T14,NH701,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),57.1,57.1,,,53.3,60.8,Race,Hispanic,C2,T14,NH701,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),54.6,54.6,,,50.4,58.7,Race,Hispanic,C2,T14,NH701,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),42.4,42.4,,,36.1,49.0,Race,Other,C2,T14,NH701,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),43.0,43.0,,,37.4,48.9,Race,Other,C2,T14,NH701,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),47.0,47.0,,,44.3,49.7,Overall,Overall,C2,T14,NH701,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),47.7,47.7,,,45.0,50.4,Overall,Overall,C2,T14,NH701,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),46.1,46.1,,,43.9,48.3,Gender,Male,C2,T14,NH701,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),45.7,45.7,,,43.5,47.8,Gender,Male,C2,T14,NH701,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),48.4,48.4,,,44.4,52.4,Gender,Female,C2,T14,NH701,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),49.2,49.2,,,45.3,53.1,Gender,Female,C2,T14,NH701,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),39.6,39.6,,,32.0,47.8,Age,20-24,C2,T14,NH701,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),41.3,41.3,,,38.5,44.1,Age,25-44,C2,T14,NH701,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),50.7,50.7,,,47.8,53.7,Age,45-64,C2,T14,NH701,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),58.0,58.0,,,53.7,62.3,Age,65+,C2,T14,NH701,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),51.0,51.0,,,48.0,53.9,Age,35+,C2,T14,NH701,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),62.7,62.7,,,56.9,68.1,Age,75+,C2,T14,NH701,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),47.2,47.2,,,43.8,50.6,Race,Non-Hispanic White,C2,T14,NH701,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),45.4,45.4,,,41.9,49.0,Race,Non-Hispanic White,C2,T14,NH701,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),51.0,51.0,,,45.8,56.2,Race,Non-Hispanic Black,C2,T14,NH701,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),51.0,51.0,,,46.2,55.8,Race,Non-Hispanic Black,C2,T14,NH701,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),39.3,39.3,,,33.9,45.0,Race,Non-Hispanic Asian,C2,T14,NH701,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),39.4,39.4,,,33.8,45.3,Race,Non-Hispanic Asian,C2,T14,NH701,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),52.6,52.6,,,50.6,54.5,Race,Hispanic,C2,T14,NH701,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),51.1,51.1,,,49.3,53.0,Race,Hispanic,C2,T14,NH701,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Crude,Percent (%),41.1,41.1,,,37.2,45.1,Race,Other,C2,T14,NH701,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),41.5,41.5,,,37.5,45.6,Race,Other,C2,T14,NH701,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH703,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH703,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH703,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH703,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH703,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH703,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T14,NH703,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T14,NH703,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T14,NH703,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T14,NH703,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T14,NH703,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T14,NH703,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH703,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH703,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH703,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH703,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH703,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH703,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH703,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH703,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH703,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH703,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH703,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH703,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH703,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH703,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH703,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH703,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH703,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T14,NH703,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T14,NH703,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T14,NH703,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T14,NH703,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T14,NH703,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T14,NH703,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH703,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH703,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH703,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH703,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH703,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH703,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH703,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),33.1,33.1,,,28.4,38.0,Race,Non-Hispanic Black,C2,T15,NH074,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH703,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH703,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH703,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH703,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH703,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH703,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH703,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH703,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T14,NH703,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T14,NH703,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T14,NH703,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T14,NH703,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T14,NH703,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T14,NH703,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH703,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH703,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH703,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH703,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH703,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH703,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH703,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH703,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH703,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH703,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH703,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Overall,Overall,C2,T14,NH703,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH703,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T14,NH703,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH703,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Female,C2,T14,NH703,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T14,NH703,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,25-44,C2,T14,NH703,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),40.9,40.9,,,36.3,45.6,Gender,Male,C2,T14,NH703,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,45-64,C2,T14,NH703,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,65+,C2,T14,NH703,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,35+,C2,T14,NH703,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,75+,C2,T14,NH703,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH703,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic White,C2,T14,NH703,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH703,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Black,C2,T14,NH703,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH703,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH703,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH703,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T14,NH703,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH703,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T14,NH703,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),38.5,38.5,,,34.0,43.2,Overall,Overall,C2,T14,NH703,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),38.2,38.2,,,33.6,43.1,Overall,Overall,C2,T14,NH703,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),40.8,40.8,,,36.1,45.6,Gender,Male,C2,T14,NH703,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),36.4,36.4,,,31.8,41.4,Gender,Female,C2,T14,NH703,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),35.8,35.8,,,30.9,41.0,Gender,Female,C2,T14,NH703,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),48.7,48.7,,,42.9,54.6,Age,20-24,C2,T14,NH703,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),43.1,43.1,,,38.0,48.4,Age,25-44,C2,T14,NH703,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),35.1,35.1,,,28.7,42.0,Age,45-64,C2,T14,NH703,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),28.4,28.4,,,22.9,34.6,Age,65+,C2,T14,NH703,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),35.2,35.2,,,30.3,40.5,Age,35+,C2,T14,NH703,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),22.0,22.0,,,16.6,28.5,Age,75+,C2,T14,NH703,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),41.2,41.2,,,34.0,48.8,Race,Non-Hispanic White,C2,T14,NH703,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),42.1,42.1,,,35.0,49.6,Race,Non-Hispanic White,C2,T14,NH703,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),29.8,29.8,,,26.5,33.4,Race,Non-Hispanic Black,C2,T14,NH703,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),30.5,30.5,,,26.8,34.5,Race,Non-Hispanic Black,C2,T14,NH703,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH703,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH703,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T14,NH703,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T14,NH703,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),35.4,35.4,,,27.5,44.2,Race,Other,C2,T14,NH703,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),35.3,35.3,,,28.3,43.1,Race,Other,C2,T14,NH703,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),41.4,41.4,,,38.8,44.2,Overall,Overall,C2,T14,NH703,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),41.1,41.1,,,38.4,43.9,Overall,Overall,C2,T14,NH703,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),44.8,44.8,,,41.5,48.1,Gender,Male,C2,T14,NH703,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),44.9,44.9,,,41.7,48.2,Gender,Male,C2,T14,NH703,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),38.0,38.0,,,35.2,40.9,Gender,Female,C2,T14,NH703,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),37.6,37.6,,,34.8,40.5,Gender,Female,C2,T14,NH703,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),52.6,52.6,,,45.0,60.2,Age,20-24,C2,T14,NH703,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),44.2,44.2,,,41.1,47.3,Age,25-44,C2,T14,NH703,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),39.7,39.7,,,36.8,42.7,Age,45-64,C2,T14,NH703,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),31.7,31.7,,,27.8,35.8,Age,65+,C2,T14,NH703,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),38.6,38.6,,,36.1,41.1,Age,35+,C2,T14,NH703,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),25.2,25.2,,,20.8,30.1,Age,75+,C2,T14,NH703,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),45.2,45.2,,,41.0,49.4,Race,Non-Hispanic White,C2,T14,NH703,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),46.2,46.2,,,41.9,50.6,Race,Non-Hispanic White,C2,T14,NH703,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),30.9,30.9,,,28.5,33.3,Race,Non-Hispanic Black,C2,T14,NH703,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),31.2,31.2,,,28.4,34.0,Race,Non-Hispanic Black,C2,T14,NH703,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH703,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T14,NH703,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T14,NH703,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T14,NH703,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),36.3,36.3,,,30.5,42.6,Race,Other,C2,T14,NH703,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),35.9,35.9,,,30.1,42.2,Race,Other,C2,T14,NH703,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),44.2,44.2,,,40.8,47.7,Overall,Overall,C2,T14,NH703,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),43.6,43.6,,,39.8,47.5,Overall,Overall,C2,T14,NH703,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),45.5,45.5,,,40.9,50.2,Gender,Male,C2,T14,NH703,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),45.9,45.9,,,41.7,50.1,Gender,Male,C2,T14,NH703,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),42.6,42.6,,,38.2,47.2,Gender,Female,C2,T14,NH703,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),41.8,41.8,,,37.1,46.8,Gender,Female,C2,T14,NH703,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),57.8,57.8,,,50.2,65.0,Age,20-24,C2,T14,NH703,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),48.3,48.3,,,44.0,52.6,Age,25-44,C2,T14,NH703,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),40.8,40.8,,,36.1,45.7,Age,45-64,C2,T14,NH703,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),32.3,32.3,,,28.7,36.0,Age,65+,C2,T14,NH703,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),39.6,39.6,,,35.8,43.6,Age,35+,C2,T14,NH703,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),26.1,26.1,,,20.7,32.3,Age,75+,C2,T14,NH703,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),46.3,46.3,,,41.4,51.3,Race,Non-Hispanic White,C2,T14,NH703,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),48.0,48.0,,,43.8,52.3,Race,Non-Hispanic White,C2,T14,NH703,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),38.2,38.2,,,34.3,42.3,Race,Non-Hispanic Black,C2,T14,NH703,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),38.4,38.4,,,34.2,42.9,Race,Non-Hispanic Black,C2,T14,NH703,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),43.3,43.3,,,39.3,47.3,Race,Non-Hispanic Asian,C2,T14,NH703,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),42.7,42.7,,,38.9,46.7,Race,Non-Hispanic Asian,C2,T14,NH703,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),32.7,32.7,,,28.8,36.8,Race,Hispanic,C2,T14,NH703,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),34.3,34.3,,,30.2,38.6,Race,Hispanic,C2,T14,NH703,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),45.2,45.2,,,39.9,50.6,Race,Other,C2,T14,NH703,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),44.8,44.8,,,39.9,49.8,Race,Other,C2,T14,NH703,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),42.2,42.2,,,39.9,44.4,Overall,Overall,C2,T14,NH703,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),41.6,41.6,,,39.4,43.8,Overall,Overall,C2,T14,NH703,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),43.9,43.9,,,41.7,46.2,Gender,Male,C2,T14,NH703,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),44.3,44.3,,,42.0,46.5,Gender,Male,C2,T14,NH703,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),40.0,40.0,,,37.2,42.8,Gender,Female,C2,T14,NH703,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),39.4,39.4,,,36.7,42.2,Gender,Female,C2,T14,NH703,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),46.0,46.0,,,38.2,54.0,Age,20-24,C2,T14,NH703,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),47.2,47.2,,,45.0,49.5,Age,25-44,C2,T14,NH703,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),39.1,39.1,,,36.7,41.6,Age,45-64,C2,T14,NH703,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),33.6,33.6,,,29.4,38.0,Age,65+,C2,T14,NH703,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),38.9,38.9,,,36.7,41.2,Age,35+,C2,T14,NH703,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),29.1,29.1,,,24.0,34.7,Age,75+,C2,T14,NH703,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),42.4,42.4,,,39.8,45.1,Race,Non-Hispanic White,C2,T14,NH703,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),43.8,43.8,,,41.0,46.6,Race,Non-Hispanic White,C2,T14,NH703,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),37.8,37.8,,,33.6,42.1,Race,Non-Hispanic Black,C2,T14,NH703,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),37.8,37.8,,,34.1,41.7,Race,Non-Hispanic Black,C2,T14,NH703,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),45.0,45.0,,,40.6,49.5,Race,Non-Hispanic Asian,C2,T14,NH703,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),45.1,45.1,,,40.7,49.5,Race,Non-Hispanic Asian,C2,T14,NH703,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),37.6,37.6,,,35.1,40.2,Race,Hispanic,C2,T14,NH703,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),39.1,39.1,,,36.6,41.8,Race,Hispanic,C2,T14,NH703,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Crude,Percent (%),44.8,44.8,,,41.5,48.3,Race,Other,C2,T14,NH703,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+); NHANES,Age-Standardized,Percent (%),44.9,44.9,,,41.6,48.3,Race,Other,C2,T14,NH703,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),29.2,29.2,,,25.8,32.8,Overall,Overall,C2,T15,NH074,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.9,29.9,,,26.4,33.7,Overall,Overall,C2,T15,NH074,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),36.2,36.2,,,31.4,41.3,Gender,Male,C2,T15,NH074,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),35.0,35.0,,,30.5,39.8,Gender,Male,C2,T15,NH074,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),23.8,23.8,,,20.6,27.3,Gender,Female,C2,T15,NH074,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),24.1,24.1,,,21.0,27.6,Gender,Female,C2,T15,NH074,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),34.9,34.9,,,28.1,42.4,Age,20-24,C2,T15,NH074,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),34.7,34.7,,,30.6,39.1,Age,25-44,C2,T15,NH074,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),27.7,27.7,,,22.9,33.2,Age,45-64,C2,T15,NH074,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),15.1,15.1,,,11.9,19.0,Age,65+,C2,T15,NH074,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),26.9,26.9,,,23.6,30.4,Age,35+,C2,T15,NH074,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),10.7,10.7,,,7.0,15.9,Age,75+,C2,T15,NH074,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),30.6,30.6,,,26.1,35.5,Race,Non-Hispanic White,C2,T15,NH074,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),33.9,33.9,,,29.0,39.1,Race,Non-Hispanic Black,C2,T15,NH074,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH074,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH074,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),28.0,28.0,,,22.7,34.0,Race,Other,C2,T15,NH074,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),24.8,24.8,,,20.3,29.9,Race,Other,C2,T15,NH074,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),28.8,28.8,,,26.5,31.2,Overall,Overall,C2,T15,NH074,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.4,29.4,,,27.1,31.8,Overall,Overall,C2,T15,NH074,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),34.2,34.2,,,31.1,37.5,Gender,Male,C2,T15,NH074,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),33.2,33.2,,,30.3,36.3,Gender,Male,C2,T15,NH074,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),24.6,24.6,,,22.2,27.2,Gender,Female,C2,T15,NH074,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),24.9,24.9,,,22.6,27.4,Gender,Female,C2,T15,NH074,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),41.7,41.7,,,35.1,48.7,Age,20-24,C2,T15,NH074,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),32.2,32.2,,,29.2,35.4,Age,25-44,C2,T15,NH074,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.0,29.0,,,25.7,32.5,Age,45-64,C2,T15,NH074,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),12.7,12.7,,,10.4,15.4,Age,65+,C2,T15,NH074,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),26.3,26.3,,,24.1,28.7,Age,35+,C2,T15,NH074,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),8.8,8.8,,,6.3,12.0,Age,75+,C2,T15,NH074,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),28.7,28.7,,,25.4,32.3,Race,Non-Hispanic White,C2,T15,NH074,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),28.8,28.8,,,25.5,32.4,Race,Non-Hispanic White,C2,T15,NH074,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),33.9,33.9,,,29.4,38.6,Race,Non-Hispanic Black,C2,T15,NH074,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),34.5,34.5,,,30.0,39.3,Race,Non-Hispanic Black,C2,T15,NH074,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH074,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH074,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.7,25.7,,,16.4,37.8,Race,Other,C2,T15,NH074,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),25.3,25.3,,,16.0,37.6,Race,Other,C2,T15,NH074,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),31.3,31.3,,,28.6,34.2,Overall,Overall,C2,T15,NH074,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),31.4,31.4,,,28.6,34.3,Overall,Overall,C2,T15,NH074,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),39.0,39.0,,,35.0,43.2,Gender,Male,C2,T15,NH074,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),38.7,38.7,,,34.7,42.9,Gender,Male,C2,T15,NH074,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),24.5,24.5,,,21.9,27.3,Gender,Female,C2,T15,NH074,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),24.3,24.3,,,21.7,27.1,Gender,Female,C2,T15,NH074,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),41.1,41.1,,,35.7,46.7,Age,20-24,C2,T15,NH074,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),36.4,36.4,,,32.0,40.9,Age,25-44,C2,T15,NH074,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),32.3,32.3,,,29.1,35.7,Age,45-64,C2,T15,NH074,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),12.5,12.5,,,10.8,14.3,Age,65+,C2,T15,NH074,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),28.5,28.5,,,25.8,31.3,Age,35+,C2,T15,NH074,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),8.5,8.5,,,7.0,10.3,Age,75+,C2,T15,NH074,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),31.7,31.7,,,28.5,35.1,Race,Non-Hispanic White,C2,T15,NH074,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),32.5,32.5,,,29.5,35.7,Race,Non-Hispanic White,C2,T15,NH074,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),34.7,34.7,,,29.2,40.6,Race,Non-Hispanic Black,C2,T15,NH074,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),34.9,34.9,,,29.4,40.8,Race,Non-Hispanic Black,C2,T15,NH074,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH074,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH074,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.5,29.5,,,21.8,38.5,Race,Other,C2,T15,NH074,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),28.7,28.7,,,21.4,37.2,Race,Other,C2,T15,NH074,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),29.0,29.0,,,26.7,31.4,Overall,Overall,C2,T15,NH074,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.0,29.0,,,27.0,31.1,Overall,Overall,C2,T15,NH074,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),35.4,35.4,,,32.5,38.4,Gender,Male,C2,T15,NH074,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),35.1,35.1,,,32.1,38.3,Gender,Male,C2,T15,NH074,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),23.2,23.2,,,20.9,25.6,Gender,Female,C2,T15,NH074,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),23.0,23.0,,,21.0,25.2,Gender,Female,C2,T15,NH074,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),41.3,41.3,,,34.6,48.3,Age,20-24,C2,T15,NH074,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),32.9,32.9,,,29.2,36.8,Age,25-44,C2,T15,NH074,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),28.3,28.3,,,24.5,32.5,Age,45-64,C2,T15,NH074,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),14.3,14.3,,,11.7,17.4,Age,65+,C2,T15,NH074,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),27.1,27.1,,,24.6,29.7,Age,35+,C2,T15,NH074,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),9.7,9.7,,,7.4,12.6,Age,75+,C2,T15,NH074,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),30.2,30.2,,,27.4,33.3,Race,Non-Hispanic White,C2,T15,NH074,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),31.2,31.2,,,27.7,35.0,Race,Non-Hispanic White,C2,T15,NH074,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),29.8,29.8,,,24.6,35.5,Race,Non-Hispanic Black,C2,T15,NH074,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.8,29.8,,,24.7,35.5,Race,Non-Hispanic Black,C2,T15,NH074,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH074,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH074,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),28.8,28.8,,,19.3,40.6,Race,Other,C2,T15,NH074,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),26.4,26.4,,,18.2,36.5,Race,Other,C2,T15,NH074,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),28.3,28.3,,,25.2,31.6,Overall,Overall,C2,T15,NH074,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),28.2,28.2,,,25.4,31.3,Overall,Overall,C2,T15,NH074,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),34.6,34.6,,,31.1,38.4,Gender,Male,C2,T15,NH074,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),34.0,34.0,,,30.3,37.9,Gender,Male,C2,T15,NH074,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),22.8,22.8,,,20.1,25.7,Gender,Female,C2,T15,NH074,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),22.3,22.3,,,19.8,24.9,Gender,Female,C2,T15,NH074,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),35.0,35.0,,,28.9,41.6,Age,20-24,C2,T15,NH074,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),33.7,33.7,,,30.3,37.2,Age,25-44,C2,T15,NH074,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),27.9,27.9,,,23.4,32.8,Age,45-64,C2,T15,NH074,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),12.1,12.1,,,10.7,13.6,Age,65+,C2,T15,NH074,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),24.8,24.8,,,21.9,28.1,Age,35+,C2,T15,NH074,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),9.5,9.5,,,7.6,11.9,Age,75+,C2,T15,NH074,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.0,29.0,,,24.9,33.6,Race,Non-Hispanic White,C2,T15,NH074,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),30.1,30.1,,,25.7,34.8,Race,Non-Hispanic White,C2,T15,NH074,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),33.2,33.2,,,30.1,36.4,Race,Non-Hispanic Black,C2,T15,NH074,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),33.6,33.6,,,30.4,36.9,Race,Non-Hispanic Black,C2,T15,NH074,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T15,NH074,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T15,NH074,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),21.3,21.3,,,15.2,29.0,Race,Other,C2,T15,NH074,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),20.1,20.1,,,14.3,27.5,Race,Other,C2,T15,NH074,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),25.9,25.9,,,24.4,27.6,Overall,Overall,C2,T15,NH074,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.6,25.6,,,24.2,27.2,Overall,Overall,C2,T15,NH074,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),30.4,30.4,,,28.3,32.6,Gender,Male,C2,T15,NH074,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),30.4,30.4,,,28.1,32.8,Gender,Male,C2,T15,NH074,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),21.8,21.8,,,20.0,23.7,Gender,Female,C2,T15,NH074,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),21.2,21.2,,,19.4,23.1,Gender,Female,C2,T15,NH074,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),36.1,36.1,,,29.4,43.4,Age,20-24,C2,T15,NH074,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),30.1,30.1,,,27.4,33.0,Age,25-44,C2,T15,NH074,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.3,25.3,,,23.4,27.3,Age,45-64,C2,T15,NH074,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),11.1,11.1,,,9.4,12.9,Age,65+,C2,T15,NH074,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),22.6,22.6,,,21.2,24.1,Age,35+,C2,T15,NH074,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),8.0,8.0,,,6.3,10.2,Age,75+,C2,T15,NH074,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.6,25.6,,,23.9,27.5,Race,Non-Hispanic White,C2,T15,NH074,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),26.9,26.9,,,25.0,29.0,Race,Non-Hispanic White,C2,T15,NH074,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),33.8,33.8,,,28.1,40.1,Race,Non-Hispanic Black,C2,T15,NH074,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),34.1,34.1,,,27.7,41.1,Race,Non-Hispanic Black,C2,T15,NH074,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T15,NH074,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T15,NH074,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),21.5,21.5,,,14.8,30.1,Race,Other,C2,T15,NH074,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),20.1,20.1,,,13.5,28.8,Race,Other,C2,T15,NH074,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),25.1,25.1,,,22.4,28.0,Overall,Overall,C2,T15,NH074,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),24.7,24.7,,,22.1,27.4,Overall,Overall,C2,T15,NH074,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),31.0,31.0,,,27.3,35.1,Gender,Male,C2,T15,NH074,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),31.4,31.4,,,27.5,35.6,Gender,Male,C2,T15,NH074,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),19.2,19.2,,,16.4,22.4,Gender,Female,C2,T15,NH074,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),18.7,18.7,,,16.1,21.6,Gender,Female,C2,T15,NH074,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.1,25.1,,,19.2,32.1,Age,20-24,C2,T15,NH074,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.8,29.8,,,26.9,33.0,Age,25-44,C2,T15,NH074,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.8,25.8,,,22.3,29.7,Age,45-64,C2,T15,NH074,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),12.0,12.0,,,9.1,15.6,Age,65+,C2,T15,NH074,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),23.3,23.3,,,20.8,26.0,Age,35+,C2,T15,NH074,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),6.1,6.1,,,4.1,9.0,Age,75+,C2,T15,NH074,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),25.2,25.2,,,21.9,28.7,Race,Non-Hispanic White,C2,T15,NH074,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),26.4,26.4,,,22.8,30.2,Race,Non-Hispanic White,C2,T15,NH074,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),29.8,29.8,,,24.7,35.5,Race,Non-Hispanic Black,C2,T15,NH074,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),29.8,29.8,,,24.7,35.4,Race,Non-Hispanic Black,C2,T15,NH074,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),12.0,12.0,,,9.8,14.5,Race,Non-Hispanic Asian,C2,T15,NH074,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),11.4,11.4,,,9.4,13.9,Race,Non-Hispanic Asian,C2,T15,NH074,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),20.1,20.1,,,17.1,23.4,Race,Hispanic,C2,T15,NH074,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),19.6,19.6,,,17.2,22.4,Race,Hispanic,C2,T15,NH074,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),20.9,20.9,,,14.6,29.1,Race,Other,C2,T15,NH074,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),21.1,21.1,,,14.7,29.4,Race,Other,C2,T15,NH074,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T15,NH074,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T15,NH074,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T15,NH074,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T15,NH074,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T15,NH074,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T15,NH074,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,20-24,C2,T15,NH074,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,25-44,C2,T15,NH074,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T15,NH074,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T15,NH074,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,35+,C2,T15,NH074,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T15,NH074,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T15,NH074,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T15,NH074,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T15,NH074,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T15,NH074,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH074,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH074,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH074,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T15,NH074,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T15,NH074,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),25.3,25.3,,,22.6,28.2,Overall,Overall,C2,T15,NH801,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),25.6,25.6,,,22.8,28.5,Overall,Overall,C2,T15,NH801,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),28.4,28.4,,,24.8,32.3,Gender,Male,C2,T15,NH801,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),27.6,27.6,,,24.2,31.3,Gender,Male,C2,T15,NH801,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),23.0,23.0,,,20.3,25.9,Gender,Female,C2,T15,NH801,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),22.9,22.9,,,20.1,25.9,Gender,Female,C2,T15,NH801,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),32.7,32.7,,,26.2,39.9,Age,20-24,C2,T15,NH801,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),30.2,30.2,,,26.8,34.0,Age,25-44,C2,T15,NH801,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),24.5,24.5,,,20.3,29.2,Age,45-64,C2,T15,NH801,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),10.7,10.7,,,8.6,13.2,Age,65+,C2,T15,NH801,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),22.8,22.8,,,20.1,25.8,Age,35+,C2,T15,NH801,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),6.3,6.3,,,4.2,9.2,Age,75+,C2,T15,NH801,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),26.0,26.0,,,22.5,29.9,Race,Non-Hispanic White,C2,T15,NH801,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.3,26.3,,,22.7,30.2,Race,Non-Hispanic White,C2,T15,NH801,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.2,26.2,,,23.2,29.4,Race,Non-Hispanic Black,C2,T15,NH801,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),26.5,26.5,,,23.5,29.6,Race,Non-Hispanic Black,C2,T15,NH801,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH801,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH801,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH801,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH801,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),27.4,27.4,,,20.8,35.2,Race,Other,C2,T15,NH801,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),24.8,24.8,,,19.2,31.5,Race,Other,C2,T15,NH801,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),24.4,24.4,,,22.3,26.7,Overall,Overall,C2,T15,NH801,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),24.8,24.8,,,22.7,27.1,Overall,Overall,C2,T15,NH801,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),27.4,27.4,,,24.8,30.1,Gender,Male,C2,T15,NH801,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.6,26.6,,,24.1,29.3,Gender,Male,C2,T15,NH801,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),22.4,22.4,,,20.0,25.0,Gender,Female,C2,T15,NH801,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),22.3,22.3,,,19.9,25.0,Gender,Female,C2,T15,NH801,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),36.4,36.4,,,28.8,44.7,Age,20-24,C2,T15,NH801,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),28.9,28.9,,,26.1,31.8,Age,25-44,C2,T15,NH801,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),23.8,23.8,,,21.2,26.7,Age,45-64,C2,T15,NH801,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),8.5,8.5,,,6.7,10.7,Age,65+,C2,T15,NH801,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),21.9,21.9,,,19.9,24.0,Age,35+,C2,T15,NH801,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),4.9,4.9,,,3.4,7.0,Age,75+,C2,T15,NH801,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),24.0,24.0,,,21.3,27.0,Race,Non-Hispanic White,C2,T15,NH801,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),24.6,24.6,,,21.8,27.6,Race,Non-Hispanic White,C2,T15,NH801,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),27.6,27.6,,,23.9,31.7,Race,Non-Hispanic Black,C2,T15,NH801,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),28.4,28.4,,,24.4,32.8,Race,Non-Hispanic Black,C2,T15,NH801,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH801,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH801,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH801,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH801,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),22.3,22.3,,,13.7,34.3,Race,Other,C2,T15,NH801,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),22.2,22.2,,,13.7,33.7,Race,Other,C2,T15,NH801,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),25.9,25.9,,,23.8,28.1,Overall,Overall,C2,T15,NH801,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),25.8,25.8,,,23.7,28.1,Overall,Overall,C2,T15,NH801,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),29.3,29.3,,,26.8,31.9,Gender,Male,C2,T15,NH801,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),28.8,28.8,,,26.5,31.3,Gender,Male,C2,T15,NH801,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),23.0,23.0,,,20.5,25.7,Gender,Female,C2,T15,NH801,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),22.5,22.5,,,20.0,25.2,Gender,Female,C2,T15,NH801,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),33.9,33.9,,,29.2,38.9,Age,20-24,C2,T15,NH801,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),31.2,31.2,,,27.8,34.7,Age,25-44,C2,T15,NH801,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),26.2,26.2,,,24.2,28.4,Age,45-64,C2,T15,NH801,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,7.3,9.5,Age,65+,C2,T15,NH801,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),23.4,23.4,,,21.2,25.7,Age,35+,C2,T15,NH801,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),5.0,5.0,,,4.1,6.2,Age,75+,C2,T15,NH801,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),26.1,26.1,,,23.8,28.5,Race,Non-Hispanic White,C2,T15,NH801,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),27.1,27.1,,,25.0,29.3,Race,Non-Hispanic White,C2,T15,NH801,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),25.2,25.2,,,20.5,30.6,Race,Non-Hispanic Black,C2,T15,NH801,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),25.8,25.8,,,21.1,31.1,Race,Non-Hispanic Black,C2,T15,NH801,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH801,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH801,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH801,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH801,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),24.3,24.3,,,17.3,33.0,Race,Other,C2,T15,NH801,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),23.3,23.3,,,16.7,31.6,Race,Other,C2,T15,NH801,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),24.5,24.5,,,22.0,27.3,Overall,Overall,C2,T15,NH801,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),24.4,24.4,,,22.1,26.9,Overall,Overall,C2,T15,NH801,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),27.7,27.7,,,24.6,31.1,Gender,Male,C2,T15,NH801,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),27.5,27.5,,,24.1,31.1,Gender,Male,C2,T15,NH801,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),21.5,21.5,,,18.8,24.5,Gender,Female,C2,T15,NH801,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),21.2,21.2,,,18.7,23.8,Gender,Female,C2,T15,NH801,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),35.6,35.6,,,28.8,43.1,Age,20-24,C2,T15,NH801,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),28.2,28.2,,,25.2,31.3,Age,25-44,C2,T15,NH801,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),24.0,24.0,,,19.8,28.8,Age,45-64,C2,T15,NH801,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),10.8,10.8,,,8.9,13.1,Age,65+,C2,T15,NH801,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),22.2,22.2,,,19.7,25.0,Age,35+,C2,T15,NH801,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),6.8,6.8,,,5.2,8.7,Age,75+,C2,T15,NH801,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),25.7,25.7,,,22.5,29.2,Race,Non-Hispanic White,C2,T15,NH801,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),27.0,27.0,,,23.3,31.0,Race,Non-Hispanic White,C2,T15,NH801,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),23.4,23.4,,,19.7,27.4,Race,Non-Hispanic Black,C2,T15,NH801,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),23.8,23.8,,,20.2,27.7,Race,Non-Hispanic Black,C2,T15,NH801,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH801,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH801,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH801,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH801,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),21.0,21.0,,,15.7,27.4,Race,Other,C2,T15,NH801,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),19.9,19.9,,,16.0,24.6,Race,Other,C2,T15,NH801,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),23.2,23.2,,,20.6,26.1,Overall,Overall,C2,T15,NH801,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),23.0,23.0,,,20.6,25.6,Overall,Overall,C2,T15,NH801,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),26.5,26.5,,,23.6,29.6,Gender,Male,C2,T15,NH801,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.3,26.3,,,23.3,29.5,Gender,Male,C2,T15,NH801,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),20.2,20.2,,,17.5,23.1,Gender,Female,C2,T15,NH801,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),19.7,19.7,,,17.3,22.4,Gender,Female,C2,T15,NH801,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),27.2,27.2,,,21.7,33.6,Age,20-24,C2,T15,NH801,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),28.2,28.2,,,24.9,31.7,Age,25-44,C2,T15,NH801,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),23.6,23.6,,,20.3,27.1,Age,45-64,C2,T15,NH801,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),8.2,8.2,,,6.8,9.8,Age,65+,C2,T15,NH801,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),20.4,20.4,,,18.0,23.1,Age,35+,C2,T15,NH801,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),5.1,5.1,,,3.8,6.9,Age,75+,C2,T15,NH801,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),23.4,23.4,,,20.1,27.0,Race,Non-Hispanic White,C2,T15,NH801,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),24.6,24.6,,,21.0,28.5,Race,Non-Hispanic White,C2,T15,NH801,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.4,26.4,,,23.0,30.2,Race,Non-Hispanic Black,C2,T15,NH801,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),27.1,27.1,,,23.5,31.0,Race,Non-Hispanic Black,C2,T15,NH801,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH801,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH801,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T15,NH801,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T15,NH801,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),17.9,17.9,,,12.6,24.8,Race,Other,C2,T15,NH801,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),17.3,17.3,,,12.2,23.9,Race,Other,C2,T15,NH801,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),20.4,20.4,,,18.8,22.1,Overall,Overall,C2,T15,NH801,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),20.8,20.8,,,19.1,22.5,Overall,Overall,C2,T15,NH801,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),22.4,22.4,,,20.5,24.4,Gender,Male,C2,T15,NH801,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),22.3,22.3,,,20.4,24.4,Gender,Male,C2,T15,NH801,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),18.5,18.5,,,16.5,20.7,Gender,Female,C2,T15,NH801,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),19.2,19.2,,,17.1,21.5,Gender,Female,C2,T15,NH801,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),27.5,27.5,,,21.4,34.5,Age,20-24,C2,T15,NH801,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),24.8,24.8,,,22.3,27.5,Age,25-44,C2,T15,NH801,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),20.3,20.3,,,17.9,22.9,Age,45-64,C2,T15,NH801,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),7.7,7.7,,,6.5,9.1,Age,65+,C2,T15,NH801,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),17.8,17.8,,,16.1,19.6,Age,35+,C2,T15,NH801,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),5.5,5.5,,,4.5,6.9,Age,75+,C2,T15,NH801,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),19.7,19.7,,,17.7,21.9,Race,Non-Hispanic White,C2,T15,NH801,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),21.1,21.1,,,19.0,23.2,Race,Non-Hispanic White,C2,T15,NH801,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),27.6,27.6,,,23.1,32.5,Race,Non-Hispanic Black,C2,T15,NH801,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),28.1,28.1,,,23.5,33.2,Race,Non-Hispanic Black,C2,T15,NH801,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH801,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH801,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T15,NH801,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T15,NH801,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),17.0,17.0,,,10.1,27.2,Race,Other,C2,T15,NH801,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.2,16.2,,,9.5,26.2,Race,Other,C2,T15,NH801,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),20.0,20.0,,,17.9,22.3,Overall,Overall,C2,T15,NH801,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),20.3,20.3,,,18.0,22.8,Overall,Overall,C2,T15,NH801,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),24.1,24.1,,,21.0,27.4,Gender,Male,C2,T15,NH801,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),24.0,24.0,,,21.1,27.2,Gender,Male,C2,T15,NH801,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),16.2,16.2,,,13.9,18.8,Gender,Female,C2,T15,NH801,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.7,16.7,,,14.3,19.5,Gender,Female,C2,T15,NH801,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),20.2,20.2,,,14.6,27.2,Age,20-24,C2,T15,NH801,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),23.9,23.9,,,20.8,27.4,Age,25-44,C2,T15,NH801,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),21.3,21.3,,,18.7,24.3,Age,45-64,C2,T15,NH801,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),9.2,9.2,,,7.2,11.8,Age,65+,C2,T15,NH801,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),18.9,18.9,,,17.0,20.9,Age,35+,C2,T15,NH801,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),3.9,3.9,,,2.7,5.6,Age,75+,C2,T15,NH801,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),20.4,20.4,,,17.6,23.6,Race,Non-Hispanic White,C2,T15,NH801,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),21.4,21.4,,,18.1,25.2,Race,Non-Hispanic White,C2,T15,NH801,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),22.1,22.1,,,18.3,26.4,Race,Non-Hispanic Black,C2,T15,NH801,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),22.3,22.3,,,18.5,26.6,Race,Non-Hispanic Black,C2,T15,NH801,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),10.1,10.1,,,8.3,12.2,Race,Non-Hispanic Asian,C2,T15,NH801,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),9.7,9.7,,,8.0,11.9,Race,Non-Hispanic Asian,C2,T15,NH801,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),16.8,16.8,,,14.2,19.7,Race,Hispanic,C2,T15,NH801,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.3,16.3,,,14.2,18.8,Race,Hispanic,C2,T15,NH801,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),18.5,18.5,,,12.4,26.7,Race,Other,C2,T15,NH801,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.5,18.5,,,12.3,26.9,Race,Other,C2,T15,NH801,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),20.9,20.9,,,18.9,23.1,Overall,Overall,C2,T15,NH801,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),20.5,20.5,,,18.5,22.6,Overall,Overall,C2,T15,NH801,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),22.0,22.0,,,19.9,24.2,Gender,Male,C2,T15,NH801,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),22.3,22.3,,,20.2,24.5,Gender,Male,C2,T15,NH801,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),19.6,19.6,,,17.1,22.4,Gender,Female,C2,T15,NH801,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),19.0,19.0,,,16.5,21.9,Gender,Female,C2,T15,NH801,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),27.9,27.9,,,23.5,32.8,Age,20-24,C2,T15,NH801,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),23.3,23.3,,,21.0,25.8,Age,25-44,C2,T15,NH801,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),21.6,21.6,,,17.9,25.9,Age,45-64,C2,T15,NH801,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),8.7,8.7,,,7.2,10.4,Age,65+,C2,T15,NH801,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),18.7,18.7,,,16.6,21.1,Age,35+,C2,T15,NH801,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),5.4,5.4,,,3.8,7.8,Age,75+,C2,T15,NH801,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),21.3,21.3,,,18.4,24.6,Race,Non-Hispanic White,C2,T15,NH801,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),22.8,22.8,,,19.8,26.0,Race,Non-Hispanic White,C2,T15,NH801,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.5,26.5,,,23.5,29.6,Race,Non-Hispanic Black,C2,T15,NH801,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),26.6,26.6,,,23.9,29.5,Race,Non-Hispanic Black,C2,T15,NH801,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),8.4,8.4,,,6.6,10.6,Race,Non-Hispanic Asian,C2,T15,NH801,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),8.3,8.3,,,6.6,10.4,Race,Non-Hispanic Asian,C2,T15,NH801,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),14.3,14.3,,,11.9,16.9,Race,Hispanic,C2,T15,NH801,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.1,14.1,,,12.1,16.4,Race,Hispanic,C2,T15,NH801,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Crude,Percent (%),16.3,16.3,,,12.8,20.4,Race,Other,C2,T15,NH801,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.0,16.0,,,12.5,20.1,Race,Other,C2,T15,NH801,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),72.4,72.4,,,69.1,75.5,Overall,Overall,C2,T15,NH803,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),72.7,72.7,,,69.5,75.7,Overall,Overall,C2,T15,NH803,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),70.4,70.4,,,66.6,73.8,Gender,Male,C2,T15,NH803,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),69.6,69.6,,,65.6,73.2,Gender,Male,C2,T15,NH803,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),75.2,75.2,,,71.7,78.3,Gender,Female,C2,T15,NH803,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),75.0,75.0,,,71.6,78.2,Gender,Female,C2,T15,NH803,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),65.0,65.0,,,56.9,72.3,Age,20-24,C2,T15,NH803,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),67.5,67.5,,,63.4,71.4,Age,25-44,C2,T15,NH803,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),73.1,73.1,,,68.5,77.2,Age,45-64,C2,T15,NH803,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),88.9,88.9,,,86.2,91.1,Age,65+,C2,T15,NH803,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),75.4,75.4,,,72.3,78.2,Age,35+,C2,T15,NH803,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),93.5,93.5,,,90.6,95.5,Age,75+,C2,T15,NH803,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),72.0,72.0,,,68.0,75.7,Race,Non-Hispanic White,C2,T15,NH803,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),71.7,71.7,,,67.5,75.5,Race,Non-Hispanic White,C2,T15,NH803,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),71.3,71.3,,,67.0,75.2,Race,Non-Hispanic Black,C2,T15,NH803,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),71.0,71.0,,,66.6,75.0,Race,Non-Hispanic Black,C2,T15,NH803,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH803,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH803,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH803,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH803,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),71.6,71.6,,,64.0,78.1,Race,Other,C2,T15,NH803,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),74.1,74.1,,,67.7,79.6,Race,Other,C2,T15,NH803,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),73.1,73.1,,,70.3,75.7,Overall,Overall,C2,T15,NH803,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),72.7,72.7,,,69.9,75.4,Overall,Overall,C2,T15,NH803,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),69.8,69.8,,,66.8,72.6,Gender,Male,C2,T15,NH803,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),70.6,70.6,,,67.7,73.3,Gender,Male,C2,T15,NH803,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),75.5,75.5,,,72.2,78.5,Gender,Female,C2,T15,NH803,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),75.6,75.6,,,72.2,78.6,Gender,Female,C2,T15,NH803,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),58.3,58.3,,,48.4,67.5,Age,20-24,C2,T15,NH803,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),68.3,68.3,,,65.0,71.6,Age,25-44,C2,T15,NH803,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),74.4,74.4,,,71.1,77.4,Age,45-64,C2,T15,NH803,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),90.3,90.3,,,88.1,92.1,Age,65+,C2,T15,NH803,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),76.1,76.1,,,73.1,78.8,Age,35+,C2,T15,NH803,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),94.3,94.3,,,92.4,95.8,Age,75+,C2,T15,NH803,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),73.2,73.2,,,69.5,76.6,Race,Non-Hispanic White,C2,T15,NH803,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),72.6,72.6,,,68.9,76.0,Race,Non-Hispanic White,C2,T15,NH803,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),70.6,70.6,,,66.6,74.3,Race,Non-Hispanic Black,C2,T15,NH803,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),70.0,70.0,,,65.6,74.0,Race,Non-Hispanic Black,C2,T15,NH803,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH803,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH803,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH803,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH803,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),76.8,76.8,,,65.0,85.5,Race,Other,C2,T15,NH803,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),76.7,76.7,,,64.5,85.6,Race,Other,C2,T15,NH803,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),72.0,72.0,,,69.8,74.1,Overall,Overall,C2,T15,NH803,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),72.0,72.0,,,69.9,73.9,Overall,Overall,C2,T15,NH803,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),68.7,68.7,,,66.4,70.8,Gender,Male,C2,T15,NH803,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),68.2,68.2,,,65.7,70.6,Gender,Male,C2,T15,NH803,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),75.7,75.7,,,72.9,78.3,Gender,Female,C2,T15,NH803,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),75.2,75.2,,,72.5,77.7,Gender,Female,C2,T15,NH803,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),61.7,61.7,,,57.2,65.9,Age,20-24,C2,T15,NH803,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),66.5,66.5,,,63.0,69.8,Age,25-44,C2,T15,NH803,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),72.0,72.0,,,69.5,74.4,Age,45-64,C2,T15,NH803,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),90.5,90.5,,,89.2,91.6,Age,65+,C2,T15,NH803,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),74.8,74.8,,,72.3,77.1,Age,35+,C2,T15,NH803,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),94.5,94.5,,,93.1,95.6,Age,75+,C2,T15,NH803,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),71.9,71.9,,,69.6,74.1,Race,Non-Hispanic White,C2,T15,NH803,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),70.7,70.7,,,68.7,72.7,Race,Non-Hispanic White,C2,T15,NH803,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),73.1,73.1,,,67.5,78.0,Race,Non-Hispanic Black,C2,T15,NH803,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),72.5,72.5,,,67.0,77.4,Race,Non-Hispanic Black,C2,T15,NH803,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),80.4,80.4,,,78.8,81.9,Age,35+,C2,T15,NH803,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH803,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH803,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH803,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH803,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),73.2,73.2,,,64.7,80.3,Race,Other,C2,T15,NH803,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),74.4,74.4,,,66.4,81.0,Race,Other,C2,T15,NH803,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),72.9,72.9,,,70.2,75.5,Overall,Overall,C2,T15,NH803,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),73.1,73.1,,,70.7,75.4,Overall,Overall,C2,T15,NH803,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),69.5,69.5,,,66.2,72.7,Gender,Male,C2,T15,NH803,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),69.8,69.8,,,66.2,73.2,Gender,Male,C2,T15,NH803,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),76.1,76.1,,,73.1,78.9,Gender,Female,C2,T15,NH803,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),76.6,76.6,,,73.9,79.2,Gender,Female,C2,T15,NH803,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),58.9,58.9,,,51.8,65.8,Age,20-24,C2,T15,NH803,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),68.8,68.8,,,65.3,72.1,Age,25-44,C2,T15,NH803,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),74.3,74.3,,,70.0,78.1,Age,45-64,C2,T15,NH803,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),88.1,88.1,,,85.5,90.4,Age,65+,C2,T15,NH803,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),76.2,76.2,,,73.5,78.7,Age,35+,C2,T15,NH803,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),92.3,92.3,,,90.2,94.1,Age,75+,C2,T15,NH803,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),71.5,71.5,,,68.1,74.7,Race,Non-Hispanic White,C2,T15,NH803,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),70.0,70.0,,,66.0,73.7,Race,Non-Hispanic White,C2,T15,NH803,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),35.0,35.0,,,31.7,38.5,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),75.1,75.1,,,71.1,78.8,Race,Non-Hispanic Black,C2,T15,NH803,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),74.7,74.7,,,70.8,78.3,Race,Non-Hispanic Black,C2,T15,NH803,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH803,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH803,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH803,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T15,NH803,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),78.8,78.8,,,73.2,83.4,Race,Other,C2,T15,NH803,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),77.6,77.6,,,70.2,83.6,Race,Other,C2,T15,NH803,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),75.1,75.1,,,72.5,77.5,Overall,Overall,C2,T15,NH803,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),74.8,74.8,,,72.0,77.4,Overall,Overall,C2,T15,NH803,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),71.7,71.7,,,69.0,74.3,Gender,Male,C2,T15,NH803,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),71.5,71.5,,,68.9,74.0,Gender,Male,C2,T15,NH803,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),77.9,77.9,,,74.7,80.9,Gender,Female,C2,T15,NH803,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),78.4,78.4,,,75.5,81.1,Gender,Female,C2,T15,NH803,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),70.0,70.0,,,63.3,75.9,Age,20-24,C2,T15,NH803,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),69.2,69.2,,,65.8,72.4,Age,25-44,C2,T15,NH803,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),74.9,74.9,,,71.4,78.2,Age,45-64,C2,T15,NH803,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),91.2,91.2,,,89.7,92.5,Age,65+,C2,T15,NH803,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),78.1,78.1,,,75.6,80.4,Age,35+,C2,T15,NH803,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),94.2,94.2,,,92.2,95.7,Age,75+,C2,T15,NH803,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),74.8,74.8,,,71.2,78.0,Race,Non-Hispanic White,C2,T15,NH803,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),73.5,73.5,,,69.6,77.0,Race,Non-Hispanic White,C2,T15,NH803,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),71.9,71.9,,,68.1,75.4,Race,Non-Hispanic Black,C2,T15,NH803,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),71.2,71.2,,,67.3,74.9,Race,Non-Hispanic Black,C2,T15,NH803,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH803,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH803,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T15,NH803,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T15,NH803,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),81.6,81.6,,,74.7,86.9,Race,Other,C2,T15,NH803,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),80.9,80.9,,,73.7,86.5,Race,Other,C2,T15,NH803,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),77.0,77.0,,,75.2,78.7,Overall,Overall,C2,T15,NH803,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),77.4,77.4,,,75.6,79.0,Overall,Overall,C2,T15,NH803,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),74.9,74.9,,,72.7,77.0,Gender,Male,C2,T15,NH803,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),74.8,74.8,,,72.7,76.9,Gender,Male,C2,T15,NH803,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),79.0,79.0,,,76.7,81.1,Gender,Female,C2,T15,NH803,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),79.8,79.8,,,77.6,81.8,Gender,Female,C2,T15,NH803,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),69.5,69.5,,,62.8,75.5,Age,20-24,C2,T15,NH803,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),72.3,72.3,,,69.2,75.2,Age,25-44,C2,T15,NH803,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),78.0,78.0,,,75.7,80.1,Age,45-64,C2,T15,NH803,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),90.8,90.8,,,89.3,92.1,Age,65+,C2,T15,NH803,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),93.6,93.6,,,92.3,94.7,Age,75+,C2,T15,NH803,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),76.1,76.1,,,73.9,78.1,Race,Non-Hispanic White,C2,T15,NH803,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),77.6,77.6,,,75.4,79.6,Race,Non-Hispanic White,C2,T15,NH803,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),70.7,70.7,,,65.7,75.3,Race,Non-Hispanic Black,C2,T15,NH803,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),71.3,71.3,,,66.4,75.7,Race,Non-Hispanic Black,C2,T15,NH803,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH803,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T15,NH803,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T15,NH803,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T15,NH803,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),82.9,82.9,,,72.6,89.9,Race,Other,C2,T15,NH803,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),82.1,82.1,,,71.5,89.3,Race,Other,C2,T15,NH803,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),77.7,77.7,,,75.2,80.1,Overall,Overall,C2,T15,NH803,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),78.0,78.0,,,75.7,80.2,Overall,Overall,C2,T15,NH803,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),73.7,73.7,,,70.4,76.8,Gender,Male,C2,T15,NH803,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),73.6,73.6,,,70.1,76.8,Gender,Male,C2,T15,NH803,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),81.6,81.6,,,78.7,84.2,Gender,Female,C2,T15,NH803,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),82.1,82.1,,,79.3,84.6,Gender,Female,C2,T15,NH803,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),77.9,77.9,,,71.2,83.4,Age,20-24,C2,T15,NH803,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),73.7,73.7,,,70.3,76.9,Age,25-44,C2,T15,NH803,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),76.5,76.5,,,73.7,79.0,Age,45-64,C2,T15,NH803,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),89.9,89.9,,,87.2,92.1,Age,65+,C2,T15,NH803,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),79.4,79.4,,,77.5,81.3,Age,35+,C2,T15,NH803,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),95.5,95.5,,,93.7,96.8,Age,75+,C2,T15,NH803,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),76.2,76.2,,,72.4,79.6,Race,Non-Hispanic White,C2,T15,NH803,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),77.3,77.3,,,74.2,80.2,Race,Non-Hispanic White,C2,T15,NH803,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),76.5,76.5,,,71.8,80.6,Race,Non-Hispanic Black,C2,T15,NH803,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),76.3,76.3,,,71.5,80.4,Race,Non-Hispanic Black,C2,T15,NH803,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),89.3,89.3,,,86.8,91.3,Race,Non-Hispanic Asian,C2,T15,NH803,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),88.9,88.9,,,86.4,91.0,Race,Non-Hispanic Asian,C2,T15,NH803,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),82.0,82.0,,,79.8,84.0,Race,Hispanic,C2,T15,NH803,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),81.4,81.4,,,78.7,83.8,Race,Hispanic,C2,T15,NH803,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),80.6,80.6,,,72.5,86.8,Race,Other,C2,T15,NH803,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),80.6,80.6,,,72.7,86.7,Race,Other,C2,T15,NH803,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),76.9,76.9,,,74.4,79.1,Overall,Overall,C2,T15,NH803,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),77.4,77.4,,,75.0,79.7,Overall,Overall,C2,T15,NH803,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),75.3,75.3,,,72.9,77.6,Gender,Male,C2,T15,NH803,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),75.0,75.0,,,72.6,77.3,Gender,Male,C2,T15,NH803,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),78.8,78.8,,,75.8,81.4,Gender,Female,C2,T15,NH803,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),79.4,79.4,,,76.4,82.1,Gender,Female,C2,T15,NH803,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),69.4,69.4,,,65.4,73.1,Age,20-24,C2,T15,NH803,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),73.9,73.9,,,71.3,76.5,Age,25-44,C2,T15,NH803,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),76.5,76.5,,,72.1,80.5,Age,45-64,C2,T15,NH803,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),90.2,90.2,,,88.1,92.0,Age,65+,C2,T15,NH803,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),79.6,79.6,,,76.8,82.1,Age,35+,C2,T15,NH803,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),93.6,93.6,,,91.0,95.5,Age,75+,C2,T15,NH803,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),76.6,76.6,,,72.9,79.9,Race,Non-Hispanic White,C2,T15,NH803,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),75.0,75.0,,,71.2,78.3,Race,Non-Hispanic White,C2,T15,NH803,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),72.2,72.2,,,69.1,75.1,Race,Non-Hispanic Black,C2,T15,NH803,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),72.1,72.1,,,69.2,74.7,Race,Non-Hispanic Black,C2,T15,NH803,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),90.2,90.2,,,87.8,92.2,Race,Non-Hispanic Asian,C2,T15,NH803,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),90.2,90.2,,,87.6,92.2,Race,Non-Hispanic Asian,C2,T15,NH803,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),83.1,83.1,,,80.8,85.3,Race,Hispanic,C2,T15,NH803,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),82.9,82.9,,,80.1,85.3,Race,Hispanic,C2,T15,NH803,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Age-Standardized,Percent (%),82.1,82.1,,,78.0,85.6,Race,Other,C2,T15,NH803,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+); NHANES,Crude,Percent (%),81.8,81.8,,,77.7,85.3,Race,Other,C2,T15,NH803,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T8,NH010,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T8,NH010,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T8,NH010,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T8,NH010,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T8,NH010,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T8,NH010,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T8,NH010,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T8,NH010,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T8,NH010,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T8,NH010,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T8,NH010,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T8,NH010,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T8,NH010,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T8,NH010,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T8,NH010,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T8,NH010,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T8,NH010,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T8,NH010,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T8,NH010,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T8,NH010,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T8,NH010,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T8,NH010,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T8,NH010,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T8,NH010,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T8,NH010,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T8,NH010,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T8,NH010,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T8,NH010,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T8,NH010,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T8,NH010,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T8,NH010,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T8,NH010,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T8,NH010,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T8,NH010,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T8,NH010,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T8,NH010,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T8,NH010,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T8,NH010,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T8,NH010,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T8,NH010,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T8,NH010,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T8,NH010,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T8,NH010,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T8,NH010,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T8,NH010,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T8,NH010,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T8,NH010,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T8,NH010,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T8,NH010,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T8,NH010,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T8,NH010,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T8,NH010,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T8,NH010,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T8,NH010,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T8,NH010,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T8,NH010,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T8,NH010,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T8,NH010,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T8,NH010,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T8,NH010,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T8,NH010,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T8,NH010,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T8,NH010,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T8,NH010,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T8,NH010,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T8,NH010,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T8,NH010,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T8,NH010,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T8,NH010,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T8,NH010,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T8,NH010,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T8,NH010,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T8,NH010,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T8,NH010,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T8,NH010,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T8,NH010,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T8,NH010,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T8,NH010,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T8,NH010,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T8,NH010,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T8,NH010,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Overall,Overall,C2,T8,NH010,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T8,NH010,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Male,C2,T8,NH010,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T8,NH010,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Gender,Female,C2,T8,NH010,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,45-64,C2,T8,NH010,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,65+,C2,T8,NH010,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Age,75+,C2,T8,NH010,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic White,C2,T8,NH010,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Black,C2,T8,NH010,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T8,NH010,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T8,NH010,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T8,NH010,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T8,NH010,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Other,C2,T8,NH010,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),74.3,74.3,,,61.4,84.0,Overall,Overall,C2,T8,NH010,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),79.8,79.8,,,71.2,86.3,Overall,Overall,C2,T8,NH010,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Gender,Male,C2,T8,NH010,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),79.9,79.9,,,66.8,88.6,Gender,Male,C2,T8,NH010,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),79.7,79.7,,,72.5,85.3,Gender,Female,C2,T8,NH010,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),72.7,72.7,,,60.6,82.2,Gender,Female,C2,T8,NH010,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),71.8,71.8,,,55.7,83.8,Age,45-64,C2,T8,NH010,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),86.2,86.2,,,79.6,91.0,Age,65+,C2,T8,NH010,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),86.0,86.0,,,78.4,91.2,Age,75+,C2,T8,NH010,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),82.5,82.5,,,70.9,90.1,Race,Non-Hispanic White,C2,T8,NH010,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),69.6,69.6,,,60.0,77.8,Race,Non-Hispanic Black,C2,T8,NH010,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Non-Hispanic Asian,C2,T8,NH010,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),64.6,64.6,,,52.1,75.3,Race,Hispanic,C2,T8,NH010,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),63.1,63.1,,,51.0,73.7,Race,Hispanic,C2,T8,NH010,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T8,NH010,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T8,NH010,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),74.6,74.6,,,70.3,78.4,Overall,Overall,C2,T8,NH010,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),65.4,65.4,,,56.2,73.7,Overall,Overall,C2,T8,NH010,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),70.1,70.1,,,56.9,80.6,Gender,Male,C2,T8,NH010,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),78.3,78.3,,,73.0,82.8,Gender,Male,C2,T8,NH010,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),70.0,70.0,,,61.6,77.1,Gender,Female,C2,T8,NH010,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),60.5,60.5,,,48.7,71.2,Gender,Female,C2,T8,NH010,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),67.1,67.1,,,57.2,75.8,Age,45-64,C2,T8,NH010,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),81.1,81.1,,,74.8,86.0,Age,65+,C2,T8,NH010,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),84.1,84.1,,,75.8,90.0,Age,75+,C2,T8,NH010,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),77.7,77.7,,,73.5,81.4,Race,Non-Hispanic White,C2,T8,NH010,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),79.1,79.1,,,68.9,86.7,Race,Non-Hispanic Black,C2,T8,NH010,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),62.6,62.6,,,45.0,77.3,Race,Non-Hispanic Asian,C2,T8,NH010,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),50.1,50.1,,,41.5,58.7,Race,Hispanic,C2,T8,NH010,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),48.2,48.2,,,42.3,54.2,Race,Hispanic,C2,T8,NH010,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Age-Standardized,Percent (%),50.4,50.4,,,34.1,66.6,Race,Other,C2,T8,NH010,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,ABCS,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+); NHANES,Crude,Percent (%),62.1,62.1,,,45.1,76.6,Race,Other,C2,T8,NH010,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),27.5,27.5,,,24.6,30.6,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.4,28.4,,,25.7,31.4,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.1,28.1,,,24.2,32.3,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),26.2,26.2,,,22.6,30.1,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),28.8,28.8,,,25.7,32.2,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.4,28.4,,,26.2,30.8,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),12.2,12.2,,,9.3,15.9,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),37.9,37.9,,,33.7,42.4,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),70.2,70.2,,,66.3,73.8,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),38.2,38.2,,,34.7,41.9,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),77.6,77.6,,,73.4,81.4,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),28.0,28.0,,,24.3,32.1,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),26.9,26.9,,,23.6,30.6,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),38.7,38.7,,,36.6,40.8,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),33.3,33.3,,,31.5,35.2,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),25.7,25.7,,,16.3,38.1,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.4,29.4,,,19.2,42.2,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),27.9,27.9,,,26.3,29.7,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),27.4,27.4,,,25.0,29.8,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),24.8,24.8,,,22.1,27.7,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),26.5,26.5,,,24.1,28.9,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.0,29.0,,,27.4,30.7,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),29.9,29.9,,,27.3,32.5,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),3.3,3.3,,,2.1,5.1,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),10.4,10.4,,,8.9,12.1,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),37.6,37.6,,,33.0,42.5,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),70.6,70.6,,,67.8,73.3,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),37.8,37.8,,,34.6,41.1,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),75.8,75.8,,,72.9,78.5,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),28.0,28.0,,,25.6,30.5,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),26.5,26.5,,,24.6,28.4,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),40.8,40.8,,,37.8,44.0,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),36.5,36.5,,,31.6,41.6,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.3,28.3,,,20.5,37.6,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),23.1,23.1,,,16.3,31.7,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),30.1,30.1,,,27.6,32.8,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.9,29.9,,,27.8,32.0,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),30.6,30.6,,,27.7,33.7,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),29.7,29.7,,,26.7,32.9,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),30.5,30.5,,,27.9,33.3,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.8,28.8,,,26.7,31.1,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),12.4,12.4,,,10.7,14.4,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),42.7,42.7,,,38.3,47.3,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),70.1,70.1,,,65.8,74.1,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),41.7,41.7,,,38.4,45.0,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),74.2,74.2,,,68.7,78.9,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),31.0,31.0,,,27.9,34.4,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.8,28.8,,,26.3,31.4,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),39.7,39.7,,,36.3,43.3,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),36.1,36.1,,,32.6,39.7,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),27.2,27.2,,,21.4,33.9,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),30.6,30.6,,,23.7,38.5,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.1,29.1,,,27.3,31.1,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),30.0,30.0,,,27.8,32.4,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),29.4,29.4,,,26.7,32.2,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.9,29.9,,,27.3,32.6,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.0,28.0,,,26.4,29.6,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),30.6,30.6,,,28.1,33.3,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),4.3,4.3,,,2.5,7.2,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),11.7,11.7,,,9.3,14.7,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),39.8,39.8,,,35.8,43.9,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),68.9,68.9,,,66.7,71.1,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),39.9,39.9,,,36.9,42.9,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),71.8,71.8,,,69.1,74.3,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),31.2,31.2,,,28.3,34.2,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.0,28.0,,,25.8,30.2,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),41.0,41.0,,,38.0,44.0,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),38.2,38.2,,,34.3,42.4,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),26.2,26.2,,,19.6,34.1,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),30.0,30.0,,,23.8,37.0,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.6,29.6,,,28.3,30.9,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),30.7,30.7,,,29.0,32.5,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),30.0,30.0,,,28.0,32.0,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),30.1,30.1,,,28.7,31.5,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.0,29.0,,,27.4,30.6,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),31.4,31.4,,,29.1,33.9,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),2.8,2.8,,,1.9,4.2,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),13.2,13.2,,,11.5,15.2,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),39.8,39.8,,,37.3,42.3,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),70.2,70.2,,,65.1,74.8,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),41.2,41.2,,,39.3,43.2,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),76.1,76.1,,,73.0,78.9,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),32.3,32.3,,,30.1,34.5,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.0,29.0,,,27.1,31.0,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),40.5,40.5,,,37.3,43.8,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),38.5,38.5,,,34.3,42.9,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),22.9,22.9,,,19.5,26.8,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),21.1,21.1,,,16.0,27.4,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),30.3,30.3,,,27.9,32.9,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.6,28.6,,,26.8,30.4,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.4,29.4,,,27.0,32.0,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),30.0,30.0,,,26.9,33.2,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),30.6,30.6,,,28.1,33.3,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),27.5,27.5,,,25.8,29.4,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),10.7,10.7,,,9.5,12.1,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),39.5,39.5,,,35.2,44.0,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),71.3,71.3,,,67.6,74.7,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),41.0,41.0,,,37.5,44.5,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),76.9,76.9,,,73.4,80.1,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),31.6,31.6,,,28.5,34.9,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),27.4,27.4,,,25.1,29.9,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),40.4,40.4,,,37.1,43.7,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),38.8,38.8,,,34.9,42.9,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),24.7,24.7,,,19.4,31.0,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.6,29.6,,,25.2,34.3,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.8,28.8,,,27.4,30.2,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),30.9,30.9,,,28.1,33.8,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),30.2,30.2,,,26.5,34.2,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.4,29.4,,,27.3,31.6,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.1,28.1,,,26.5,29.8,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),31.6,31.6,,,29.2,34.1,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),12.6,12.6,,,10.1,15.5,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),40.6,40.6,,,37.6,43.7,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),67.3,67.3,,,63.5,71.0,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),41.9,41.9,,,39.4,44.5,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),77.0,77.0,,,73.9,79.9,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),32.3,32.3,,,28.9,36.0,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),27.6,27.6,,,26.0,29.2,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),41.7,41.7,,,40.1,43.4,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),40.5,40.5,,,37.6,43.5,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),22.5,22.5,,,18.4,27.2,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),24.2,24.2,,,21.2,27.5,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),25.7,25.7,,,22.5,29.1,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),20.1,20.1,,,16.1,24.7,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),24.3,24.3,,,20.0,29.2,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),25.8,25.8,,,22.6,29.2,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.4,29.4,,,27.7,31.1,Overall,Overall,C2,T9,NH020,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),31.6,31.6,,,29.8,33.5,Overall,Overall,C2,T9,NH020,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),31.8,31.8,,,30.1,33.6,Gender,Male,C2,T9,NH020,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),30.6,30.6,,,28.7,32.6,Gender,Male,C2,T9,NH020,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.1,28.1,,,25.7,30.5,Gender,Female,C2,T9,NH020,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),31.4,31.4,,,28.6,34.4,Gender,Female,C2,T9,NH020,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),2.5,2.5,,,1.5,4.0,Age,18-24,C2,T9,NH020,Crude,BOC03,AGE01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),12.9,12.9,,,11.0,15.1,Age,25-44,C2,T9,NH020,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),41.2,41.2,,,38.2,44.2,Age,45-64,C2,T9,NH020,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),69.5,69.5,,,66.6,72.3,Age,65+,C2,T9,NH020,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),42.8,42.8,,,40.2,45.3,Age,35+,C2,T9,NH020,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),75.1,75.1,,,70.4,79.3,Age,75+,C2,T9,NH020,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),33.4,33.4,,,30.9,36.1,Race,Non-Hispanic White,C2,T9,NH020,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.5,28.5,,,26.5,30.5,Race,Non-Hispanic White,C2,T9,NH020,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),40.6,40.6,,,37.7,43.6,Race,Non-Hispanic Black,C2,T9,NH020,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),40.2,40.2,,,37.7,42.8,Race,Non-Hispanic Black,C2,T9,NH020,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),24.9,24.9,,,20.8,29.4,Race,Non-Hispanic Asian,C2,T9,NH020,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),25.6,25.6,,,22.8,28.7,Race,Non-Hispanic Asian,C2,T9,NH020,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),26.1,26.1,,,23.8,28.6,Race,Hispanic,C2,T9,NH020,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),20.9,20.9,,,18.1,24.0,Race,Hispanic,C2,T9,NH020,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Crude,Percent (%),24.7,24.7,,,20.8,28.9,Race,Other,C2,T9,NH020,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),27.5,27.5,,,24.4,30.8,Race,Other,C2,T9,NH020,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),63.7,63.7,,,56.9,69.9,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),69.0,69.0,,,64.6,73.1,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),66.4,66.4,,,61.8,70.7,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),63.6,63.6,,,57.7,69.1,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),60.1,60.1,,,48.8,70.4,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),71.4,71.4,,,66.3,76.0,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),60.8,60.8,,,47.3,72.7,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),75.0,75.0,,,67.9,80.9,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),67.9,67.9,,,64.3,71.3,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),70.5,70.5,,,66.4,74.3,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),66.5,66.5,,,63.0,69.7,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),69.7,69.7,,,66.2,73.0,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),65.0,65.0,,,57.8,71.5,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),66.0,66.0,,,53.2,76.8,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),74.4,74.4,,,65.5,81.7,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),53.0,53.0,,,43.2,62.6,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),53.9,53.9,,,42.7,64.7,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),62.8,62.8,,,59.2,66.3,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),70.5,70.5,,,67.5,73.4,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),65.0,65.0,,,62.2,67.7,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),56.0,56.0,,,52.7,59.2,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),74.4,74.4,,,67.7,80.1,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),75.0,75.0,,,68.6,80.5,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),58.1,58.1,,,50.3,65.5,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),72.2,72.2,,,67.6,76.5,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),74.2,74.2,,,71.1,77.0,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),71.7,71.7,,,68.3,74.8,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),72.7,72.7,,,68.4,76.6,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),70.2,70.2,,,66.2,73.9,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),61.1,61.1,,,54.2,67.5,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),75.1,75.1,,,69.3,80.2,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),78.1,78.1,,,74.3,81.5,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),41.5,41.5,,,31.7,52.0,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),75.4,75.4,,,71.6,78.9,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),66.8,66.8,,,60.1,72.9,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),67.1,67.1,,,60.6,73.1,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),75.9,75.9,,,70.4,80.7,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),74.9,74.9,,,70.0,79.3,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),68.2,68.2,,,56.4,78.0,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),58.3,58.3,,,37.0,76.9,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),66.5,66.5,,,57.2,74.7,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),75.1,75.1,,,69.0,80.3,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),79.7,79.7,,,75.7,83.2,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),77.0,77.0,,,73.5,80.2,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),74.6,74.6,,,69.3,79.2,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),75.4,75.4,,,70.7,79.5,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),67.3,67.3,,,56.9,76.2,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),65.6,65.6,,,55.0,74.9,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),74.5,74.5,,,67.4,80.6,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),83.5,83.5,,,72.5,90.7,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),67.9,67.9,,,63.3,72.2,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),77.9,77.9,,,74.5,81.0,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),72.2,72.2,,,67.4,76.5,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),63.2,63.2,,,58.5,67.7,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),83.1,83.1,,,73.4,89.7,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),83.3,83.3,,,79.3,86.6,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),41.2,41.2,,,25.3,59.3,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),60.3,60.3,,,52.4,67.8,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),81.0,81.0,,,76.8,84.6,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),82.4,82.4,,,78.8,85.6,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),80.1,80.1,,,76.9,83.0,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),77.6,77.6,,,71.3,82.8,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),78.3,78.3,,,74.4,81.8,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),66.2,66.2,,,60.5,71.4,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),72.2,72.2,,,65.3,78.1,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),80.5,80.5,,,76.2,84.3,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),74.9,74.9,,,57.6,86.8,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),72.2,72.2,,,55.1,84.6,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),73.9,73.9,,,66.1,80.5,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),79.7,79.7,,,77.3,81.8,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),76.1,76.1,,,71.2,80.4,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),67.8,67.8,,,59.0,75.5,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),83.0,83.0,,,76.6,87.9,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),82.9,82.9,,,80.5,85.0,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),73.0,73.0,,,62.1,81.6,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),80.4,80.4,,,77.7,82.9,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),83.1,83.1,,,80.5,85.4,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),81.0,81.0,,,79.3,82.6,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),82.8,82.8,,,78.3,86.6,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),76.4,76.4,,,65.7,84.6,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),80.8,80.8,,,78.0,83.3,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),80.8,80.8,,,75.2,85.4,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),74.7,74.7,,,66.7,81.3,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),82.0,82.0,,,79.0,84.6,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),73.5,73.5,,,67.7,78.5,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),69.1,69.1,,,60.8,76.3,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),78.6,78.6,,,75.2,81.6,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),80.4,80.4,,,73.1,86.1,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),85.1,85.1,,,81.7,88.0,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),66.6,66.6,,,57.7,74.4,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),84.0,84.0,,,80.4,87.0,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),85.4,85.4,,,81.0,88.9,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),83.3,83.3,,,80.2,85.9,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),84.7,84.7,,,79.4,88.9,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),81.7,81.7,,,77.5,85.2,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),72.9,72.9,,,64.4,80.0,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),81.2,81.2,,,74.2,86.7,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),86.6,86.6,,,81.8,90.2,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),81.5,81.5,,,68.1,90.1,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),70.4,70.4,,,57.6,80.7,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),74.4,74.4,,,69.3,78.9,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),82.4,82.4,,,78.4,85.7,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),79.4,79.4,,,75.5,82.8,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),68.3,68.3,,,62.8,73.3,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),81.6,81.6,,,74.2,87.2,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),85.1,85.1,,,80.1,89.1,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),71.1,71.1,,,61.7,79.0,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),82.9,82.9,,,77.6,87.2,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),87.5,87.5,,,84.1,90.3,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),83.6,83.6,,,79.8,86.9,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),87.3,87.3,,,82.9,90.7,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),83.1,83.1,,,77.5,87.5,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),73.3,73.3,,,64.7,80.4,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),82.1,82.1,,,76.7,86.4,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),84.4,84.4,,,81.7,86.8,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),70.9,70.9,,,64.4,76.7,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),58.6,58.6,,,47.2,69.2,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),71.6,71.6,,,60.6,80.6,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),80.3,80.3,,,75.7,84.2,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),72.3,72.3,,,58.7,82.8,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),60.7,60.7,,,43.2,75.8,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),80.3,80.3,,,77.1,83.1,Overall,Overall,C2,T9,NH021,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),84.7,84.7,,,82.2,87.0,Overall,Overall,C2,T9,NH021,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),76.1,76.1,,,70.7,80.7,Gender,Male,C2,T9,NH021,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),81.4,81.4,,,77.6,84.7,Gender,Male,C2,T9,NH021,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),86.7,86.7,,,83.4,89.4,Gender,Female,C2,T9,NH021,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),88.0,88.0,,,84.9,90.4,Gender,Female,C2,T9,NH021,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH021,Crude,BOC03,AGE01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),78.5,78.5,,,74.3,82.1,Age,25-44,C2,T9,NH021,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),84.3,84.3,,,80.9,87.2,Age,45-64,C2,T9,NH021,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),88.2,88.2,,,84.6,91.0,Age,65+,C2,T9,NH021,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),85.5,85.5,,,82.6,88.0,Age,35+,C2,T9,NH021,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),87.6,87.6,,,81.0,92.2,Age,75+,C2,T9,NH021,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),83.5,83.5,,,80.2,86.3,Race,Non-Hispanic White,C2,T9,NH021,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),86.1,86.1,,,82.4,89.1,Race,Non-Hispanic White,C2,T9,NH021,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),80.0,80.0,,,73.3,85.3,Race,Non-Hispanic Black,C2,T9,NH021,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),85.4,85.4,,,81.5,88.6,Race,Non-Hispanic Black,C2,T9,NH021,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),77.4,77.4,,,68.4,84.5,Race,Non-Hispanic Asian,C2,T9,NH021,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),67.4,67.4,,,51.6,80.0,Race,Non-Hispanic Asian,C2,T9,NH021,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),73.4,73.4,,,63.2,81.6,Race,Hispanic,C2,T9,NH021,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),78.2,78.2,,,74.9,81.2,Race,Hispanic,C2,T9,NH021,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Crude,Percent (%),78.3,78.3,,,68.1,85.9,Race,Other,C2,T9,NH021,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),72.0,72.0,,,58.3,82.6,Race,Other,C2,T9,NH021,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),47.8,47.8,,,41.6,54.1,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),58.3,58.3,,,52.1,64.2,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),54.3,54.3,,,47.9,60.6,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),45.8,45.8,,,39.4,52.4,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),50.1,50.1,,,40.9,59.2,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),61.8,61.8,,,55.7,67.5,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),43.0,43.0,,,31.4,55.5,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),65.6,65.6,,,59.2,71.5,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),60.0,60.0,,,53.8,66.0,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),61.1,61.1,,,55.5,66.5,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),58.1,58.1,,,50.6,65.3,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),60.2,60.2,,,54.7,65.4,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),49.7,49.7,,,44.8,54.7,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),50.7,50.7,,,39.3,62.0,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),62.9,62.9,,,54.6,70.5,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),36.6,36.6,,,25.5,49.4,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),35.6,35.6,,,25.5,47.2,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),51.0,51.0,,,47.6,54.5,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),60.3,60.3,,,57.1,63.5,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),54.1,54.1,,,50.9,57.3,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),44.1,44.1,,,40.6,47.6,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),62.9,62.9,,,55.7,69.5,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),65.4,65.4,,,59.3,71.1,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),42.3,42.3,,,35.4,49.6,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),61.3,61.3,,,57.1,65.3,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),67.1,67.1,,,62.2,71.7,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),61.9,61.9,,,58.3,65.3,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),65.8,65.8,,,59.4,71.7,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),60.3,60.3,,,56.6,63.9,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),48.7,48.7,,,43.6,53.7,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),60.2,60.2,,,56.6,63.6,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),65.0,65.0,,,62.4,67.5,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),66.3,66.3,,,46.2,81.8,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),39.1,39.1,,,28.8,50.4,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),54.1,54.1,,,46.5,61.5,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),64.7,64.7,,,59.9,69.2,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),63.4,63.4,,,56.9,69.5,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),52.9,52.9,,,45.2,60.4,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),58.2,58.2,,,46.7,68.9,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),65.8,65.8,,,61.5,70.0,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),51.5,51.5,,,39.2,63.6,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),61.8,61.8,,,54.6,68.5,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),74.0,74.0,,,69.6,77.9,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),66.5,66.5,,,61.7,71.0,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),66.7,66.7,,,60.8,72.1,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),64.9,64.9,,,59.6,69.7,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),54.5,54.5,,,43.6,65.1,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),54.5,54.5,,,46.2,62.6,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),65.8,65.8,,,58.5,72.4,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),68.0,68.0,,,52.5,80.3,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),59.2,59.2,,,41.0,75.1,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),52.7,52.7,,,48.3,57.1,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),67.8,67.8,,,63.6,71.8,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),60.5,60.5,,,55.1,65.7,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),47.1,47.1,,,42.9,51.2,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),74.5,74.5,,,66.2,81.3,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),74.7,74.7,,,70.7,78.3,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),40.5,40.5,,,33.5,47.8,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),70.2,70.2,,,66.2,74.0,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),77.7,77.7,,,74.2,80.8,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),70.7,70.7,,,67.2,73.9,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),72.1,72.1,,,66.4,77.1,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),69.3,69.3,,,64.2,73.9,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),51.2,51.2,,,43.7,58.6,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),64.0,64.0,,,57.1,70.4,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),72.4,72.4,,,67.6,76.7,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),59.2,59.2,,,43.1,73.5,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),52.7,52.7,,,39.1,65.9,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),62.4,62.4,,,56.6,67.9,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),71.6,71.6,,,69.3,73.8,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),66.5,66.5,,,61.8,70.9,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),55.2,55.2,,,48.4,61.8,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),72.8,72.8,,,66.6,78.2,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),76.2,76.2,,,74.2,78.1,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),57.3,57.3,,,48.2,66.1,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),71.1,71.1,,,67.3,74.6,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),79.7,79.7,,,77.2,82.0,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),73.7,73.7,,,71.5,75.9,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),79.4,79.4,,,75.2,83.0,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),73.1,73.1,,,70.6,75.4,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),64.2,64.2,,,56.4,71.4,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),64.5,64.5,,,57.2,71.1,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),70.5,70.5,,,64.1,76.2,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),37.1,37.1,,,23.6,52.9,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),76.3,76.3,,,72.8,79.6,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),64.8,64.8,,,58.7,70.5,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),58.5,58.5,,,51.4,65.3,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),71.5,71.5,,,67.9,74.8,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),81.0,81.0,,,76.4,84.8,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),74.9,74.9,,,66.3,81.9,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),56.0,56.0,,,47.0,64.6,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),77.8,77.8,,,72.8,82.1,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),82.0,82.0,,,78.2,85.3,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),78.1,78.1,,,74.6,81.1,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),81.2,81.2,,,75.7,85.7,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),77.1,77.1,,,72.5,81.1,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),65.3,65.3,,,57.7,72.2,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),70.1,70.1,,,60.9,77.9,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),78.0,78.0,,,71.9,83.0,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),77.0,77.0,,,66.9,84.7,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),63.2,63.2,,,50.8,74.1,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),62.7,62.7,,,57.3,67.8,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),75.0,75.0,,,70.7,78.9,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),69.2,69.2,,,65.2,72.9,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),53.9,53.9,,,48.4,59.3,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),73.1,73.1,,,64.8,80.0,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),80.4,80.4,,,75.0,84.9,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),54.6,54.6,,,46.2,62.7,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),75.4,75.4,,,68.9,81.0,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),84.0,84.0,,,79.9,87.4,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),77.0,77.0,,,72.7,80.8,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),83.7,83.7,,,77.8,88.2,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),77.1,77.1,,,71.2,82.1,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),65.0,65.0,,,56.6,72.6,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),68.1,68.1,,,61.9,73.6,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),74.6,74.6,,,70.2,78.5,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),62.8,62.8,,,55.5,69.6,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),47.4,47.4,,,36.8,58.2,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),55.5,55.5,,,44.8,65.6,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),70.1,70.1,,,62.7,76.6,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),59.3,59.3,,,48.1,69.6,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),41.9,41.9,,,32.8,51.5,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),64.6,64.6,,,59.5,69.4,Overall,Overall,C2,T9,NH022,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),75.4,75.4,,,71.0,79.3,Overall,Overall,C2,T9,NH022,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),70.5,70.5,,,65.2,75.2,Gender,Male,C2,T9,NH022,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),59.7,59.7,,,53.0,66.0,Gender,Male,C2,T9,NH022,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),71.8,71.8,,,65.3,77.6,Gender,Female,C2,T9,NH022,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),80.2,80.2,,,75.3,84.2,Gender,Female,C2,T9,NH022,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH022,Crude,BOC03,AGE01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),57.5,57.5,,,50.1,64.6,Age,25-44,C2,T9,NH022,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),75.8,75.8,,,70.7,80.2,Age,45-64,C2,T9,NH022,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),82.6,82.6,,,77.9,86.4,Age,65+,C2,T9,NH022,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),76.8,76.8,,,72.4,80.8,Age,35+,C2,T9,NH022,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),80.9,80.9,,,74.2,86.1,Age,75+,C2,T9,NH022,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),77.3,77.3,,,71.1,82.5,Race,Non-Hispanic White,C2,T9,NH022,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),68.7,68.7,,,60.5,75.9,Race,Non-Hispanic White,C2,T9,NH022,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),62.2,62.2,,,58.0,66.3,Race,Non-Hispanic Black,C2,T9,NH022,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),75.4,75.4,,,71.4,79.0,Race,Non-Hispanic Black,C2,T9,NH022,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),65.8,65.8,,,57.3,73.4,Race,Non-Hispanic Asian,C2,T9,NH022,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),46.5,46.5,,,38.8,54.5,Race,Non-Hispanic Asian,C2,T9,NH022,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),57.4,57.4,,,48.5,65.9,Race,Hispanic,C2,T9,NH022,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),66.3,66.3,,,61.1,71.1,Race,Hispanic,C2,T9,NH022,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Crude,Percent (%),68.6,68.6,,,60.2,75.8,Race,Other,C2,T9,NH022,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),57.7,57.7,,,48.0,66.9,Race,Other,C2,T9,NH022,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),26.8,26.8,,,22.3,31.9,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),30.8,30.8,,,26.1,36.0,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),32.6,32.6,,,26.2,39.6,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),27.7,27.7,,,22.0,34.3,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),26.7,26.7,,,20.3,34.2,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),29.3,29.3,,,24.3,34.9,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),28.6,28.6,,,20.0,39.2,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),39.6,39.6,,,34.0,45.4,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),24.2,24.2,,,19.8,29.3,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),32.3,32.3,,,27.4,37.6,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),16.2,16.2,,,12.4,20.9,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),33.5,33.5,,,28.7,38.8,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),30.0,30.0,,,25.4,35.0,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),21.6,21.6,,,15.3,29.6,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),28.0,28.0,,,22.3,34.5,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),32.9,32.9,,,29.1,37.0,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),34.8,34.8,,,31.8,37.8,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),33.1,33.1,,,29.2,37.3,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),27.7,27.7,,,23.6,32.1,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),43.4,43.4,,,36.2,50.9,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),36.1,36.1,,,32.2,40.2,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),28.8,28.8,,,23.5,34.7,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),38.9,38.9,,,34.3,43.7,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),32.1,32.1,,,28.8,35.7,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),35.3,35.3,,,32.2,38.5,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),30.6,30.6,,,24.8,37.0,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),35.7,35.7,,,32.1,39.4,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),32.7,32.7,,,27.6,38.3,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),32.5,32.5,,,28.2,37.0,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),32.6,32.6,,,29.7,35.7,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),33.2,33.2,,,18.2,52.6,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),19.5,19.5,,,11.1,32.0,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),35.9,35.9,,,28.9,43.6,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),39.4,39.4,,,35.0,44.0,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),41.9,41.9,,,35.4,48.7,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),36.2,36.2,,,29.2,43.8,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),38.6,38.6,,,28.0,50.4,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),37.1,37.1,,,32.9,41.4,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),41.8,41.8,,,30.4,54.3,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),39.3,39.3,,,33.2,45.7,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),38.6,38.6,,,34.4,42.9,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),40.3,40.3,,,36.0,44.8,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),28.6,28.6,,,23.5,34.2,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),40.9,40.9,,,35.8,46.2,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),37.8,37.8,,,27.5,49.4,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),30.9,30.9,,,26.5,35.7,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),37.4,37.4,,,31.7,43.6,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),31.6,31.6,,,24.0,40.4,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),34.8,34.8,,,24.1,47.3,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),36.5,36.5,,,32.5,40.8,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),43.4,43.4,,,40.3,46.6,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),41.1,41.1,,,36.3,45.9,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),33.4,33.4,,,29.1,38.0,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),51.8,51.8,,,41.3,62.1,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),45.7,45.7,,,42.9,48.4,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),30.9,30.9,,,23.9,39.0,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),48.2,48.2,,,43.7,52.7,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),43.9,43.9,,,40.5,47.5,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),44.7,44.7,,,41.7,47.8,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),39.1,39.1,,,33.3,45.2,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),44.8,44.8,,,41.5,48.2,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),37.2,37.2,,,30.8,44.1,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),37.6,37.6,,,32.5,43.0,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),42.0,42.0,,,38.7,45.5,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),44.3,44.3,,,30.5,59.0,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),41.3,41.3,,,29.0,54.8,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),45.7,45.7,,,39.8,51.8,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),48.4,48.4,,,45.3,51.4,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),46.3,46.3,,,41.7,50.9,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),40.4,40.4,,,34.2,46.8,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),54.0,54.0,,,45.8,62.0,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),50.3,50.3,,,47.5,53.0,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),47.8,47.8,,,39.2,56.5,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),49.6,49.6,,,44.7,54.6,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),48.1,48.1,,,44.3,51.9,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),49.5,49.5,,,46.6,52.4,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),43.2,43.2,,,38.7,47.7,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),50.9,50.9,,,47.6,54.1,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),50.0,50.0,,,43.5,56.5,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),39.5,39.5,,,32.5,47.0,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),43.2,43.2,,,38.7,47.9,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),35.8,35.8,,,24.3,49.3,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),20.3,20.3,,,13.9,28.6,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),45.9,45.9,,,40.5,51.4,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),53.4,53.4,,,50.0,56.7,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),49.3,49.3,,,45.0,53.6,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),39.6,39.6,,,33.1,46.5,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),56.0,56.0,,,48.5,63.2,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),57.2,57.2,,,52.8,61.4,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),36.0,36.0,,,27.9,45.0,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),57.1,57.1,,,52.5,61.6,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),55.1,55.1,,,50.6,59.5,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),54.5,54.5,,,51.2,57.8,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),50.2,50.2,,,44.1,56.4,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),56.5,56.5,,,52.4,60.4,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),49.1,49.1,,,42.5,55.8,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),43.0,43.0,,,33.9,52.7,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),47.3,47.3,,,41.6,53.0,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),50.8,50.8,,,39.0,62.5,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),43.9,43.9,,,31.4,57.2,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),46.3,46.3,,,40.1,52.7,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),51.9,51.9,,,47.1,56.6,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),48.9,48.9,,,44.5,53.4,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),38.7,38.7,,,33.1,44.6,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),55.6,55.6,,,46.6,64.2,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),54.6,54.6,,,48.6,60.5,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),45.9,45.9,,,35.5,56.7,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),56.3,56.3,,,49.6,62.8,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),50.1,50.1,,,45.0,55.2,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),53.2,53.2,,,48.4,57.8,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),41.7,41.7,,,33.5,50.4,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),53.9,53.9,,,47.6,60.0,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),49.9,49.9,,,40.8,59.1,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),44.9,44.9,,,38.2,51.8,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),48.7,48.7,,,43.1,54.3,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),45.4,45.4,,,38.2,52.9,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),34.7,34.7,,,24.8,46.1,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),40.4,40.4,,,29.9,51.7,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),45.9,45.9,,,38.7,53.4,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),46.0,46.0,,,35.4,56.8,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),32.4,32.4,,,24.7,41.1,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),49.2,49.2,,,43.9,54.5,Overall,Overall,C2,T9,NH023,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),54.0,54.0,,,48.9,58.9,Overall,Overall,C2,T9,NH023,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),50.9,50.9,,,44.2,57.6,Gender,Male,C2,T9,NH023,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),44.4,44.4,,,37.7,51.2,Gender,Male,C2,T9,NH023,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),56.6,56.6,,,50.0,62.9,Gender,Female,C2,T9,NH023,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),56.9,56.9,,,52.0,61.6,Gender,Female,C2,T9,NH023,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,18-24,C2,T9,NH023,Crude,BOC03,AGE01,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),46.3,46.3,,,39.9,52.9,Age,25-44,C2,T9,NH023,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),57.0,57.0,,,49.7,64.0,Age,45-64,C2,T9,NH023,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),54.1,54.1,,,49.2,58.9,Age,65+,C2,T9,NH023,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),54.8,54.8,,,49.6,59.9,Age,35+,C2,T9,NH023,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),47.4,47.4,,,39.1,55.8,Age,75+,C2,T9,NH023,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),57.4,57.4,,,50.0,64.6,Race,Non-Hispanic White,C2,T9,NH023,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),55.6,55.6,,,47.1,63.7,Race,Non-Hispanic White,C2,T9,NH023,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),39.2,39.2,,,33.7,45.0,Race,Non-Hispanic Black,C2,T9,NH023,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),46.3,46.3,,,40.2,52.5,Race,Non-Hispanic Black,C2,T9,NH023,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),41.5,41.5,,,35.1,48.2,Race,Non-Hispanic Asian,C2,T9,NH023,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),33.7,33.7,,,25.3,43.3,Race,Non-Hispanic Asian,C2,T9,NH023,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),41.4,41.4,,,34.8,48.3,Race,Hispanic,C2,T9,NH023,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),47.6,47.6,,,42.4,52.9,Race,Hispanic,C2,T9,NH023,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Crude,Percent (%),42.9,42.9,,,33.8,52.6,Race,Other,C2,T9,NH023,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,ABCS,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension; NHANES,Age-Standardized,Percent (%),41.1,41.1,,,28.3,55.1,Race,Other,C2,T9,NH023,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),37.4,37.4,,,35.5,39.4,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),37.2,37.2,,,35.3,39.1,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),46.5,46.5,,,43.9,49.2,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),46.6,46.6,,,43.9,49.3,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.1,28.1,,,26.1,30.1,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),27.9,27.9,,,26.0,30.0,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),27.7,27.7,,,23.0,33.0,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),36.2,36.2,,,32.9,39.6,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),45.1,45.1,,,41.2,49.0,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),33.4,33.4,,,29.8,37.2,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),40.1,40.1,,,37.5,42.8,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),25.6,25.6,,,21.1,30.7,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),38.0,38.0,,,35.5,40.6,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),38.0,38.0,,,35.4,40.7,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),38.3,38.3,,,34.8,41.9,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),38.5,38.5,,,35.1,42.0,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),32.9,32.9,,,26.8,39.7,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),33.6,33.6,,,27.0,41.0,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),36.1,36.1,,,34.3,38.0,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),36.3,36.3,,,34.6,38.0,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),44.1,44.1,,,41.2,47.1,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),43.9,43.9,,,41.0,46.9,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.2,28.2,,,26.0,30.6,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),28.6,28.6,,,26.3,31.1,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),28.5,28.5,,,25.0,32.3,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),34.9,34.9,,,32.0,38.0,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),41.7,41.7,,,39.5,43.9,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),39.1,39.1,,,37.3,40.9,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),33.0,33.0,,,28.4,38.1,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),36.6,36.6,,,34.6,38.6,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),36.1,36.1,,,34.0,38.3,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),37.5,37.5,,,33.0,42.4,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),37.9,37.9,,,33.2,43.0,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),48.6,48.6,,,39.6,57.7,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),48.6,48.6,,,39.7,57.6,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),36.0,36.0,,,34.3,37.8,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),36.3,36.3,,,34.5,38.1,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),42.6,42.6,,,39.9,45.2,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),42.5,42.5,,,39.9,45.1,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),29.5,29.5,,,27.8,31.2,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),30.1,30.1,,,28.2,32.2,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),24.8,24.8,,,21.3,28.6,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),34.9,34.9,,,31.1,38.9,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),42.6,42.6,,,39.2,46.1,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),36.4,36.4,,,32.5,40.6,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),40.1,40.1,,,38.3,42.0,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),31.8,31.8,,,27.9,36.0,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),36.8,36.8,,,34.5,39.2,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),36.1,36.1,,,33.7,38.5,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),36.5,36.5,,,33.3,39.8,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),36.8,36.8,,,33.6,40.1,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),39.1,39.1,,,32.4,46.1,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),39.0,39.0,,,32.5,45.9,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),36.5,36.5,,,34.4,38.6,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),36.8,36.8,,,34.9,38.8,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),42.7,42.7,,,40.6,44.7,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),42.6,42.6,,,40.6,44.7,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),30.0,30.0,,,26.7,33.4,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),31.2,31.2,,,28.1,34.4,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),28.9,28.9,,,22.7,36.0,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),34.1,34.1,,,30.5,37.9,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),42.0,42.0,,,38.8,45.3,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),38.3,38.3,,,35.1,41.6,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),39.2,39.2,,,37.4,41.1,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),37.6,37.6,,,35.2,40.1,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),38.1,38.1,,,35.5,40.8,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),37.2,37.2,,,34.3,40.3,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),38.5,38.5,,,35.8,41.4,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),38.3,38.3,,,35.7,41.1,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),27.1,27.1,,,21.5,33.4,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),27.9,27.9,,,21.7,35.0,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),36.0,36.0,,,33.7,38.3,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),36.3,36.3,,,34.0,38.8,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),43.2,43.2,,,40.5,46.1,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),43.1,43.1,,,40.3,45.9,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.7,28.7,,,26.2,31.4,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),29.8,29.8,,,27.3,32.4,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),25.3,25.3,,,20.6,30.8,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),33.0,33.0,,,29.4,36.9,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),41.9,41.9,,,38.4,45.5,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),39.9,39.9,,,36.5,43.4,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),40.0,40.0,,,38.0,42.1,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),37.3,37.3,,,33.4,41.4,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),37.3,37.3,,,34.3,40.5,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),36.4,36.4,,,33.3,39.5,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),34.5,34.5,,,32.2,36.9,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),34.3,34.3,,,31.9,36.6,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),31.4,31.4,,,24.5,39.3,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),31.8,31.8,,,25.2,39.2,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),35.0,35.0,,,33.0,36.9,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),35.4,35.4,,,33.4,37.4,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),41.4,41.4,,,38.8,44.1,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),41.4,41.4,,,38.8,44.0,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.2,28.2,,,26.4,30.1,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),29.6,29.6,,,27.5,31.7,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),22.8,22.8,,,18.6,27.6,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),32.1,32.1,,,29.1,35.2,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),40.3,40.3,,,37.1,43.5,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),41.0,41.0,,,37.1,45.0,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),38.9,38.9,,,36.7,41.1,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),40.2,40.2,,,35.7,44.9,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),35.8,35.8,,,33.5,38.1,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),34.8,34.8,,,32.6,37.0,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),37.2,37.2,,,33.9,40.6,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),37.2,37.2,,,33.8,40.8,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),33.5,33.5,,,26.5,41.3,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),34.6,34.6,,,27.5,42.4,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),37.7,37.7,,,35.6,39.8,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),38.3,38.3,,,36.2,40.5,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),42.4,42.4,,,40.1,44.7,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),42.3,42.3,,,40.1,44.5,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),32.6,32.6,,,29.8,35.5,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),34.3,34.3,,,31.6,37.1,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),25.8,25.8,,,21.5,30.5,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),34.5,34.5,,,30.9,38.2,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),44.5,44.5,,,40.8,48.3,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),42.2,42.2,,,38.6,45.9,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),42.3,42.3,,,40.1,44.6,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),35.6,35.6,,,31.2,40.2,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),39.9,39.9,,,37.3,42.5,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),38.7,38.7,,,36.0,41.4,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),39.5,39.5,,,35.6,43.6,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),39.5,39.5,,,35.5,43.6,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),32.1,32.1,,,28.7,35.6,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),33.0,33.0,,,30.2,35.9,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),33.4,33.4,,,30.7,36.2,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),31.9,31.9,,,28.8,35.1,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),34.7,34.7,,,31.1,38.4,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),35.3,35.3,,,31.3,39.4,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),33.8,33.8,,,32.0,35.8,Overall,Overall,C2,T9,NH024,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),34.6,34.6,,,32.7,36.6,Overall,Overall,C2,T9,NH024,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),39.8,39.8,,,37.0,42.7,Gender,Male,C2,T9,NH024,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),39.6,39.6,,,36.7,42.5,Gender,Male,C2,T9,NH024,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),28.0,28.0,,,26.0,30.1,Gender,Female,C2,T9,NH024,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),29.6,29.6,,,27.6,31.7,Gender,Female,C2,T9,NH024,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),24.1,24.1,,,21.0,27.5,Age,18-24,C2,T9,NH024,Crude,BOC03,AGE01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),27.8,27.8,,,24.2,31.8,Age,25-44,C2,T9,NH024,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),40.4,40.4,,,37.5,43.4,Age,45-64,C2,T9,NH024,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),43.6,43.6,,,39.4,47.8,Age,65+,C2,T9,NH024,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),38.7,38.7,,,36.2,41.3,Age,35+,C2,T9,NH024,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),35.6,35.6,,,29.7,41.9,Age,75+,C2,T9,NH024,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),35.0,35.0,,,32.3,37.7,Race,Non-Hispanic White,C2,T9,NH024,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),33.1,33.1,,,30.4,35.8,Race,Non-Hispanic White,C2,T9,NH024,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),36.9,36.9,,,35.0,38.9,Race,Non-Hispanic Black,C2,T9,NH024,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),37.0,37.0,,,34.9,39.0,Race,Non-Hispanic Black,C2,T9,NH024,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),30.1,30.1,,,27.0,33.3,Race,Non-Hispanic Asian,C2,T9,NH024,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),30.1,30.1,,,27.5,32.7,Race,Non-Hispanic Asian,C2,T9,NH024,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),34.4,34.4,,,32.1,36.8,Race,Hispanic,C2,T9,NH024,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),32.6,32.6,,,30.1,35.2,Race,Hispanic,C2,T9,NH024,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Crude,Percent (%),31.9,31.9,,,27.9,36.1,Race,Other,C2,T9,NH024,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+); NHANES,Age-Standardized,Percent (%),32.3,32.3,,,28.3,36.5,Race,Other,C2,T9,NH024,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),20.3,20.3,,,17.9,22.8,Overall,Overall,C2,T9,NH201,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),19.7,19.7,,,17.2,22.4,Overall,Overall,C2,T9,NH201,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),18.2,18.2,,,15.2,21.6,Gender,Male,C2,T9,NH201,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),19.3,19.3,,,16.2,22.8,Gender,Male,C2,T9,NH201,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),20.8,20.8,,,18.6,23.2,Gender,Female,C2,T9,NH201,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),21.1,21.1,,,18.5,24.0,Gender,Female,C2,T9,NH201,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T9,NH201,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),8.7,8.7,,,6.5,11.6,Age,25-44,C2,T9,NH201,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),22.9,22.9,,,19.5,26.7,Age,45-64,C2,T9,NH201,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),53.2,53.2,,,48.7,57.6,Age,65+,C2,T9,NH201,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),25.9,25.9,,,23.0,29.1,Age,35+,C2,T9,NH201,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),65.2,65.2,,,59.6,70.3,Age,75+,C2,T9,NH201,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),19.1,19.1,,,16.2,22.3,Race,Non-Hispanic White,C2,T9,NH201,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.3,18.3,,,15.7,21.2,Race,Non-Hispanic White,C2,T9,NH201,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),28.2,28.2,,,25.1,31.5,Race,Non-Hispanic Black,C2,T9,NH201,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),24.7,24.7,,,21.9,27.6,Race,Non-Hispanic Black,C2,T9,NH201,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH201,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH201,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH201,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH201,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),24.7,24.7,,,14.1,39.7,Race,Other,C2,T9,NH201,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),26.0,26.0,,,15.0,41.3,Race,Other,C2,T9,NH201,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.9,18.9,,,17.5,20.4,Overall,Overall,C2,T9,NH201,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),18.4,18.4,,,16.9,20.0,Overall,Overall,C2,T9,NH201,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),17.2,17.2,,,15.6,18.9,Gender,Male,C2,T9,NH201,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.0,18.0,,,16.3,19.8,Gender,Male,C2,T9,NH201,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),19.2,19.2,,,17.8,20.8,Gender,Female,C2,T9,NH201,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),19.6,19.6,,,17.7,21.6,Gender,Female,C2,T9,NH201,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T9,NH201,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),7.4,7.4,,,6.5,8.5,Age,25-44,C2,T9,NH201,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),23.0,23.0,,,20.1,26.1,Age,45-64,C2,T9,NH201,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),47.8,47.8,,,44.4,51.2,Age,65+,C2,T9,NH201,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),24.4,24.4,,,22.1,26.8,Age,35+,C2,T9,NH201,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),52.6,52.6,,,47.1,58.0,Age,75+,C2,T9,NH201,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),17.7,17.7,,,16.1,19.4,Race,Non-Hispanic White,C2,T9,NH201,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),18.4,18.4,,,16.7,20.3,Race,Non-Hispanic White,C2,T9,NH201,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),25.6,25.6,,,22.3,29.1,Race,Non-Hispanic Black,C2,T9,NH201,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),28.6,28.6,,,26.4,30.9,Race,Non-Hispanic Black,C2,T9,NH201,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH201,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH201,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH201,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH201,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),19.9,19.9,,,13.9,27.5,Race,Other,C2,T9,NH201,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),16.5,16.5,,,11.2,23.7,Race,Other,C2,T9,NH201,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),19.0,19.0,,,16.6,21.6,Overall,Overall,C2,T9,NH201,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.8,18.8,,,16.6,21.3,Overall,Overall,C2,T9,NH201,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.4,18.4,,,15.3,22.0,Gender,Male,C2,T9,NH201,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),17.9,17.9,,,14.8,21.5,Gender,Male,C2,T9,NH201,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),20.0,20.0,,,18.0,22.1,Gender,Female,C2,T9,NH201,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.9,18.9,,,17.1,20.8,Gender,Female,C2,T9,NH201,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T9,NH201,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),7.2,7.2,,,5.6,9.3,Age,25-44,C2,T9,NH201,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),26.0,26.0,,,21.7,30.8,Age,45-64,C2,T9,NH201,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),43.1,43.1,,,39.0,47.3,Age,65+,C2,T9,NH201,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),24.9,24.9,,,21.9,28.2,Age,35+,C2,T9,NH201,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),53.0,53.0,,,48.2,57.6,Age,75+,C2,T9,NH201,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),17.8,17.8,,,15.3,20.6,Race,Non-Hispanic White,C2,T9,NH201,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),19.0,19.0,,,16.2,22.2,Race,Non-Hispanic White,C2,T9,NH201,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),23.5,23.5,,,20.2,27.2,Race,Non-Hispanic Black,C2,T9,NH201,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),25.7,25.7,,,22.1,29.6,Race,Non-Hispanic Black,C2,T9,NH201,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH201,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH201,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH201,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH201,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),19.2,19.2,,,15.2,24.1,Race,Other,C2,T9,NH201,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),21.5,21.5,,,16.6,27.4,Race,Other,C2,T9,NH201,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),17.5,17.5,,,16.0,19.1,Overall,Overall,C2,T9,NH201,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),17.1,17.1,,,15.5,18.8,Overall,Overall,C2,T9,NH201,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),17.8,17.8,,,15.7,20.2,Gender,Male,C2,T9,NH201,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),18.1,18.1,,,15.8,20.6,Gender,Male,C2,T9,NH201,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),17.2,17.2,,,15.5,18.9,Gender,Female,C2,T9,NH201,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.7,15.7,,,14.6,17.0,Gender,Female,C2,T9,NH201,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),4.0,4.0,,,2.3,6.9,Age,20-24,C2,T9,NH201,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),8.1,8.1,,,6.3,10.4,Age,25-44,C2,T9,NH201,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),20.6,20.6,,,17.8,23.8,Age,45-64,C2,T9,NH201,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),38.6,38.6,,,36.1,41.3,Age,65+,C2,T9,NH201,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),22.1,22.1,,,20.1,24.1,Age,35+,C2,T9,NH201,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),43.7,43.7,,,40.1,47.4,Age,75+,C2,T9,NH201,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),17.6,17.6,,,15.8,19.6,Race,Non-Hispanic White,C2,T9,NH201,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.1,16.1,,,14.3,18.1,Race,Non-Hispanic White,C2,T9,NH201,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),23.3,23.3,,,20.9,25.9,Race,Non-Hispanic Black,C2,T9,NH201,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),24.5,24.5,,,22.5,26.7,Race,Non-Hispanic Black,C2,T9,NH201,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH201,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH201,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH201,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH201,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),14.6,14.6,,,10.6,19.8,Race,Other,C2,T9,NH201,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.9,16.9,,,12.8,22.1,Race,Other,C2,T9,NH201,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),16.4,16.4,,,15.6,17.3,Overall,Overall,C2,T9,NH201,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.9,15.9,,,14.8,17.0,Overall,Overall,C2,T9,NH201,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),16.7,16.7,,,15.5,18.0,Gender,Male,C2,T9,NH201,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.8,16.8,,,15.3,18.3,Gender,Male,C2,T9,NH201,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),16.1,16.1,,,15.0,17.3,Gender,Female,C2,T9,NH201,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.9,14.9,,,13.8,16.0,Gender,Female,C2,T9,NH201,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),2.8,2.8,,,1.7,4.5,Age,20-24,C2,T9,NH201,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),6.9,6.9,,,5.8,8.2,Age,25-44,C2,T9,NH201,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),20.0,20.0,,,18.2,22.0,Age,45-64,C2,T9,NH201,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),36.5,36.5,,,32.5,40.7,Age,65+,C2,T9,NH201,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),20.8,20.8,,,19.5,22.2,Age,35+,C2,T9,NH201,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),43.4,43.4,,,39.7,47.2,Age,75+,C2,T9,NH201,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),16.4,16.4,,,15.3,17.6,Race,Non-Hispanic White,C2,T9,NH201,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.8,14.8,,,13.6,16.2,Race,Non-Hispanic White,C2,T9,NH201,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),22.6,22.6,,,19.5,26.0,Race,Non-Hispanic Black,C2,T9,NH201,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),23.4,23.4,,,20.7,26.3,Race,Non-Hispanic Black,C2,T9,NH201,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH201,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH201,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH201,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH201,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),13.9,13.9,,,10.4,18.3,Race,Other,C2,T9,NH201,Crude,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.9,14.9,,,11.7,18.8,Race,Other,C2,T9,NH201,AgeStdz,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),14.6,14.6,,,13.4,15.8,Overall,Overall,C2,T9,NH201,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.9,13.9,,,12.8,15.1,Overall,Overall,C2,T9,NH201,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),15.7,15.7,,,14.5,16.9,Gender,Male,C2,T9,NH201,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.5,15.5,,,14.3,16.7,Gender,Male,C2,T9,NH201,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),13.5,13.5,,,12.0,15.2,Gender,Female,C2,T9,NH201,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.2,12.2,,,10.8,13.8,Gender,Female,C2,T9,NH201,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T9,NH201,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),6.9,6.9,,,5.7,8.2,Age,25-44,C2,T9,NH201,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),17.0,17.0,,,14.9,19.2,Age,45-64,C2,T9,NH201,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),32.0,32.0,,,28.4,35.9,Age,65+,C2,T9,NH201,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),18.6,18.6,,,16.8,20.6,Age,35+,C2,T9,NH201,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),38.3,38.3,,,33.4,43.4,Age,75+,C2,T9,NH201,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),14.1,14.1,,,12.6,15.8,Race,Non-Hispanic White,C2,T9,NH201,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.6,12.6,,,11.2,14.1,Race,Non-Hispanic White,C2,T9,NH201,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),21.4,21.4,,,18.2,25.0,Race,Non-Hispanic Black,C2,T9,NH201,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),22.0,22.0,,,19.2,25.1,Race,Non-Hispanic Black,C2,T9,NH201,AgeStdz,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH201,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH201,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH201,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH201,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),12.5,12.5,,,9.1,17.1,Race,Other,C2,T9,NH201,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.7,14.7,,,10.7,19.8,Race,Other,C2,T9,NH201,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),15.3,15.3,,,13.6,17.2,Overall,Overall,C2,T9,NH201,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.4,14.4,,,12.8,16.1,Overall,Overall,C2,T9,NH201,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),15.9,15.9,,,14.0,18.0,Gender,Male,C2,T9,NH201,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.5,15.5,,,13.8,17.4,Gender,Male,C2,T9,NH201,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),14.8,14.8,,,12.7,17.1,Gender,Female,C2,T9,NH201,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.1,13.1,,,11.2,15.2,Gender,Female,C2,T9,NH201,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T9,NH201,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),6.8,6.8,,,5.1,9.0,Age,25-44,C2,T9,NH201,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),17.7,17.7,,,15.1,20.7,Age,45-64,C2,T9,NH201,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),33.6,33.6,,,30.4,36.9,Age,65+,C2,T9,NH201,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),19.6,19.6,,,17.4,22.1,Age,35+,C2,T9,NH201,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),44.9,44.9,,,37.9,52.0,Age,75+,C2,T9,NH201,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),15.3,15.3,,,12.9,18.0,Race,Non-Hispanic White,C2,T9,NH201,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.1,13.1,,,11.2,15.4,Race,Non-Hispanic White,C2,T9,NH201,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),21.8,21.8,,,19.3,24.6,Race,Non-Hispanic Black,C2,T9,NH201,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),22.3,22.3,,,19.6,25.2,Race,Non-Hispanic Black,C2,T9,NH201,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),12.6,12.6,,,10.2,15.3,Race,Non-Hispanic Asian,C2,T9,NH201,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.4,13.4,,,11.7,15.4,Race,Non-Hispanic Asian,C2,T9,NH201,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),11.5,11.5,,,9.3,14.0,Race,Hispanic,C2,T9,NH201,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.3,14.3,,,12.0,17.0,Race,Hispanic,C2,T9,NH201,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),13.1,13.1,,,10.8,15.8,Race,Other,C2,T9,NH201,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),13.7,13.7,,,11.2,16.6,Race,Other,C2,T9,NH201,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),15.1,15.1,,,13.3,17.0,Overall,Overall,C2,T9,NH201,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.1,14.1,,,12.5,16.0,Overall,Overall,C2,T9,NH201,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),16.2,16.2,,,13.7,19.1,Gender,Male,C2,T9,NH201,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.7,15.7,,,13.3,18.6,Gender,Male,C2,T9,NH201,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),14.0,14.0,,,12.4,15.9,Gender,Female,C2,T9,NH201,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.5,12.5,,,11.0,14.1,Gender,Female,C2,T9,NH201,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Age,20-24,C2,T9,NH201,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),6.9,6.9,,,5.7,8.5,Age,25-44,C2,T9,NH201,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),17.7,17.7,,,14.7,21.2,Age,45-64,C2,T9,NH201,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),32.0,32.0,,,28.3,35.9,Age,65+,C2,T9,NH201,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),19.3,19.3,,,17.0,21.9,Age,35+,C2,T9,NH201,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),39.6,39.6,,,32.0,47.7,Age,75+,C2,T9,NH201,Crude,BOC03,AGE08,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),14.7,14.7,,,12.0,17.9,Race,Non-Hispanic White,C2,T9,NH201,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),12.7,12.7,,,10.3,15.4,Race,Non-Hispanic White,C2,T9,NH201,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),22.5,22.5,,,20.1,25.0,Race,Non-Hispanic Black,C2,T9,NH201,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),22.7,22.7,,,20.4,25.1,Race,Non-Hispanic Black,C2,T9,NH201,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),15.0,15.0,,,13.1,17.1,Race,Non-Hispanic Asian,C2,T9,NH201,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),15.6,15.6,,,13.8,17.6,Race,Non-Hispanic Asian,C2,T9,NH201,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),11.5,11.5,,,9.7,13.5,Race,Hispanic,C2,T9,NH201,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),14.1,14.1,,,12.2,16.2,Race,Hispanic,C2,T9,NH201,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Crude,Percent (%),14.7,14.7,,,12.0,17.9,Race,Other,C2,T9,NH201,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),16.5,16.5,,,13.6,19.7,Race,Other,C2,T9,NH201,AgeStdz,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),40.1,40.1,,,36.8,43.4,Overall,Overall,C2,T9,NH203,Crude,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),39.1,39.1,,,35.9,42.3,Overall,Overall,C2,T9,NH203,AgeStdz,BOC01,OVR01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),31.2,31.2,,,26.8,36.0,Gender,Male,C2,T9,NH203,AgeStdz,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),32.5,32.5,,,28.0,37.4,Gender,Male,C2,T9,NH203,Crude,BOC02,GEN01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),47.4,47.4,,,43.8,51.1,Gender,Female,C2,T9,NH203,Crude,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),47.5,47.5,,,44.5,50.6,Gender,Female,C2,T9,NH203,AgeStdz,BOC02,GEN02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),67.4,67.4,,,59.3,74.5,Age,20-24,C2,T9,NH203,Crude,BOC03,AGE02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),54.1,54.1,,,49.1,59.0,Age,25-44,C2,T9,NH203,Crude,BOC03,AGE04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),27.9,27.9,,,23.6,32.6,Age,45-64,C2,T9,NH203,Crude,BOC03,AGE05,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),8.2,8.2,,,6.2,10.9,Age,65+,C2,T9,NH203,Crude,BOC03,AGE06,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),30.3,30.3,,,26.5,34.4,Age,35+,C2,T9,NH203,Crude,BOC03,AGE07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),5.2,5.2,,,3.9,6.9,Age,75+,C2,T9,NH203,Crude,BOC03,AGE08,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),39.7,39.7,,,35.5,44.0,Race,Non-Hispanic White,C2,T9,NH203,Crude,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),40.4,40.4,,,36.1,44.8,Race,Non-Hispanic White,C2,T9,NH203,AgeStdz,BOC04,RAC01,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),30.4,30.4,,,27.7,33.3,Race,Non-Hispanic Black,C2,T9,NH203,AgeStdz,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),34.2,34.2,,,30.6,38.1,Race,Non-Hispanic Black,C2,T9,NH203,Crude,BOC04,RAC02,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH203,Crude,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH203,AgeStdz,BOC04,RAC03,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH203,Crude,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH203,AgeStdz,BOC04,RAC04,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),39.4,39.4,,,28.6,51.4,Race,Other,C2,T9,NH203,Crude,BOC04,RAC07,59,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),36.8,36.8,,,26.0,49.1,Race,Other,C2,T9,NH203,AgeStdz,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),40.9,40.9,,,38.4,43.4,Overall,Overall,C2,T9,NH203,AgeStdz,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),41.4,41.4,,,38.8,44.0,Overall,Overall,C2,T9,NH203,Crude,BOC01,OVR01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),34.9,34.9,,,30.9,39.2,Gender,Male,C2,T9,NH203,Crude,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),34.0,34.0,,,29.8,38.4,Gender,Male,C2,T9,NH203,AgeStdz,BOC02,GEN01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),48.2,48.2,,,45.6,50.8,Gender,Female,C2,T9,NH203,AgeStdz,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),47.6,47.6,,,43.9,51.2,Gender,Female,C2,T9,NH203,Crude,BOC02,GEN02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),66.1,66.1,,,60.4,71.3,Age,20-24,C2,T9,NH203,Crude,BOC03,AGE02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),56.7,56.7,,,53.3,60.0,Age,25-44,C2,T9,NH203,Crude,BOC03,AGE04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),29.4,29.4,,,25.7,33.5,Age,45-64,C2,T9,NH203,Crude,BOC03,AGE05,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),10.7,10.7,,,8.0,14.3,Age,65+,C2,T9,NH203,Crude,BOC03,AGE06,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),31.9,31.9,,,28.6,35.3,Age,35+,C2,T9,NH203,Crude,BOC03,AGE07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),8.2,8.2,,,5.8,11.5,Age,75+,C2,T9,NH203,Crude,BOC03,AGE08,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),40.8,40.8,,,37.9,43.8,Race,Non-Hispanic White,C2,T9,NH203,Crude,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),42.1,42.1,,,39.2,45.1,Race,Non-Hispanic White,C2,T9,NH203,AgeStdz,BOC04,RAC01,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),29.7,29.7,,,26.8,32.8,Race,Non-Hispanic Black,C2,T9,NH203,AgeStdz,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),32.6,32.6,,,29.3,36.1,Race,Non-Hispanic Black,C2,T9,NH203,Crude,BOC04,RAC02,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH203,Crude,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH203,AgeStdz,BOC04,RAC03,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH203,Crude,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH203,AgeStdz,BOC04,RAC04,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),31.9,31.9,,,23.4,41.8,Race,Other,C2,T9,NH203,Crude,BOC04,RAC07,59,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),28.8,28.8,,,20.7,38.5,Race,Other,C2,T9,NH203,AgeStdz,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),40.5,40.5,,,37.8,43.3,Overall,Overall,C2,T9,NH203,AgeStdz,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),40.1,40.1,,,37.2,43.0,Overall,Overall,C2,T9,NH203,Crude,BOC01,OVR01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),35.0,35.0,,,31.0,39.1,Gender,Male,C2,T9,NH203,Crude,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),34.4,34.4,,,30.6,38.5,Gender,Male,C2,T9,NH203,AgeStdz,BOC02,GEN01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),47.1,47.1,,,44.8,49.3,Gender,Female,C2,T9,NH203,AgeStdz,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),45.1,45.1,,,42.2,48.0,Gender,Female,C2,T9,NH203,Crude,BOC02,GEN02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),72.9,72.9,,,68.2,77.1,Age,20-24,C2,T9,NH203,Crude,BOC03,AGE02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),56.9,56.9,,,52.0,61.7,Age,25-44,C2,T9,NH203,Crude,BOC03,AGE04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),24.9,24.9,,,21.4,28.8,Age,45-64,C2,T9,NH203,Crude,BOC03,AGE05,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),11.8,11.8,,,9.2,15.0,Age,65+,C2,T9,NH203,Crude,BOC03,AGE06,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),29.4,29.4,,,26.2,32.8,Age,35+,C2,T9,NH203,Crude,BOC03,AGE07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),9.0,9.0,,,5.9,13.5,Age,75+,C2,T9,NH203,Crude,BOC03,AGE08,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),39.2,39.2,,,35.7,42.8,Race,Non-Hispanic White,C2,T9,NH203,Crude,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),41.5,41.5,,,38.3,44.9,Race,Non-Hispanic White,C2,T9,NH203,AgeStdz,BOC04,RAC01,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),31.9,31.9,,,27.8,36.3,Race,Non-Hispanic Black,C2,T9,NH203,AgeStdz,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),34.2,34.2,,,30.0,38.6,Race,Non-Hispanic Black,C2,T9,NH203,Crude,BOC04,RAC02,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH203,Crude,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH203,AgeStdz,BOC04,RAC03,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH203,AgeStdz,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH203,Crude,BOC04,RAC04,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),37.8,37.8,,,30.9,45.2,Race,Other,C2,T9,NH203,Crude,BOC04,RAC07,59,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),35.0,35.0,,,26.9,44.1,Race,Other,C2,T9,NH203,AgeStdz,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),41.8,41.8,,,39.0,44.6,Overall,Overall,C2,T9,NH203,AgeStdz,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),40.8,40.8,,,38.6,43.1,Overall,Overall,C2,T9,NH203,Crude,BOC01,OVR01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),35.3,35.3,,,33.0,37.8,Gender,Male,C2,T9,NH203,Crude,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),35.0,35.0,,,32.1,38.0,Gender,Male,C2,T9,NH203,AgeStdz,BOC02,GEN01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),49.2,49.2,,,45.8,52.5,Gender,Female,C2,T9,NH203,AgeStdz,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),46.2,46.2,,,43.3,49.2,Gender,Female,C2,T9,NH203,Crude,BOC02,GEN02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),67.4,67.4,,,58.9,74.9,Age,20-24,C2,T9,NH203,Crude,BOC03,AGE02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),56.7,56.7,,,52.2,61.0,Age,25-44,C2,T9,NH203,Crude,BOC03,AGE04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),30.3,30.3,,,26.8,34.0,Age,45-64,C2,T9,NH203,Crude,BOC03,AGE05,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),13.7,13.7,,,11.0,16.9,Age,65+,C2,T9,NH203,Crude,BOC03,AGE06,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),32.5,32.5,,,30.0,35.2,Age,35+,C2,T9,NH203,Crude,BOC03,AGE07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),10.2,10.2,,,8.7,11.9,Age,75+,C2,T9,NH203,Crude,BOC03,AGE08,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),39.1,39.1,,,36.3,41.9,Race,Non-Hispanic White,C2,T9,NH203,Crude,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),41.9,41.9,,,38.3,45.7,Race,Non-Hispanic White,C2,T9,NH203,AgeStdz,BOC04,RAC01,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),31.1,31.1,,,28.8,33.5,Race,Non-Hispanic Black,C2,T9,NH203,AgeStdz,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),32.6,32.6,,,30.4,34.9,Race,Non-Hispanic Black,C2,T9,NH203,Crude,BOC04,RAC02,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH203,Crude,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH203,AgeStdz,BOC04,RAC03,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH203,AgeStdz,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Hispanic,C2,T9,NH203,Crude,BOC04,RAC04,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),55.0,55.0,,,48.4,61.5,Race,Other,C2,T9,NH203,Crude,BOC04,RAC07,59,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),51.6,51.6,,,45.4,57.7,Race,Other,C2,T9,NH203,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),42.0,42.0,,,39.7,44.3,Overall,Overall,C2,T9,NH203,AgeStdz,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),41.0,41.0,,,38.2,43.8,Overall,Overall,C2,T9,NH203,Crude,BOC01,OVR01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),34.9,34.9,,,31.8,38.1,Gender,Male,C2,T9,NH203,Crude,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),34.9,34.9,,,32.1,37.8,Gender,Male,C2,T9,NH203,AgeStdz,BOC02,GEN01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),49.3,49.3,,,46.7,52.0,Gender,Female,C2,T9,NH203,AgeStdz,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),46.7,46.7,,,43.6,49.8,Gender,Female,C2,T9,NH203,Crude,BOC02,GEN02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),69.9,69.9,,,62.7,76.1,Age,20-24,C2,T9,NH203,Crude,BOC03,AGE02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),57.9,57.9,,,53.6,62.0,Age,25-44,C2,T9,NH203,Crude,BOC03,AGE04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),30.5,30.5,,,27.4,33.8,Age,45-64,C2,T9,NH203,Crude,BOC03,AGE05,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),11.3,11.3,,,9.1,14.0,Age,65+,C2,T9,NH203,Crude,BOC03,AGE06,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),31.6,31.6,,,29.1,34.2,Age,35+,C2,T9,NH203,Crude,BOC03,AGE07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),7.8,7.8,,,5.6,10.8,Age,75+,C2,T9,NH203,Crude,BOC03,AGE08,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),39.5,39.5,,,36.1,43.0,Race,Non-Hispanic White,C2,T9,NH203,Crude,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),42.5,42.5,,,39.4,45.7,Race,Non-Hispanic White,C2,T9,NH203,AgeStdz,BOC04,RAC01,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),34.5,34.5,,,31.0,38.2,Race,Non-Hispanic Black,C2,T9,NH203,AgeStdz,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),35.9,35.9,,,31.8,40.3,Race,Non-Hispanic Black,C2,T9,NH203,Crude,BOC04,RAC02,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH203,Crude,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH203,AgeStdz,BOC04,RAC03,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH203,Crude,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH203,AgeStdz,BOC04,RAC04,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),48.2,48.2,,,41.9,54.6,Race,Other,C2,T9,NH203,AgeStdz,BOC04,RAC07,59,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),50.6,50.6,,,42.2,58.9,Race,Other,C2,T9,NH203,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),42.8,42.8,,,40.0,45.7,Overall,Overall,C2,T9,NH203,Crude,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),44.2,44.2,,,41.8,46.6,Overall,Overall,C2,T9,NH203,AgeStdz,BOC01,OVR01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),36.8,36.8,,,33.8,39.9,Gender,Male,C2,T9,NH203,AgeStdz,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),36.5,36.5,,,33.3,39.9,Gender,Male,C2,T9,NH203,Crude,BOC02,GEN01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),48.8,48.8,,,45.9,51.8,Gender,Female,C2,T9,NH203,Crude,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),52.0,52.0,,,49.5,54.4,Gender,Female,C2,T9,NH203,AgeStdz,BOC02,GEN02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),74.4,74.4,,,69.0,79.1,Age,20-24,C2,T9,NH203,Crude,BOC03,AGE02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),59.6,59.6,,,56.7,62.4,Age,25-44,C2,T9,NH203,Crude,BOC03,AGE04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),32.4,32.4,,,27.9,37.3,Age,45-64,C2,T9,NH203,Crude,BOC03,AGE05,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),13.2,13.2,,,10.5,16.3,Age,65+,C2,T9,NH203,Crude,BOC03,AGE06,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),33.5,33.5,,,30.0,37.1,Age,35+,C2,T9,NH203,Crude,BOC03,AGE07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),9.4,9.4,,,7.3,11.9,Age,75+,C2,T9,NH203,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),42.2,42.2,,,39.0,45.4,Race,Non-Hispanic White,C2,T9,NH203,Crude,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),45.5,45.5,,,42.9,48.2,Race,Non-Hispanic White,C2,T9,NH203,AgeStdz,BOC04,RAC01,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),32.1,32.1,,,28.2,36.2,Race,Non-Hispanic Black,C2,T9,NH203,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),11.3,11.3,,,8.7,14.5,Age,75+,C2,T9,NH203,Crude,BOC03,AGE08,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),32.8,32.8,,,27.5,38.6,Race,Non-Hispanic Black,C2,T9,NH203,Crude,BOC04,RAC02,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH203,Crude,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-1.0,-,Data not available,,,Race,Non-Hispanic Asian,C2,T9,NH203,AgeStdz,BOC04,RAC03,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH203,Crude,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),,-2.0,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,Race,Hispanic,C2,T9,NH203,AgeStdz,BOC04,RAC04,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),48.0,48.0,,,41.1,54.9,Race,Other,C2,T9,NH203,Crude,BOC04,RAC07,59,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),43.8,43.8,,,38.0,49.8,Race,Other,C2,T9,NH203,AgeStdz,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),41.9,41.9,,,39.5,44.3,Overall,Overall,C2,T9,NH203,AgeStdz,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),39.9,39.9,,,36.9,43.1,Overall,Overall,C2,T9,NH203,Crude,BOC01,OVR01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),35.0,35.0,,,31.2,38.9,Gender,Male,C2,T9,NH203,Crude,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),35.6,35.6,,,32.8,38.6,Gender,Male,C2,T9,NH203,AgeStdz,BOC02,GEN01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),48.4,48.4,,,45.2,51.7,Gender,Female,C2,T9,NH203,AgeStdz,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),44.7,44.7,,,41.5,48.0,Gender,Female,C2,T9,NH203,Crude,BOC02,GEN02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),71.0,71.0,,,64.7,76.5,Age,20-24,C2,T9,NH203,Crude,BOC03,AGE02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),57.1,57.1,,,52.3,61.7,Age,25-44,C2,T9,NH203,Crude,BOC03,AGE04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),28.4,28.4,,,25.7,31.2,Age,45-64,C2,T9,NH203,Crude,BOC03,AGE05,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),13.9,13.9,,,10.8,17.6,Age,65+,C2,T9,NH203,Crude,BOC03,AGE06,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),30.0,30.0,,,27.5,32.7,Age,35+,C2,T9,NH203,Crude,BOC03,AGE07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),9.7,9.7,,,7.0,13.4,Age,75+,C2,T9,NH203,Crude,BOC03,AGE08,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),37.8,37.8,,,34.1,41.6,Race,Non-Hispanic White,C2,T9,NH203,Crude,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),41.8,41.8,,,38.7,45.0,Race,Non-Hispanic White,C2,T9,NH203,AgeStdz,BOC04,RAC01,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),31.6,31.6,,,27.1,36.5,Race,Non-Hispanic Black,C2,T9,NH203,AgeStdz,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),32.1,32.1,,,27.4,37.3,Race,Non-Hispanic Black,C2,T9,NH203,Crude,BOC04,RAC02,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),52.0,52.0,,,47.0,57.0,Race,Non-Hispanic Asian,C2,T9,NH203,Crude,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),49.6,49.6,,,46.5,52.7,Race,Non-Hispanic Asian,C2,T9,NH203,AgeStdz,BOC04,RAC03,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),47.5,47.5,,,43.7,51.4,Race,Hispanic,C2,T9,NH203,AgeStdz,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),52.8,52.8,,,47.6,58.0,Race,Hispanic,C2,T9,NH203,Crude,BOC04,RAC04,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),46.9,46.9,,,41.9,51.9,Race,Other,C2,T9,NH203,Crude,BOC04,RAC07,59,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),45.2,45.2,,,40.6,49.8,Race,Other,C2,T9,NH203,AgeStdz,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),45.2,45.2,,,43.4,46.9,Overall,Overall,C2,T9,NH203,AgeStdz,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),43.1,43.1,,,41.1,45.0,Overall,Overall,C2,T9,NH203,Crude,BOC01,OVR01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),37.4,37.4,,,34.9,40.0,Gender,Male,C2,T9,NH203,Crude,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),38.4,38.4,,,35.8,41.0,Gender,Male,C2,T9,NH203,AgeStdz,BOC02,GEN01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),52.1,52.1,,,50.1,54.2,Gender,Female,C2,T9,NH203,AgeStdz,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),48.4,48.4,,,45.8,51.1,Gender,Female,C2,T9,NH203,Crude,BOC02,GEN02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),70.8,70.8,,,66.9,74.4,Age,20-24,C2,T9,NH203,Crude,BOC03,AGE02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),62.5,62.5,,,59.3,65.7,Age,25-44,C2,T9,NH203,Crude,BOC03,AGE04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),32.6,32.6,,,29.1,36.3,Age,45-64,C2,T9,NH203,Crude,BOC03,AGE05,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),12.1,12.1,,,10.4,14.1,Age,65+,C2,T9,NH203,Crude,BOC03,AGE06,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),33.1,33.1,,,30.7,35.5,Age,35+,C2,T9,NH203,Crude,BOC03,AGE07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),42.1,42.1,,,39.4,44.9,Race,Non-Hispanic White,C2,T9,NH203,Crude,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.9,46.9,,,44.4,49.5,Race,Non-Hispanic White,C2,T9,NH203,AgeStdz,BOC04,RAC01,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),33.0,33.0,,,30.6,35.6,Race,Non-Hispanic Black,C2,T9,NH203,AgeStdz,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),33.2,33.2,,,30.4,36.2,Race,Non-Hispanic Black,C2,T9,NH203,Crude,BOC04,RAC02,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),52.1,52.1,,,47.7,56.6,Race,Non-Hispanic Asian,C2,T9,NH203,Crude,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),51.3,51.3,,,48.5,54.1,Race,Non-Hispanic Asian,C2,T9,NH203,AgeStdz,BOC04,RAC03,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),46.0,46.0,,,42.6,49.4,Race,Hispanic,C2,T9,NH203,AgeStdz,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),51.1,51.1,,,47.1,55.2,Race,Hispanic,C2,T9,NH203,Crude,BOC04,RAC04,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Crude,Percent (%),50.1,50.1,,,45.1,55.2,Race,Other,C2,T9,NH203,Crude,BOC04,RAC07,59,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure status among US adults (20+); NHANES,Age-Standardized,Percent (%),47.8,47.8,,,43.2,52.5,Race,Other,C2,T9,NH203,AgeStdz,BOC04,RAC07,59,
